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Abstract 
Phage display has attracted a great deal of interest in the identification of peptides specific 
to nanomaterials revealing distinctive binding behaviour. Though significant progress has 
been made in selecting and screening of biomolecule binding peptides, the accuracy of 
molecular recognition for inorganic materials is still challenging due to the limitations of 
phage display libraries and biopanning process. The study presented in this thesis is aimed 
at isolating mineral binding peptides by phage display and verifying them experimentally 
and/ or bioinformatically; exploring the role of electrostatic/ non-electrostatic interactions in 
the aqueous phase and the factors responsible for the adsorption or desorption of peptide or 
phage from the mineral surface. 
Firstly, silica binding peptides LPVRLDW, NDLMNRA, GQSEKHL and GASESYL have been 
identified using the phage display technique by varying experimental conditions including 
pH, detergent, washing and elution buffers to remove unique 7-mer peptide binding phages 
from amorphous hydrophilic silica nanoparticles via disruption of the molecular interactions 
between the phage attached peptides and the nanoparticles. A repanning method reported 
here, has experimentally reproduced the majority of the initially discovered silica binders; 
alongside identifying/ recovering additional peptide sequences HYIDFRW, KIAVIST and 
YSLKQYQ that may have been overlooked in the routine approach to biopanning. Secondly, 
an alternative three step elution method reported here, has eluted and recovered most target 
silica binders including ADIRHIK in the early panning rounds and removed the phage clones 
that are bound to silica by hydrophobic, hydrogen bonding and electrostatic attractions or 
repulsions; as opposed to one specific buffer being used for all panning rounds including 
elution steps in traditional biopanning experiments. Also, the phage clones that resist 
detection to single elution step have been eluted in the other successive elution steps, thereby 
recovering and improving the elution procedure for silica surfaces. In addition, these three 
different elution buffers have eluted phage clones that are interaction or charge specific 
subject to change in the elution buffer pH condition. The experimental results demonstrate 
that this sequential three step elution process was able to isolate tightly bound target silica 
binders in one or two biopanning rounds than the more typical four to five; thereby reducing 
biopanning rounds, cost and effort. Moreover, the bioinformatic analysis to cross check the 
authenticity/ quality of target binders has been reported.  
Furthermore, selected silica binding peptides isolated from phage display experiments were 
synthesized by a solid phase peptide synthesis approach and peptide-silica interactions 
explored in vitro, using quantitative and qualitative techniques. The fluorometric analysis of 
these peptides revealed that the peptide adsorption to silica surfaces would have more than 
one type of interactions (i.e. electrostatic/ hydrophobic/ H-bonding and Van der Waals) and 
could be influenced by the experimental conditions. More significantly, an increase in 
binding activity to negatively charged silica nanoparticles was noticed for the peptides 
(HYIDFRW, KIAVIST and YSLKQYQ) modified with an amide (NH2) group as opposed to 
a carboxyl group at the C-terminal end; driving an increase in overall charge or pI of the 
peptides. Insights from the studies presented may provide valuable information for designing 
and engineering of silica directed constructs for a range of biomedical and nanotechnological 
applications.    
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Chapter 1: Introduction 
 
Over the past two decades, the popularity of using combinatorial phage display techniques 
for selecting and recognising material-binding peptides with a unique attraction for any 
target, and specifically inorganic materials has achieved considerable interest in the 
development of advanced bio- or nano-materials. However, the accuracy of molecular 
recognition for inorganic materials is still challenging due to the limitations of phage display 
libraries and biopanning process. It is still unclear whether (i) we are eluting all of the strong 
binders from the available phage library, (ii) what the limits of detergent and elution 
conditions are, (iii)  the issue of binding to non-specific targets or fast growers1,2, (iv) under-
representation of the desired sequences and their properties due to having bias towards 
peptide position, composition, and expression3, (v) pH and interaction specific intrinsic bias4 
and (vi) are their differences between aliquot to aliquot behaviour of same library. 
Additionally, another important factor to consider is the limited fundamental understanding 
of peptide- inorganic material interactions which is a major bottle neck for generating 
peptide based inorganic nanomaterials with improved biocompatibility, solubility, 
functionality and increased physico-chemical properties4–12. This thesis presents the 
isolation and identification of silica binding peptides using the standard and optimised phage 
display approaches by exploring the elution strategies. Although, the optimised elution 
approach developed is specifically from silica, it could be applied to other inorganic material 
surfaces. Experimental and bioinformatics methods are used to check the reproducibility and 
authenticate the target binders. Further, selected peptides identified by phage display were 
chosen to study the effect of overall or individual charge, pH, C-terminal groups (acid or 
amine) of peptides and changes occurring at peptide-silica interface in vitro in solution.  
Chapter 1 introduces the literature review and discuss the status of combinatorial phage 
display techniques with inorganic materials, specifically silica, and their applications 
including patents relevant to this study. It also includes statements as to the importance, 
motivation, and objectives of this research project. 
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1.1 Overview of Combinatorial Phage Display Technologies 
In the last century, a combinatorial approach originally adapted by the microbiology 
community has attracted considerable interest and brought an innovative dimension in 
synthesising and engineering new advanced materials by mimicking the naturally occurring 
biomolecules that direct biomineralization process. Molecular recognition is the central 
phenomenon of all biological systems and recognises molecules with high specificity and 
diversity. Using this molecular recognition principle, several systems have been studied to 
examine the binding events happening at the molecular level. Some of the well-studied 
systems include antigen-antibody, peptide-protein, protein-DNA, and more recently 
biomolecule-inorganic surfaces13,14.  
Various techniques have been established for acquiring peptide sequences with specific 
affinity to inorganic material. The theoretical molecular approach is one of these techniques 
used to design inorganic-binding peptides. This approach is similar to that used in the 
pharmaceutical industry for target drugs15. However, this technique is currently both time 
consuming and expensive, thus making it not a suitable option. The other technique is to 
extract biomineralizing proteins; this is done by isolation, purification, and cloning of protein 
from hard tissue16–18. Proteins extracted via this method have previously been used as 
nucleators, growth modifiers, or for enzymes in the synthesis of specific inorganics. The key 
limitation of this technique is the complexity of extracting the required proteins, given that 
hard tissue contains several types of proteins that are differentially active in 
biomineralization and spatially distributed19,20. Proteins that are tissue-extracted are limited 
to be used in the regeneration of inorganics of their original association. Thus, an alternative 
route to the techniques mentioned would be combinatorial display techniques21–24.  
Currently existing combinatorial display technologies include phage display25–30, cell 
surface display31–34, ribosome and mRNA display35–41 and rational design42–44 technologies. 
Ever since the establishment of in vitro combinational biology protocols, such as phage 
display (PD)25,45 and cell-surface display (CSD)46, they have been used for the identification 
of biological ligands and for the mapping of epitopes of antibodies. Libraries have also been 
screened for different biological activities: catalyst properties, altered affinity and specificity 
to target molecules. This has applications in the designing of drugs, enzymes, antibodies, 
DNA-binding, proteins and diagnostic agents47–49. Combinatorial display technology has 
advantages as it does not require the prior knowledge of the required amino acid sequence; 
sequences can randomly be selected and enriched. In comparison to an in vivo system50, 
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which has a developed library size of 107-10, in vitro methods have a much larger developed 
library size of 1015. 
Cell surface display and phage display are approaches which are based on their link between 
the genotype and phenotype of different organisms. On one hand, phage display utilises 
bacteriophages as a vector, whereas cell surface display uses bacteria or yeast51. Through the 
genetic engineering of bacteriophage genomes or bacterial plasmids, randomised segments 
of a gene can be produced to gain a library52. This random library sequence is then expressed 
on the surface of a phage coat protein or a bacterial flagella protein. In the case of other in 
vitro selection techniques, such as Ribosome display and mRNA display, both commence 
with the transcription of the DNA library to generate the mRNA and do not require a 
transformation or cell growth step. Both methods are considered to be promising display 
technologies for antibodies as they consist of larger libraries (1015), cell-free system with 
fewer expression bias53. The key difference between these two approaches is that mRNA 
display involves DNA spacer linkers with puromycin which is responsible for forming 
covalent bonds between RNA and polypeptide54. The ribosome within Ribosome display 
contains a random peptide fold with is produced by fusing the DNA library to a C-terminal 
region absent of a stop codon. The absence of the stop codon helps in creating a protein-
ribosome-mRNA complex. The mRNA dissociates as the complex binds with the 
immobilized target, thus allowing the determination of the peptide sequence through reverse 
transcription53. 
 
 Phage display and biopanning process  
Phage display/Biopanning is an affinity selection technique commonly used for identifying 
novel peptides bound to a specific target through a repetitive process. This includes binding 
of phage displayed peptides to target material, removal of weakly bound phages through 
detergent washing; removal of strongly bound phages through elution and multiplying the 
eluted phage in a host bacterium E. coli ER2738 strain. Phage display library is created by 
fusing DNA fragments into the genome of the phage or phagemid and displaying the random 
peptides on the surface of the phage coat proteins4.  
G.P Smith, for the first time used the phage display technology as a powerful tool to identify 
ligands for numerous targets in 198525. The phage display approach was originally employed 
to recognise and particularly to study protein-protein, peptide-protein or antigen-antibody 
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interactions1,4,10,25,47,55. In the recent years, the phage display technique has extended its 
applications to engineering antibodies, targeting organs, studying networks and sites of 
protein-peptide interactions, studying their use in vaccines, therapeutics, diagnostics and 
drug discovery28,56–63. More recently, phage or cell surface displayed libraries have become 
ubiquitous in selecting and screening peptides having strong affinity towards a range of 
inorganic material surfaces64. Due to these advances, it is now possible to produce novel 
materials using biological linkers on more than one type of material to create hybrids with 
unique mechanical, electronic, photonic or magnetic properties24,65.  
The techniques applied in combinational biology protocols are often also used in the field of 
molecular biomimetics, for the selection of peptide sequences with specific physical 
properties, that selectively bind to surfaces of inorganic compound in nano- and 
biotechnology22,24. The libraries are constructed by incorporating randomised 
oligonucleotides with a specific gene encoded on phage genomes on bacterial plasmids21,22 
(see step 1 of Figure 1.1). This then leads to the combining of a random peptide sequence 
with a protein existing on the surface of the organism (as shown in step 2). This leads to each 
phage or cell displaying a dissimilar and random peptide sequence (step 3). This step is 
followed with the heterogenous mixture of cells or phages encountering the inorganic 
substrate (step 4). Any unbound or weakly bound phages, or cells are eliminated with several 
washing cycles, whereas the bound phage or cell are separately eluted from the surface (step 
5 to 6). With phage display protocol, the strong binding eluted phage are intensified by 
infecting the host again (step 7), and as for cell surface display, the cell is permitted to grow 
(step 7 to 8). This step represents one complete round of biopanning. It is common practice 
to repeat at least three to five complete biopanning cycles to ensure enrichment of binders. 
The final step (step 9) involves sequencing the individual clones to attain the amino acid 
sequence of the peptide binders to the target substrate material66. 
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Figure 1.1. Typical phage/ cell surface display and biopanning process used for 
selecting polypeptide sequences that have binding affinity to given inorganic 
substrates. Image reprinted66. 
 
An important advantage of phage display compared to other commercial technologies is the 
possibility of screening many clones. When compared to other standard screening methods 
of cDNA libraries, they are restricted to the number of plaques or colonies that can be 
screened by hybridization (~104)67. Peptides from libraries which are synthetically 
manufactured are generally screened on grids or pins, with the binding peptides being 
identified by sequencing a tag associated to the selected bead in suspension. The 
disadvantage of the technology is the limiting number of random peptide sequences which 
can be screened, which is between 103-104. Synthetic peptides that are screened for libraries 
in solution may have up to 1015 different sequences, but the requirement of low stringency 
during binding results in a selection of peptides with highly differing affinities. Phage 
display allows for the easy screening of more than 109 different sequences, and the 
amplification of the selected phage by propagating them in E. coli over multiple round of 
screening to ensure the selection of the most strongly binding peptide sequences. 
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Other advantages of using a phage display technique for selecting binding peptides includes 
1) Large number of amino acid sequences can be screened easily. 2) Allows for a direct 
connection between the peptide and DNA sequence. This creates a physical link between the 
protein that is displayed and the DNA encoding, allowing for a vast number of proteins to 
be screened by an in vitro selection procedure known as "biopanning". 3) Phage displayed 
peptides or proteins can easily be exposed to solvents; hence the peptide/protein can hold its 
functions and affinities during the phage display process. 4) If the target is a biomolecule, 
the molecular recognition is highly specific and the results are mostly reproducible and 
reliable unlike inorganic material targets where molecular recognition is not highly specific 
and results appear to be dependent on a variety of physical (e.g. morphology, size, crystal 
phase, orientation) and chemical (hydrogen bonding, polarity and charge effects) 
properties25,68.  
 
 M13 Phage structure and life cycle 
The filamentous bacteriophage are a group of viruses that belong to a genus known as 
Inovirus. The virus contains a circular DNA genome which is encased in a long protein 
capsid cylinder and the genome may consist of ssDNA, dsDNA, ssRNA or dsRNA69,70. The 
bacteriophage is known to mainly infect Gram-negative bacteria by binding to the pili and 
infecting the bacteria, while not killing the host bacteria71–73. The filamentous phage is 
separated into three classes which are closely related, both genetically and phenotypically: 
M13, fl and fd. M13 phage is one of the most commonly studied filamentous phage for phage 
display technology as their small genome makes them easy to manipulate. Assembly of a 
longer phage particles is possible by inserting DNA into non-essential parts of the phage. 
These phages have the possibility to be produced in higher amounts and are stable in hard 
environments74,75. In general, filamentous phage are not lytic and so strains of phage-infected 
E. coli can release new phage particles without bacterial lysis. Other types of virus-like 
systems used in phage display are the phagemid, which are plasmids containing an f1 origin 
of replication from a phage to enable their single-stranded replication and packaging into 
phage particles, as well as an origin of replication (ori) for double-stranded replication. 
Phagemids can be considered as cloning vectors but need helper phage for completing their 
infection process by providing the structural and functional proteins necessary for packaging 
phagemid into virion particles. The biofilm life cycle and virulence of Pseudomonas 
aeruginosa are dependent on a filamentous prophage76. 
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The M13 phage has roughly a diameter of 10 nm and a length of ~1 µm, consisting of a 
single-stranded DNA genome of 6407 nucleotides. The genome is made up of 11 genes (as 
shown in Figure 1.2) which are grouped according to their individual function (Table 1.1): 
(i) Different types of capsid coat proteins present in the M13 bacteriophage includes, pIII, 
pVI, pVII, pVIII and pIX, (ii) All DNA replication proteins consist of pII, pV and pX, and 
(iii) the assembly proteins pI, pIV and pXI. pIII functions in cell recognition, stability and 
infection73,77–82. The phage is surrounded by a coat protein which is composed of two fusion 
proteins: one is pIII (minor coat protein), and the second is pVIII (major coat protein). pVIII 
contain ~2,700 proteins and covers the length of the particle, while at one end are pIII and 
pVI and at the other end are pVII and pIX, each containing roughly five proteins. The phage 
pIII has two main domains know as N-terminal (N1 and N2) and C-terminal domain. The 
N1 domain is responsible for the translocation of the viral DNA into E. coli. The domain N2 
is responsible for increasing the recognition of the host cell by binding to the F pilus on the 
bacterium, while the C-terminal domain integrates the pIII into phage coat76,82,83. 
 
Figure 1.2: Diagrammatic representation of M13 bacteriophage genome and the 
location of genes. Image adapted from ref 84. 
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The infection process starts when the code protein III N-terminus attaches to the tip of F-
pilus on the bacterium. This binding leads to the injection of ss-DNA (+) strand of the phage 
into the bacterial cell. This is followed by the creation of a double stranded (or known as a 
replicative) form of phage, which forms when the host polymerase uses the (+) strand as a 
template to generate a complementary (-) strand. The (-) strand of RF DNA are responsible 
for generating the mRNA, which are used in the synthesis of phage proteins. To produce 
new phage, the genome needs to replicate by using newly generated pII to cut the RF DNA 
to begin the replication of the (+) strand, which results in a collection of RF DNA molecules 
to be produced by the host enzyme78–82. pII is also responsible for forming the ss-DNA by 
ligating the molecular ends of the newly synthesised (+) strand. The newly formed ss-DNA 
binds to the pV dimer to avoid the conversion back to RF DNA. The ratio of RF to (+) strand 
DNA synthesis is dependent on the amount of pV present. The pX is mostly involved in 
replication but is also believed to participate in the inhibition of pII function and regulate 
RF/ (+) strand synthesis. pI, pXI and pIV are all involved in assembly, which occurs in the 
inner membrane. The C-termini of pI and pXI interacts with pIV to create a channel to aid 
the secretion of phage. The pVII and pIX also required as it interacts with the pV-ss-DNA 
complex for the secretion step. During the extrusion step, the pV which is bound to ss-DNA 
is substituted with pVIII followed with the addition of pVI and pII near the central end of 
the releasing particle. During this first-generation post infection, which is then followed by 
bacterial cells, roughly 100-200 phages are produced per generation73,77–82.   
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Figure 1.3: Schematic representation of the structure of filamentous phage (wild 
versus engineered) and their coat proteins (right). Image adapted84. 
 
Table 1.1: Types of genes and their functions in filamentous bacteriophage76. 
Genes Function  
Number of amino 
acids 
Molecular weight 
(Da/mol) 
pI Assembly 348 39,502 
pII DNA replication 410 46,137 
pIII Minor capsid protein 406 45,522 
pIV Assembly 405 43,476 
pV Binding ssDNA 87 9682 
pVI Coat protein (minor) 112 12,342 
pVII Coat protein (minor) 33 3599 
pVIII Coat protein (major) 50 5235 
pIX Coat protein (minor) 32 3650 
pX DNA Replication 111 12,672 
pXI Assembly 108 12,424 
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The principal difference between the wild type and genetically engineered phage is that the 
addition of an oligo inserts at gene III and protein at pIII as shown in Figure 1.3. In the phage 
display process, the phage particle utilizes the copies of coat protein. The selection of coat 
proteins in the phage library depends on the type of display being looked for. For example, 
pIII phage capsid protein allows for monovalent display (binds to one target) making the 
selection of high affinity bodies. However, the polyvalent is also an option. While pVIII 
allows for polyvalent display (binds to many targets) displaying multiple copies allowing 
avid binding making the selction lower affinity. As shown in Table 1.2, filamentous phage 
display system is mostly constructed on the fusion of N-terminal to the coat protein. There 
are 5 copies of pIII present per virion which all can be fused to short peptides without 
interfering with phage infectivity.  The main pVIII copies are present ~2700 per virion, with 
~10% reliably being fused to peptide or protein. Thus, peptides expressed as pIII fusions 
exist at low valency (1-5 copies per virion) compared to pVIII fusions which are present at 
high valency (~200 copies per virion). The low valency of pIII display limits selection to 
higher affinity ligands, whereas the increased avidity and high valency of pVIII display 
allows selection of very low affinity ligands73,77,78,80–82. 
 
Table 1.2. M13 phage coat proteins, composition and their display fusions. 
Protein Number 
of amino 
acids 
Molecular weight 
(Da) 
Copies per phage Type of display 
pIII 406 45,522 5 N or C 
pVI 112 12,342 5 C 
pVII 33 3599 5 N 
pVIII 50 5235 2700 N or C 
pIX 32 3650 5 N 
 
All the Ph.D. libraries are pIII fusions (5 copies of the peptide per virion). Monovalent 
display on pIII has been enabled through the development of so-called phagemid systems, 
which have become the most commonly used type of phage display system73,77,79,82. 
Normally, the foreign sequence gets fused with the amino terminus of pIII (5 copies) or 
pVIII (2700 copies) coat proteins85,86. Coat protein III contains three domains D1, D2 and 
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D3. These domains are connected by glycine rich linkers. The D1 domain consists of 6 β 
strands and 1 N-terminal α helix87,88. In phage display technology, the peptides are displayed 
on the N-terminal α helix on domain D1 by fusion as shown below73,76,78,80–82.  
Displayed peptide       Tag              α helix        
XXXXXXXXXXXXGGGSAETVSCLAKSHTENS……………. 
Vectors are used in phage display and are classified according to three parameters: 1) Type 
of coat protein used for display (pIII or pVIII). 2) Whether the displayed peptide or protein 
has fused to all clones of pIII or pVIII or just a portion of them. 3) Whether the insert is 
encoded by phage genome or other genomes (e.g. phagemid)47. The classification of vectors 
commonly used for phage display are shown in Table 1.376. As an example, type 3 vector 
insert is encoded by pIII gene, which leads to the display of foreign protein or peptide in all 
pIII copied. As for type 33, the phage genome allows two types of pII molecule; first is a 
recombinant while the other is wild type. This outcome only allows some of the expressed 
pIII protein to be fused with the foreign protein or peptide. One must be aware that type 33 
is different from type 3+3, in that two copies of the pIII gene do exist in both but are on 
different systems: one is a wild type which is on a helper phage, while the recombinant form 
is found on the phagemid genome. Like the relation between 33 and 3+3, type 88 and 8+8 
are the same respectively, except with pVIII being using for display76,82,83,85.  
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Table 1.3. Classification of vectors and display fusions most commonly employed 
in phage display76.  
Type of 
display 
Displayed 
coat protein 
Display on all 
or few copies 
of coat 
proteins 
Number of 
coat protein 
genes involved 
in fusion 
Fusion type 
(phage or 
phagemid 
genome) 
Example 
Vectors 
3 pIII All 1 Phage M13KE 
8 pVIII All 1 
Phage M13KE 
33 pIII Few 2 Phage M13KE 
88 pVIII Few 2 Phage F88-4 
3+3 pIII Few 2 Phagemid pComb 3 
8+8 pVIII Few 2 
Phagemid pComb 3 
 
Compared to other phage used in phage display technology, M13 and filamentous 
bacteriophages fd and f1 are more useful due to their non-lytic nature89. This allows for the 
simplification of the intermediate phage purification steps during the panning rounds70.  
Other phage that use in phage display research preciously (T4, T7 and lambda) are all lytic, 
thus requires more slow purification steps between panning round to avoid amplifying phage 
in presence on cellular protein or protease which may degrade the target during panning 
rounds72,82. 
 
 Phage display libraries 
The most frequently used and commercially available phage display libraries are the 
filamentous phage M13 such as Ph.D. 7, Ph. 12, Ph.D. C7C (New England Biolabs) and 
spherical T7 phage (T7 select, Merck)55. Among the Ph.D libraries available in the market 
(Table 1.4), Ph.D. 7 is the best characterised and most reliable. Though Ph.D. 12 library is 
not sufficient enough to cover the entire sequence space but the library was the one mostly 
used in the recent literature11,90. Ph.D. C7C library is not a particular choice for phage display 
experiments due to conformational constraint. 
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Table 1.4: Types of M13 phage peptide libraries and their advantages. 
Ph.D. library 
type 
Number of 
clones 
Likely sequences Comments 
Ph.D. 7 2.8 x 109 207 = 1.28 x 109 Best characterized 
Ph.D. 12 1.9 x 109 2012 = 4.1 x 1015 Insufficient to cover the whole 
sequence space  
Ph.D. C7C 3.7 x 109 207 = 1.28 x 109 Conformational constraint 
 
PhD.-7 library contains randomised 7-mer peptides, which is fused to a coated protein pIII 
of M13 via flexible linker, Gly-Gly-Gly-Ser. The PhD.-7 library consists of 2.8 x 109 
independent clones. This library is useful for targets requiring binding elements concentrated 
in a short stretch of amino acids. This is the best characterised library so far57. The PhD.-12 
library contains randomised 12-mer peptides. Like PhD.-7 library, PhD.-12 are also fused to 
pIII via Gly-Gly-Gly-Ser. PhD.-12 library contain 1.9 x 109 independent clones, or only a 
small fraction of the 2012= 4.1 x 1015 possible sequences. This library is useful for targets 
requiring 7 or fewer defined residues for binding, but this which is not contained within the 
7-residues of the PhD.7 library. For example, the motif ADTXXAPXY has only six defined 
positions, but cannot be present in the PhD.-7 library. In addition, 12-mer is long enough to 
fold into short structural elements, which may be useful when panning against targets 
requiring structured ligands. The limitation of this library is that the increased length of 
randomised segment may allow for the selection of sequences with multiple weak binding 
interactions, instead of a few strong interactions.  
In contrast to the above two mentioned libraries, PhD.C7C library consists of randomised 7-
mer peptides; each of these peptides are flanked by a pair of cysteine residues. Cysteine 
residues can spontaneously form disulphide bonds, in absence of a reducing agent. Similar 
to the other two libraries, this library is fused to pIII via the Gly-Gly-Gly-Ser spacer and 
contains 3.7 x 109 independent clones. This library is useful for targets whose native ligands 
are in a surface loop (e.g. antibodies with structural epitopes). A major disadvantage of the 
PhD.C7C library is that the disulfide constraint may “freeze out” a conformation required 
for target binding. This results in outcomes that are impossible to predict in advance so one 
cannot predict which library is suitable for a given target. Thus, it is the recommendation of 
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research labs (e.g. New England Biolabs) for PhD.7 library to be tried first regardless of 
target. An alternative to this would be for all the libraries to be tried simultaneously, due to 
the ease of carrying out panning experiments in parallel using multiwall plates. 
Phage display and cell surface display are both in vivo techniques which rely of the genetic 
modification of the vector to produce a library. The process by which phages or cells uptake 
DNA is at a disadvantage as the resulting library only contains up to 1013 varieties46,49. An 
additional disadvantage of phage display and cell surface display are that it is more sensitive 
to biases. For example, during the amplification step the phages are required to infect the 
host bacteria, however this introduces the possibility of poor infectivity or loss of clones, 
regardless of them being strong target binders. Additionally, some phages are inclined to 
produce a larger progeny compared to other phages, leading to certain clones to repeatedly 
be identified. Despite these disadvantages to in vivo display technology, the technique is 
relatively simple and does not require high level of expertise compared to ribosome display 
and mRNA display. For these reasons, phage display and cell surface display have 
commercialized kits are most commonly used in display technologies91. For the purpose of 
screening inorganic materials, the structure of the of the target material must be taken into 
consideration to select a suitable display technique. As an example, during biopanning on 
materials which are in powder form, a prior centrifugation step will be required to separate 
the eluted phage from the powder. With this particular example, phage display would be a 
more suitable technique as flagella might be sheared off from the cell by centrifugal 
force92,93. 
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1.2 Overview of Silica (SiO2) 
In nature, silica also known as silicon dioxide (SiO2) is the most commonly available and 
abundant mineral present in the earth’s crust94. Naturally, it exits mainly in amorphous or in 
crystalline states that include quartz, cristobalite and tridymite forms94. The crystalline silica, 
also known as α-quartz is the major and primary constituent present in sand, soil and even 
rocks. While, the amorphous silica is commonly precipitated or deposited in bacteria, 
diatoms, sponges, plants and animals95. The process by which silica forms in living 
organisms with the help of biomolecules involving complex polymerisation reactions is 
termed as biosilicification. These organic molecules such as proteins, polyamines and 
proteoglycans are reported to be the key biomolecules that are responsible for controlling 
the structure of silica during the biomineralization process10,96–98. To date, silica has been 
one of the most widely studied and used minerals with applications ranging from biocatalysis 
through to nanotechnology and biomedical fields due to its low toxicity and biocompatible 
properties99,100.  
 Silica synthesis and chemistry  
Naturally, silica synthesis occurs through a process of biosilicification96 with the help of 
biomolecules that are present within the organisms. A lot of studies have been reported 
showing the formation of silica in vivo with the help of proteins including silicatein in 
sponges101,102 and silaffins in diatoms96,97,103–106. Inspired by nature’s way of synthesising 
biosilica, research groups have started understanding the role of biomimetic peptides in 
synthesising silica particles in the laboratory or in vitro under controlled conditions4,10,59,107. 
Silica is mainly synthesised from orthosilicic acid, Si(OH)4 under the influence of aqueous 
solution by sol-gel process. The sol-gel process refers to the solid dispersion of nanoparticles 
in liquid (sol) which later agglomerate to form a continuous three-dimensional network 
throughout the liquid (gel). The method involves initial hydrolysis of silicon alkoxide (e.g. 
tetraethoxysilane, TEOS or tetramethoxysilane, TMOS) to from an orthosilicic acid, 
Si(OH)4. This is then followed by subsequent condensation as shown in the following 
equation, specifically for the formation of TEOS which contain silanol groups108:  
1. Hydrolysis;                     Si(OC2H5)4 + H2O → Si(OC2H5)3OH + C2H5OH 
2. Water condensation;      ≡Si-O-H + H-O-Si≡ → ≡ Si-O-Si≡  + H2O  
3. Alcohol Condensation;  ≡Si-OC2H5 + H-O-Si≡ → Si-O-Si + C2H5OH 
 Chapter 1 : Introduction 
 
 
40 
Polymerisation between adjacent silanol groups or ethoxyl groups leads to siloxane bridges 
Si-O-Si, thus forming the silica structure (example shown in Figure 1.4)94,108. The size of the 
silica particle is largely dependent  on the rate of nucleation of hydrolysis and the rate of 
growth of condensation process109. The addition of acid (i.e. HCl) or base (i.e. NH3) is known 
to increase the rate of hydrolysis, either due to the increase of hydronium or hydroxide group 
in the system. The synthesis of silica particles in basic conditions with a size ranging 10 nm 
to 2 µm, is shown to be possible by changing the concentration of the reactants110. Studies 
carried out on the growth of silica microparticles in low pH (i.e. acetic acid111, tartaric acid112 
or nitric acid113) have in general shown low porosity and thus are more dense particles 
compared to silica synthesised in alkali condition. However a more recent method for 
making silica nanoparticles is through microwave-assisted acid catalysis using HCl114.  
 
 
Figure 1.4. Schematic representation of silica formation pathways from Si(OH)4 
or orthosilicic acid through to dimers, oligomers, particles and sols. Also, 
biomolecules are shown to act at any stage of the silica formation. Image adapted94.   
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At concentrations higher than the solubility of amorphous silica (~100 ppm), orthosilicic 
acid undergoes autopolymerisation between two orthosilicic acid molecules, forming a 
cyclic species with optimum number of Si-O-Si bonds. These cyclic structures later form the 
three-dimensional structure which makes the particle. This form of the oligomers aids the 
nucleation for stable particles to aggregate and forms a network or gel (Figure 1.4)115. 
Particles can continue to grow in circumneutral pH until the amount of soluble silica reaches 
the solubility of amorphous silica particle. In the presence of salt of other charged species, 
the repulsion between individual silica particle is reduced (or cancels out), leading to particle 
aggregation, forming a three-dimensional network. As the amount of orthosilicic acid 
decreases, smaller and more soluble particles of silica (< 5 nm) dissolve releasing silicic acid 
which gets deposited on bigger spheres by the process of ‘Ostwald ripening’94,116. The 
process via which silica is synthesised in aqueous systems is dependent on the pH, the 
presence of salts, temperature and pressure in the system. In a natural environment silica 
formation occurs in the presence of various ions, and biomolecules, polyamines and proteins 
associating with silica from sponges which all will affect the condensation process for of 
silica94. 
The structure of silica consists of a combination of oxygen and silicon forming silicates. The 
properties of a silica particle, regardless of its size, is largely dependent the chemistry of the 
silica surface. Silica is known to be sensitive to undergo hydrolysis is the presence of water. 
The process of hydrolysis converts siloxane bonds (Si-O-Si) of silica to silanol groups (Si-
OH). The general mechanism via which silica gets hydrolysed with water is:  
≡Si-OR + H2O → ≡Si-OH +OH  
Literature studies have shown that organic molecules with polar bonds and water molecules 
are adsorbed onto silica surface via hydrogen bonding at silanol sites. These sites have the 
ability to both donate and accept a proton, resulting in a negative or positive charge 
respectively. These silanol groups can give silica either hydrophilic (silanol) or hydrophobic 
(siloxane) character by either accepting proton or by donating proton under the influence of 
aqueous solution. The pH plays an important role in deciding the type of groups present on 
the surface of silica117. For example, with increase in pH the silanols groups undergoes 
deprotonation giving more negative charge to the silanol groups117. The isoelectric point of 
pH was determined to be present at pH-2-3. Different forms of silanol groups found on the 
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silica surface include internal (Si-OH), isolated (≡SiOH), geminal (=Si(OH)2) and vicinal or 
bridged forms which can be seen in the Figure 1.5118. 
 
 
Figure 1.5. Silica surface consisting of different types of silanol groups and their 
chemistry. Image reprinted119. 
 
Also, depending on the type of chemical solutions used during the Stöber silica process, the 
surface functionalisation of silica can be changed to either hydrophilic or hydrophobic 
surface. The hydrophobic silica surface consisting of methyl or phenyl groups can be 
achieved by using MTES (methyltriethoxysilane) and PTES (phenyltriethoxysilane). In the 
same way, by using TEOS (tetraethyl orthosilicate) and APTES ((3-Aminopropyl) 
triethoxysilane) the silica surface can be functionalised with pristine (amine) and amino 
propyl groups respectively. Therefore, these functionalised silica surfaces have been used to 
study the formation of cancer by monitoring the cell aggregation or disaggregation120–122. An 
example of this is the production of silica upon tissue culture polystyrene (TCP) and its 
application for further functionalization using fluorinated alkoxysilane. This has been shown 
to produce a material derived from cell culture media, which has differential adoption profile 
of serum, thence allowing for the better control of in vitro cancer cell aggregation-
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disaggregation events122. Studies have also shown that with the right silica surface chemistry 
(i.e. hydrophilic or superhydrophobic film) may aid the adhesion and proliferation of cell120. 
 
 Silica biomolecule interactions and their applications 
The growing applications of silica with chemically attached peptides or biomolecules in 
nanomedicine has driven researchers to focus on increasing their understanding of how 
peptides or biomolecules bind to silica, the type of interactions and the mechanisms 
involved4,10,122,123. In Figure 1.6 are shown a range of proposed interaction mechanisms 
involved at the silica-biomolecule interface. For example, Zhou et al., (1999)  proposed a 
mechanism by which silicatein-α (70% of the silicatein filament obtained from sponges) 
catalyses the hydrolysis of alkoxysilanes at neutral pH via an acid/base reaction through the 
activity of the serine and histidine side chains, specifically, between the hydroxyl group of 
serine-26 and the imidazole side group of histidine-165 (Figure 1.6, A)123. Because of high 
structural homology of silicatein-α to the hydrolytic enzyme, cathepsin L; this reaction was 
based on the mechanism of peptide bond hydrolysis by the analogous well known protease 
Cathepsin-L123. Nicklin and co-workers studied the absorption of serum proteins to specific 
surfaces122. In this study, it was demonstrated that fluorinated silica surfaces (FS) provide 
the necessary environment to selectively adsorb serum proteins from the medium, which, 
were able to disrupt cellular adhesion and promote cellular aggregation (Figure 1.6, B). 
Moreover, the capacity of the FS surface to support cellular adherence was seen to increase 
with culture time. The properties of the functionalised surface facilitate the study of cancer 
cell aggregation and disaggregation as a single dynamic process in vitro, as the cells 
biological response towards the material changes in tandem with the surface properties.  
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Figure 1.6. Proposed interaction mechanisms involved at the silica-biomolecule 
interface A) Mechanism proposed for alkoxysilane catalytic hydrolysis by silicatein active sites 
(serine and histidine) reprinted with permission123. B) competitive protein exchange occurring 
upon the fluoro-silica during cell culture in serum supplemented medium reprinted with 
permission122. C) type of interactions occurring at the silica-peptide interface of phage displayed 
peptides reprinted with permission4,10.  
 
In an alternative approach, phage displayed peptides of different charge at neutral pH have 
also been studied at the aqueous silica interface (Figure 1.6, C)4,10. These peptides: 
KLPGWSG (positively charged), AFILPTG (neutral) and LDHSLHS (negatively charged); 
showed the role of electrostatic/hydrophobic interactions and hydrogen bonding at the 
aqueous silica interface. The study was also able to show that at low concentrations of 
peptide, peptide self-assembly is more likely favoured than silica-peptide interactions, thus, 
aggregates stay in solution until a certain concentration is reached4,10. Our research group 
have shown and given examples concerning silica-biomolecule adsorption mechanisms. A 
few examples include, study of the particular properties of the material itself (e.g. silica4,10,124 
and ZnO125–127), we have shown that the size of particles4,10,44 and charge/ functionality on 
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particles4,107 have clear effects on the binding of small peptides to minerals; and  the route 
by which a material is formed125–127 by moderating peptide mineral interaction. 
As yet, many other studies regarding silica-biomolecule adsorption mechanisms have been 
reported, and have been summarized in highly recommended reviews such as peptide 
binding mechanisms on nanoparticle surfaces9, molecular biomimetics using genetically 
engineered peptides60, proteins and peptides-directed inorganic material synthesis5, amino 
acid adsorption on mineral surface128, computational modelling of silica-biomolecule 
interactions129,  simulations studies and recognition mechanisms of biomolecules130 and 
fundamental theoretical and experimental approaches to understand biomolecule-
biomaterial interactions131. 
 
Figure 1.7: Schematic representation of Silica-biomolecule interactions and their 
applications. Figure adapted from132.  
 
Continued research efforts by researchers has led to silica being a key material in the design 
of novel bio-nanostructures, further broadening its application from nanotechnology to 
biomedical and further industrial fields as shown schematically in Figure 1.7. Further, a 
review published by Thota and Perry12 showed the recent advancements of solid material 
binding peptides including their applications and patents that have been reported. 
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Four examples specific to the applications of silica-biomolecule attachment are shown in 
Figures 1.8 and 1.9. The therapeutic use of mesoporous SiNPs as a potential drug delivering 
agent involving a variety of pharmaceutical drugs including ibuprofen, doxorubicin, 
docetaxel, therapeutic genes (plasmid DNA, antisense oligonucleotides, and siRNA), and 
therapeutic protein cytochrome C (Figure 1.8, A)133. A controlled silica biomineralization 
process involves selective exposure of lysine amino groups on genetically engineered 
tobacco mosaic virus templates, chemically conjugating the synthetic peptides and the 
subsequent final coating with silica (Figure 1.8, B). 
  
 
Figure 1.8:  Specific applications of silica-biomolecule attachment reported: (A) 
mesoporous silica nanoparticles acting as delivery vehicles carrying potential drugs, peptides and 
proteins reprinted with permission from133. (B) controlled silica biomineralization process using 
peptide equipped TMV (tobacco mosaic virus) as templates reprinted with permission from134.  
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Altintoprak et al., (2015). Jin and co-workers (Figure 1.9, A) synthesized a DNA-silica 
complex able to (i) condense DNA through the positively charged quaternary ammonium 
group of N-trimethoxysilylpropyl-N,N,N-trimethylammonium chloride (TMAPS) and (ii) 
stabilize silica mineralization by co-condensing with the silica source, in this case TEOS. 
Further, the formation of various DNA liquid crystals was achieved by varying DNA 
concentration and the TMAPS/DNA molar ratio, which allowed control of the DNA 
interaxial separation135.    
 
 
Figure 1.9: Specific applications of silica-biomolecule attachment reported: (A) 
Silica mineralisation induced by DNA liquid crystals reprinted with permission from 135 and (B) 
enzyme immobilization in silica nanospheres via attaching to cobalt coated resin by affinity binding 
where agarose beads ( ), Co2+ coated agarose beads ( ), his-tagged peptide ( ), enzyme ( ) 
and silica nanospheres ( ) reprinted with permission from136.  
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Luckarift and co-workers (Figure 1.9, B) reported a method for preparation of a solid support 
for immobilization of the enzyme butyrylcholinesterase. For this, a pre-packed column with 
agarose beads was charged with cobalt (II) ions for the attachment of the His-tag R5 peptide.  
Afterwards, the tetramethyl orthosilicate (TMOS) solution together with the enzyme were 
added to the system and silica nanospheres precipitated onto the peptide bound to the 
column, subsequently, immobilising the enzyme. These silica-immobilised enzyme reactor 
columns were used as a model liquid chromatography system to effectively screen 
cholinesterase inhibitors136.  
 
1.3 Combinatorial Display Process on Nanomaterial Surfaces  
The connection between inorganic materials and biomolecules is not new in nature and exists 
naturally through the process of biomineralization. Through this, complex inorganic 
nanostructures including metal oxides and minerals are synthesized by certain species like 
magnetite, an iron oxide (Mms Proteins) in bacteria137–139, silica (silaffins) in diatoms96,97,103-
106, silica (silicatein) in sponges101,102, aragonite and calcite (chitin, proteins and 
polysaccharides) in mollusks140. Though artificial processes have been used to reproduce the 
biominerals or materials, their quality is challenging. In order to meet the quality and 
demand, several research groups started a quest for better alternate routes to produce more 
efficient, reliable and bulk bionanomaterials using inspiration from nature.  
This lead to the discovery of novel biomimetic approaches where peptides having affinity 
towards any target inorganic material can be isolated and practically reproduced using a 
range of combinational display techniques (Figure 1.10) such as phage display25–30, bacterial/ 
yeast display31–34, ribosome, mRNA or cDNA display35–41,141 and rational design42–44. 
 
 Chapter 1 : Introduction 
 
 
49 
 
Figure 1.10: Schematic representation of different types of combinatorial display 
approaches such as phage display, bacterial surface display, yeast surface 
display, ribosome display, mRNA or cDNA display and rational design used for 
selecting and screening of inorganic material12.  
 
So far, a range of biomimetic peptides showing specific affinity and molecular recognition 
for metals (Ag142–144, Au7,19, Pt66, Pd142), metal oxides (SiO2
4,10,24,65,145, ZnO146,147, 
TiO2
8,59,148, Fe2O3
149,150, IrO2
151, Al2O3
10,152, Cu2O
146), minerals (calcite, hydroxyapatite, 
graphite, mica, sapphire)153–155, semiconductors (CdS, GaN, GaAs and ZnS)23,86,156, carbon 
materials (graphene, carbon nanotubes)157,158 and polymer materials159,160 have been isolated 
as shown in Figure 1.10.    
 
1.4 Applications of Inorganic Material Binding Peptides  
Material binding peptides have attracted considerable interest in the development of 
innovative nanostructured materials in particular because of their promising and growing 
applications in nanobiotechnology. These material binding peptides are also called inorganic 
binding peptides (IOBPs) or substrate binding peptides (SUBPs) or solid binding peptides 
(SBPs) or genetically engineered peptides for inorganics (GEPIs). Material binding peptides 
are short amino acid peptide sequences that are genetically constructed and show specific 
affinity to a target material using combinatorial display approach. Although nanomaterials 
have been designed and produced decades ago, their utilization in nano- or bio-technology 
is limited due to poor solubility, stability and biocompatibility issues. The surface properties 
of nanomaterials including solubility, structure, charge and stability are all factors that 
determine its ability to interact safely in a system161. However, several strategies have been 
developed to overcome the toxicity concerns and eventually, material binding peptides came 
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into existence by managing greater control over the nanomaterials without compromising 
their physical, chemical and functional properties. These material binding peptides act as 
molecular linkers (Figure 1.11) by mediating immobilization between inorganic materials 
and biomolecules thereby replacing traditional chemical conjugation methods (e.g. coupling 
reactions) which required harsh chemical reagents and high temperatures, leading to the 
reduced stability and biocompatibility of the biomolecule to the nanomaterial surface.  
 
 
Figure 1.11. Schematic representation of solid binding peptides as molecular 
linkers to link solid materials like nanoparticles and to a wide range of 
biomolecules such as antigens, antibodies, peptides, proteins, enzymes and 
functional peptide motifs. Image reproduced11. 
 
Inorganic material binding peptides have been shown to have many applications, 
including nanomaterial synthesis, self-assembly, coatings, biomolecule immobilization 
as shown in Figure 1.12. Specific examples of these applications are discussed in the 
following section. The material binding peptides have been used to produce a biocompatible 
coating which bind to the nanomaterial in highly-specific manner, which under biological 
condition are usually unable to initiate a cytotoxic or immunogenic response. An example 
of this is the lanthanide oxide binding short peptide sequence, known as RE-1, which was 
 Chapter 1 : Introduction 
 
 
51 
found to form a coating on the surface on the nanocrystal. The stable immobilization of RE-
1 on the lanthanide oxide nanocrystal eliminated the cytotoxicity by preventing 
sedimentation and reducing non-specific interaction with cell  in vivo (mice) and in vitro 
(HeLa cells)162,163.The immobilization of biomolecules onto nanomaterial is believed to 
occur via weak interactions (such as hydrogen, electrostatic and hydrophobic bonding), 
direct coupling or coupling reaction on self-assembled monolayers (SAMs). However, under 
these conditions the biomolecule can attach to surfaces with changing positions and 
orientation, thus causing a loss in functional property164–166.  
 
 
Figure 1.12: Schematic representation of inorganic material binding peptides 
and applications. 
 
Discrimination of different materials in proximity is a critical requirement in nanofabrication 
technologies (e.g. lab-on-chip, microfluidics and microarray). Material binding peptides is 
ideal for this type of technology as it binds to nano- and macro- materials with high 
selectivity. Such example of material binding peptide ability has been demonstrated for the 
highly selective simultaneous co-assembly of varying fluorescein material on gold/silica 
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surface167,168. In contract, SAMs lack the capacity to differentiate materials with similar 
surface such as gold and silver169.  
The functionalization of nanomaterial with biomolecules such as enzymes and antibodies 
has been of interest for diagnostics and therapeutic technologies to improve enzyme activity, 
loading and stability as well as sensing, imaging and targeting170. The application of enzyme 
coupled nanomaterials is of specific interest for industrial processes such as bioremediation 
and biofuel production171. Earlier immobilization methods developed (adsorption, 
entrapment and covalent attachment) are not ideal as it can involve the use of functional 
groups that alter the active site of the enzyme, thus changing its catalytic properties172. 
Material binding peptides are useful for this purpose as it doesn’t change catalytic functions 
during the immobilization of enzyme onto nanomaterials. An example of this is the use of 
gold-binding peptide (GBP1) for the self-assembly or organophosphorus hydrolase (OPH) 
onto gold nanoparticle-coated sensor173. Results showed that the coupled GBP1-OPH had 
retained its native conformation post immobilization and showed comparatively faster and 
more sensitive detection of organophosphorus pesticide than unmodified enzyme. Such 
reaction can also be economically friendly through the attachment of enzymes to magnetic 
nonmaterial, allowing easy recovery and reusability171. Some material binding peptides can 
to bind to their respective materials even under extreme industrial conditions (pH and 
temperature). In specific, a silica-binding peptide (GGGGS) has shown aid the 
immobilization of thermostable enzymes on silica containing material at varied pH range (5-
9 pH) and high temperature (80◦C)174.  
For immobilization of antibodies with nanomaterial, a novel method has been established to 
tackle the low immunogenicity of antibodies to produce material-binding antibodies using 
material binding peptides; conventional methods also often lead to unpredictable changes in 
the orientation on the antibody which decreased the density and availability of antigen-
binding sites. For this new method, genetically engineered antibodies are grafted onto 
material binding peptides to form a fused protein, which then undergoes phage display and 
selection. Recent study have use to facilitate antibodies for the self-assembly of hybrid 
nanomaterial175. However, the use of antibodies as scaffolds for material binding peptides is 
complex and lacks versatility as it requires the initial modification of the antibodies. Using 
antibody-binding proteins (ABPs) that binds easily to the Fc region of an antibody can ensure 
the right orientation, thus avoids the prior modification of the antibody for increased 
versatility while retaining their biological activity176,177. Recent study has also shown the 
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ability of specific material binding peptides (zinc oxide-binding peptide, ZBP) to be used for 
the delivery of tumour-specific antigens into dendritic cells (DCs). The ZBP enables the 
assembly carcinoembryonic antigen (CEA) on Fe3O4-ZnO nanoparticle. Results from the 
study on mice immunized with modified DCs showed rapid recognition of the ZBP-CEA 
functionalized particle by the DCs, leading to suppressed tumour growth and prolonged 
survival when compared to the control mice11,178. 
An alternative to using antibodies is bioactive peptide motifs, which are short amino acid 
sequences that can serve as biorecognition elements. Compared to antibodies, bioactive 
peptide motifs can easily be engineered and are stable in a range of conditions but 
unfortunately, contain several reactive sites which encourage non-specific coupling and 
orientation during bioconjugation process. The orientation of bioactive sensors during 
immobilization can be controlled using material binding peptides by forming bifunctional 
peptides. Synthesis of these peptides generally involves glycine-rich spacers between both 
functional regions which provided flexibility and prevents spatial constrains. However, it 
cannot be certain if a bifunctional peptide will retain the properties of both the bioactive 
peptide and the material binding peptides, thus further changes will be necessary for specific 
functionality179–181.  
Studies by Brown (1992), pioneered the utilization and isolation of material binding 
peptides, initially exploring iron oxide binding peptides from cell surface libraries149, to later 
isolating gold binding peptides from bacterial cell surface display library19. The gold binding 
peptides isolated has had significant application in various human studies from becoming 
material synthesisers22, peptidic linkers for immobilization of nanomaterials180, protein 
fusion partners for oriented protein immobilization182. Whaley et al., (2000), reported the 
first instance of positively charged gold binding peptides selected with phage display using 
gold powder as target material23. The same group of researchers, also isolated gold binding 
peptides carried out in thin gold film. In this study, the peptide was displayed on the pVIII 
phage coat protein = and was used to assemble gold nanoparticles while additional peptides 
expressed on the same coat protein were used to create 2D optical assemblies with CdSe 
nanocrystals183. Naik et al., (2002), also reported the isolation of another gold binding 
peptide (AG3), which originally was targeted for silver surfaces but can also be used for the 
synthesis of gold nanoparticles184,185. Recent study by Kim et al., (2008) has used PD 
approach and gold powder as target material for the isolation of gold binding peptides; one 
peptide called Midas-2 was specifically used for the synthesis of gold nanoparticle, which 
 Chapter 1 : Introduction 
 
 
54 
yielded poly-disperse nanoparticles. Various mutation-based analysis was also carried out 
by replacing amino acid groups with glycine, to investigate the relationship between primary 
structure of the binding peptide and the shape-size of the nanoparticle synthesized. Midas-
11 (a mutant of Midas-2) exhibited to produce large gold platelets with a width of 24 µm 
and thickness of 30-150 nm, in both hexagonal and trigonal planar186. The work presented 
by Kim et al. and Brown et al. are both good examples of specific material binding peptide 
properties used in controlling size and shape of nanostructures. 
Similar to gold, silver binding peptides were also screened and selected for binding with acid 
etched nanosized silver particles. The isolated 12-mer peptides, AG3 and AG4, were 
identified using localized surface plasmon resonance band, according to the ability to bind 
to silver and the capability to form silver nanoparticles186. Immobilized AG4 has also 
demonstrated the ability to grow a range of silver nanoparticles in a microfluidic system 
made of elastomers. The silver binding particles in solution were studies using nuclear 
magnetic resonance (NMR), and the data showed that residues Leru5, Phe6 and Arg7 were 
suggested to be the point of contact for the multiple AG4 peptides bound during the synthesis 
of the silver nanoparticle186.  
Titanium is also a bionanomaterial that has widely studied and used due to its good 
biocompatibility and its application for implant material. For this reason, Liu et al., (2010), 
screened peptides from 12-mer and 7-mer PD libraries for a commercially used titanium 
material (cp-Ti). The researchers were able to detect surface bound clones, and characterize 
the binding of the phages on cp-Ti using confocal microscopy187. The metal oxides form of 
titanium is titanium oxide, also known as titania (TiO2), and has also been used in various 
applications for biomedical systems and optoelectronic devices. Material binding peptides 
have also been used in conjunction with titania for the fabrication of conductive 
nanostructure (e.g., nanofibers and nanowires), for their application in nanoelectronics (i.e. 
power cells, computer processor and optical fibres). The purpose of the material binding 
peptide in this case is to mediate the synthesis of an inorganic-inorganic nanocomposite (see 
Figure 1.12). In a paper by Inoue et al., (2014), a genetically modified self-assembling case-
shaped protein (CDT1) was used to co-display a 12 single-walled carbon-nanotubes 
(SWNT)-binding and TiO2-mineralising peptide. This bifunctional protein was used to 
mediate the formation of thin layers of titania on SWNTs. After further processing to 
eliminate protein using high temperature, a highly-conductive nanocomposite was produced 
for its application in dye-sensitised solar cell (DSSC) photoelectrodes188. 
 Chapter 1 : Introduction 
 
 
55 
Silica is another metal oxide material which has similar applications to titania. Silica binding 
peptides was first isolated from a phage library by Naik et al., which contained high amounts 
of arginine and histidine amino acid groups and displayed the ability to precipitate silica 
from silicilic acid24. Another group of researchers were able to identify silica binding 
peptides, which is high in proline amino acid groups, that has affinity towards single 
crystalline quartz surface. The analysis of these strongly binding peptides was carried out 
using a surface plasmon resonance spectroscopy (SPR)189.  
Another metal oxide that has application in optoelectronic application is Zinc oxide 
(ZnO)190. Certain zinc oxide binding 12-mer peptides have already been identified using 
micrometre sized ZnO particles as the target material; the identified peptides were also able 
to distinguish between ZnO and ZnS147. Another study has proposed a novel method to 
synthesize fluorescent ZnO particle with unique morphology, not previously achieved with 
low temperature approach which required complex chemicals191. Though the research on 
using phage display technology to discover material binding peptides for the metal oxides 
mentioned here (titanium oxide, silica, zinc oxide) is vast, there is still more to be explored 
for the remaining oxide materials. A possible reason for this may be because other metal 
oxides are not as widely used and/or that peptides may not be suitable for functionalization 
of other metal oxide surfaces under their specific processing. 
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1.5 Motivation of Project and Objectives 
Nature is always an inspiration and mystery when it either comes to synthesizing materials 
either on its own or by using biomolecules thereby providing greater control of physical, 
chemical and biological parameters60,94,183,185. One way to find solutions is to mimic nature. 
However, to mimic nature’s method of synthesizing materials needs the identification of 
functionally active biomolecules as well as the capacity to direct the synthesis in in vitro 
conditions. Molecular recognition is the central principle of all biological systems. Using 
this molecular binding feature, several systems have been well studied including peptide-
protein, antigen-antibody, enzyme-protein and nucleic acid-protein interactions. With 
increasing use of biopanning to display material specific peptides and then use those 
identified peptides to reproduce same materials in vitro or in vivo under controlled conditions 
that have potential applications in biomedical and bio-nanotechnology have grown rapidly, 
it is very important to elute, identify and verify the authenticity of genuine target binders 
without falling into the net of non-specific binders. Though, significant progress has been 
made in selecting and screening of biomolecule binding peptides, but when the target is a 
mineral/ inorganic material surface it is challenging due to their complex surface chemistry. 
It is still unclear whether we are eluting and recovering all of the strong binders from the 
available phage library and whether there are differences between library batch to batch 
behaviour. Amorphous silica nanoparticles have been selected as a target material because 
of its importance as 20th century materials and for their growing potential applications due 
to low toxicity and biocompatible properties. The M13 Ph.D.-7 library system was selected 
because this is one of the best-characterised and most reliable recommended libraries. 
Compared to 12-mer peptides, shorter 7-mer peptides are easier to work with as they can be 
easily exposed to solvent environments during the process of phage display, unlike 12-mer 
peptides which are known to degrade, are harder to purify and are unstable in harsh 
conditions (at high temperature and changes in pH). In addition, the increased length of the 
sequence in 12-mer peptide library may result in identifying sequences with multiple weak 
interactions, rather than selecting few strong interactions. However, the 7-mer peptide 
sequences are useful targets that require binding elements concentrated in a short stretch of 
aminoacids. Furthermore, not many studies on heptapetides which have affinity toward silica 
have been reported using the PhD- 7 library. Thus, keeping in mind the limitations of using 
12-mer peptides, 7-mer peptides were chosen to be studied as they easy to work with and 
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have various applications in nanomaterial synthesis24,65,192 and for understanding mechanism 
via which silica-biomolecules interact4,59,107,124,132. 
The main goal of the project was to develop alternate approaches to elute and identify 
material binding peptides using phage display technique. Then, to explore and understand 
the influence of electrostatic/non- electrostatic interactions on the molecular scale in 
governing biomolecule selection. 
Specific objectives of the project were:  
• Isolate and identify silica binding peptides (7mers) through biopanning against 
hydrophilic silica by exploring different elution strategies.  
• Investigate and predict the behaviour of biomolecules (sequence diversity, functionality 
and promiscuity) such as the identified peptides by looking at their physicochemical 
properties and related bioinformatics.  
• Study and understand in vitro interactions between selected peptides isolated by phage 
display and silica surfaces in solution. 
• Explore conditions such as pH, detergent, washing and elution buffers needed to bind or 
detach the peptide from silica surfaces via electrostatic/ non-electrostatic interactions in 
solution. 
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Chapter 2: Instrumentation and Experimental Section 
 
In brief, this chapter introduces the instrumental principles and experimental methods 
including the materials that have been used to identify mineral binding peptides with 
reference to silica, to synthesize and characterize peptides and/ or silica nanoparticles and to 
study their interactions. The phage display of biopanning technique has been used to select 
NEB Ph.D.-7 mer library against silica nanoparticles which were amplified in bacteria by a 
repetitive process. The amplified phages from the biopanning round of interest were isolated 
and phage clones collected by carrying out a blue-white screening process. Using 
polyethylene glycol (PEG) solution, single-stranded phage DNA has been precipitated and 
the purity of the DNA analysed using a NanoDrop spectrophotometer. Further, these DNA 
samples have been sequenced with a modified Sanger sequencing method by Eurofins 
Genomics UK and the authenticity of sequences determined using bioinformatics tools such 
as in-silico sequence convertor; multiple sequence alignment programs (Clustal W2 and 
Clustal Omega), npeptide property calculators (Innovagen and Bachem) and peptide 
database search engine (MimoDB tools) respectively. Selected peptides identified by the 
phage display process have been synthesized using solid phase peptide synthesis (SPPS) 
protocol while the quality and purity of these synthesized peptides have been analysed by 
matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry 
and high-performance liquid chromatography (HPLC) respectively. The silica nanoparticles 
used for phage display and binding studies were already available in the Perry laboratory 
and had been synthesized by the Stöber process and characterized using dynamic light 
scattering (DLS), zeta potential and transmission electron microscopy (TEM). A range of 
quantitative and qualitative techniques including fluorescamine assay, Raman spectroscopy 
and transmission electron microscopy has been used to study the binding of peptides onto 
the surface of silica nanoparticles.  
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2.1 Materials and Methods 
 Materials 
2.1.1.1 Heptapeptide phage display peptide library (Ph.D.™-7) 
In this study, Ph.D.-7 phage display peptide library kit (#E8100S) purchased from New 
England Biolabs (NEB) has been used for panning against already characterized amorphous 
silica nanoparticles of size 82 ± 4 nm. This library is based on M13 phage vector engineered 
for pentavalent display of peptides on pIII minor coat protein. The Ph.D.-7 phage display 
peptide library kit was supplied with 100 µl of Ph.D.-7 library (enough for 10 biopanning 
experiments) containing 1 x 1013 pfu/ml (2.8 x 109 independent clones supplied in TBS with 
50% glycerol). Also, this library contains roughly 109 electroporated sequences amplified 
once to give approximately 100 copies of each sequence in 10 µl of the provided phage 
peptide library.  
For the entire phage display work, two separate aliquots of NEB Ph.D.-7 phage library kits 
(Lot: 0211212 and Lot: 0221501) were used at different times of this project. The first library 
(Lot: 0211212) batch was used for initial biopanning and repanning experiments via 
following traditional biopanning process as described in chapter 3. As, the first batch of 
library was finished for more panning experiments, a second batch (Lot: 0221501) was 
ordered and used to test the optimised biopanning approach (alternative three step elution 
process) as defined in Chapter 4.  
2.1.1.2 E. coli host strain (K12 ER2738) 
F´ proA+B+ lacIq Δ(lacZ)M15 zzf::Tn10(TetR)/fhuA2 glnV Δ(lac-proAB) thi-1 Δ(hsdS-
mcrB)5. The E. coli host strain ER2738 was supplied with 50% glycerol and included within 
the NEB Ph.D.-7 phage display peptide library kit (#E8100S). This E. coli F+ strain has been 
used for the entire phage display work for propagating and screening the M13 phage clones.   
2.1.1.3 Silica nanoparticles  
The same batch of amorphous hydrophilic silica nanoparticles of size 82 ± 4 nm was used 
as target for biopanning and subsequent binding studies that were already available in the 
Perry laboratory and had been synthesized by the Stöber process and characterized using 
varied techniques4,107. More information about the properties and measurements of silica 
particles is described in Table 2.6 under the section 2.1.2.6 in this chapter. 
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2.1.1.4  Phage display reagents 
All the phage display work was performed under aseptic conditions using a Bunsen burner, 
disinfectants and by sterilizing the chemicals and materials used in the process for 15 
minutes under 1.5 atm at 121 ºC in an autoclave. All other chemicals and reagents used for 
phage display or biopanning were purchased from Sigma Aldrich and Fisher scientific. 
These include LB broth and LB agar from Fisher scientific; and the remaining chemicals 
including isopropyl β-D-1 thiogalactopyranoside (IPTG), 5-bromo-4-chloro-3-indolyl β D 
galactopyranoside (X-gal), tris-HCl, sodium chloride (NaCl), polyethylene glycol (PEG-
8000), TBS tablets, Tween 20 detergent, sodium iodide (NaI), sodium azide (NaN3), 
ethylenediamine tetra aceticacid (EDTA), tetracycline, glycine-HCl, magnesium chloride 
(MgCl2) and triethylamine (TEA) were brought from Sigma Aldrich.   
The following stock solutions were prepared prior to starting the biopanning procedure and 
kept for use as required.    
 
2.1.1.4.1 Washing buffers 
 
• TBS buffer stock solution  
One tablet (purchased from Sigma Aldrich) dissolved in 15 ml of deionized water yields 50 
mM Tris and 150 mM sodium chloride, pH 7.5, at room temperature (25 °C). Thirty TBS 
tablets were dissolved in 300 ml of deionized distilled water and the solution was sterilized 
by autoclaving for 15 minutes under 1.5 atm at 121 ºC.  After autoclaving for 15 minutes the 
pH was adjusted to 7.5 using 1 M HCl concentration and stored at room temperature.  
 
• TBST buffer solution (TBS with 0.1%-0.9% [v/v] Tween 20) 
An appropriate amount of Tween 20 detergent (volume fraction) (Sigma Aldrich) was added 
to the sterilized TBS solution of pH 7.5 to reach the desired detergent concentrations as 
below. 
20 µl of Tween 20 was added to 20 ml TBS to get 0.1% TBST (TBS +0.1% [v/v] Tween 20) 
60 µl of Tween 20 was added to 20 ml TBS to get 0.3% TBST (TBS +0.3% [v/v] Tween 20) 
100 µl of Tween 20 added to 20 ml TBS to get 0.5% TBST (TBS +0.5% [v/v] Tween 20)  
140 µl of Tween 20 added to 20 ml TBS to get 0.7% TBST (TBS +0.7% [v/v] Tween 20) 
180 µl of Tween 20 added to 20 ml TBS to get 0.9% TBST (TBS +0.9% [v/v] Tween 20) 
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2.1.1.4.2 Elution buffers 
• 0.2 M Glycine-HCl, pH-2.2, pKa = 2.35 
446.12 mg of Glycine-HCl was dissolved with 50 ml of autoclaved nuclease free water 
and pH was adjusted to 2.2 by adding drop by drop of 0.2 M HCl. Stored at 4 ºC.  
• 4 M MgCl2, pH-6.1 
40 g of magnesium chloride hexahydrate was dissolved with 50 ml of distilled water 
and pH was noted as 6.1. Stored at 4 ºC. 
• 100 mM Triethylamine, pH-11 
1.75 ml of concentrated triethylamine solution was dissolved in water and made up to 
the final volume to 50 ml with distilled water. The pH was noted as 11. Stored at 4 ºC. 
• 0.2 M Glycine-HCl, pH-7 
446.12 mg of Glycine-HCl was dissolved with 50 ml of autoclaved nuclease free water 
and pH was adjusted to 7 by adding drop by drop of 1 M NaOH. Stored at 4 ºC.  
• 0.2 M Glycine-HCl, pH-11 pKa = 9.78 
446.12 mg of Glycine-HCl was dissolved with 50 ml of autoclaved nuclease free water 
and pH was adjusted to 11 by adding drop by drop of 1 M NaOH. Stored at 4 ºC.  
 
2.1.1.4.3 Culture media  
The culture media and reagents used for culturing the phage or bacteria were 
purchased from Sigma Aldrich and Fisher scientific. The LB broth and LB agar 
media were obtained from Fisher scientific; while the chemicals tetracycline 
isopropyl β-D-1 thiogalactopyranoside (IPTG) and 5-bromo-4-chloro-3-indolyl β 
D galactopyranoside (X-gal) were bought from Sigma Aldrich.  
• Luria-Bertani (LB) agar medium 
17.5 g of LB agar Lennox powder (tryptone: yeast extract: sodium chloride: select agar) was 
dissolved in 500 ml of distilled water and was sterilized by autoclaving for 15 minutes under 
1.5 atm at 121 ºC. In order not to solidify, the agar media was stored at 45 ºC to 55 ºC until 
the media was used for preparing LB agar and X-Gal/ IPTG plates.  
• Luria-Bertani (LB) broth medium 
2g of LB broth Lennox powder (tryptone: yeast extract: sodium chloride) was dissolved in 
100 ml of distilled water. Stored at room temperature after autoclaving at 121 ºC for 15 min. 
• Tetracycline stock solution  
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200 mg of tetracycline (20 mg/ ml) was taken and made to the final volume of 10 ml by 
adding 70% ethanol. To protect the light sensitive tetracycline stock, the tube was wrapped 
with aluminium foil and stored in the dark at -20 ºC.    
• X-Gal/ IPTG stock solution 
0.31 g of IPTG and 0.25 g of X-Gal were dissolved and made up to a volume of 6.25 ml with 
dimethyl formide (DMF). To protect the light sensitive X-Gal/ IPTG stock solution, the tube 
was wrapped with aluminium foil and stored in dark at -20 ºC.   
 
2.1.1.4.4 Other stock solutions 
All other chemicals and reagents used for preparing stock solutions including 
sodium chloride (NaCl), polyethylene glycol (PEG-8000), sodium iodide (NaI), 
sodium azide (NaN3), ethylenediamine tetra aceticacid (EDTA), Tris base, Tris-
HCl and 1M HCl were brought from Sigma Aldrich.   
• PEG/ NaCl stock solution (20% (w/v) PEG 8000 and 2.5 M NaCl) 
4 g of PEG 8000 and 2.92 g of NaCl were taken and total volume was made up to 20 ml with 
sterilized nuclease free water. Stored at room temperature after autoclaving for 15 minutes 
under 1.5 atm at 121 ºC. 
• Sodium Iodide (NaI) buffer stock solution (10 mM Tris-HCl of pH-8.0, 1 mM EDTA, 
4 M NaI) 
24.2 mg of Tris-HCl, 5.8 mg of EDTA and 11.99 g of NaI were taken and the volume was 
made up to 50 ml with autoclaved nuclease free water. To protect the light sensitive iodide 
buffer stock, the tube was wrapped with aluminium foil and stored in the dark at room 
temperature.  
• Sodium azide (NaN3)-TBS stock solution  
1 mg of NaN3 was taken and dissolved in 50 ml of TBS solution to get 0.02% (w/v). 
• Tris HCl solution  
6 g of ultrapure Tris base was dissolved with 50 ml of autoclaved nuclease free water to get 
1M concentration and pH was adjusted to 9.1 by adding 1M HCl. Stored at 4 ºC. 
 
2.1.1.4.5 Peptide synthesis reagents  
Selected silica binding peptides identified by phage display were synthesised by using the 
following reagents in an automated single channel microwave assisted solid phase peptide 
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synthesizer (CEM Corporation Liberty1) by following the standard peptide synthesis 
procedure via Fmoc chemistry as described in the following chapter under the section 
2.1.2.6.1.  These reagents include piperazine, trifluoroacetic acid (TFA), DODT (3,6-dioxa-
1,8-octanedithiol), DIEA (N, N-diisopropylethylamine) and thianisole (TIS) were purchased 
from Sigma Aldrich. Other chemicals like N, N-dimethylformamide (DMF), 
dichloromathane (DCM), N-methyl-2-pyrrolidone (NMP) and diethyl ether were bought 
from Fisher Scientific. All Fmoc protected amino acids and resins used for peptide synthesis 
were purchased from Novabiochem®. The resins used for synthesising C-terminal with acid 
and amide groups include C1-TCP Pro Tide and Fmoc-Rink Amide ProTide Resins 
respectively. Further details about the synthesis process, reagents used, and the peptides 
synthesized is described in the following chapter under the section 2.1.2.6.1.  
2.1.1.4.6 Peptide characterization reagents  
The high purity solvents including HPLC graded acetonitrile (≥99.93%), water and TFA 
(≥98.0%) used for preparing samples for HPLC and mass spectrometry were purchased from 
Sigma Aldrich.  
2.1.1.4.7 Reagents used for binding studies 
The chemicals used for binding studies including phosphate buffered saline (PBS) tablets, 
fluorescamine dye were purchased from Sigma Aldrich. The EM Stain 336 (Uranyl Acetate 
Alternative) used for staining phage samples on TEM grids of QUANTIFOIL 100 Holey 
carbon films +2 nm (Cu 300 mesh) were obtained from Agar Scientific.  
• Phosphate buffered saline (PBS) stock solution 
One tablet (Sigma Aldrich) dissolved in 200 ml of deionized water yields 137 mM NaCl, 2.7 
mM KCl and 10 mM phosphate buffer solution of approximately pH 7.4 at room temperature 
(25 °C). Five PBS tablets were dissolved in 1 litre of deionized distilled water and the 
solution was sterilized by autoclaving for 15 minutes under 1.5 atm at 121 ºC.  After 
autoclaving for 15 minutes the pH was adjusted to 7.5 using 1 M HCl concentration and 
stored at 4 °C.  
• Peptides stock solutions 
Peptide stock solutions ranging 2 -5 mM of selected peptides were prepared by dissolving 
calculated amount of peptide with desired autoclaved PBS buffer solution.  
• Fluorescamine dye stock solution 
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5 mg of fluorescamine dye with purity ≥98% (TLC) was dissolved with 1 ml of HPLC graded 
acetonitrile. To protect the light sensitive fluorescamine stock solution, the tube was 
wrapped with aluminium foil and stored in the dark at room temperature. 
• EM Stain 336 (Uranyl Acetate Alternative) solution 
EM Stain 336 (Uranyl Acetate Alternative) used for staining phage samples on TEM grids 
was brought from Agar Scientific. This stain is a mixture of lanthanum salts, samarium 
triacetate (Sm(CH3COO)3) and gadolinium triacetate Gd(CH3COO)3. The supplied EM stain 
336 was dissolved 4x times with distilled water and stored at 4 ºC. 
• TEM Grids  
TEM grids of QUANTIFOIL 100 Holey carbon films +2 nm (Cu 300 mesh) were purchased 
from Agar Scientific.  
 
 Methods 
2.1.2.1 Phage Display Process 
Chapter 1 provides a general introduction to the phage display process and more details 
including step by step protocol followed to isolate silica binders is described in the 
subsequent sub sections under this “Phage Display Process”. 
2.1.2.1.1 Biopanning technique and protocol 
Biopanning, is a powerful affinity-based technique used to screen genetically engineered 
phage library with a proposed target through a series of repetitive processes in vitro or in 
vivo. The typical biopanning process (Figure 2.1) involving continuous repetitive steps 
include binding of peptide library with target material, incubation, washing with detergents 
to remove unbound phages; eluting strong target binders by elution buffers, amplification in 
bacteria, extraction and purification of single stranded phage DNA; selection of genetically 
inserted target binders by blue-white screening process and analysis of phage DNA57. Due 
to its growing importance in basic to applied sciences for identifying peptides or antibodies 
having specific molecular affinity for protein (e.g. cell or organic specific, antigens, 
receptors etc.)193 and non-protein targets (e.g. nanoparticles)66; it has been widely employed 
for epitope mapping, monoclonal antibody production and in the development of advanced 
vaccines, diagnostics and therapeutics194–199. 
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Figure 2.1. Typical working principle of biopanning affinity process, selection 
and screening of material binding peptides using peptide phage libraries. Image 
reproduced with permission from Springer 2006 57. 
 
Also, antibody phage display technique permits in vitro selection or in E.coli to produce 
monoclonal antibody fragments with specificity to a given target27. This technology is a 
suitable source for reagents as it overcomes some of the limitations associated with 
conventional animal-produced antibodies, such as variations for batch-to-batch production 
200. Antigen binding fragments (Fab) are one of the fragments most commonly used in 
research. Using the phage display vectors (eg. pComb3X) the antibody fragments are fused 
to the coat protein pIII of bacteriophage in E.coli to generate library of phages201. More 
details about the phage display technique has been discussed in section 1.1, Chapter 1. 
 
Experimental protocol: 
For this phage display study, the typical protocol applied for the initial (traditional) and 
optimised biopanning methods are clearly discussed in the following sub steps. While, the 
details of phage display experiments and elution conditions used to elute silica binding 
peptides via traditional and optimized elution biopanning methods were shown in the Table 
2.1.  
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Target cleaning step 
To remove any impurities, present in the target silica nanoparticles, 1 mg of target silica was 
weighed in a 1.5 ml micro centrifuge tube, washed with 1 ml 0.1% TBST concentration 
(0.1% Tween 20 [v/v] in 1ml of TBS), vortex rotated for 3 min and centrifuged (Eppendorf 
MiniSpin® GL010) at 10,000 x g for 4 min. The pellet was collected by removing the 
supernatant. The same process was repeated 3 times to make sure all the contaminants were 
washed off from silica surface.  
Binding step 
In this target binding step, 10 µl of Ph.D.-7 (Lot: 0211212) library containing 1 x 1013 pfu/ml 
was exposed to 1 mg/ ml of silica nanoparticles in TBS buffer. This phage library-silica 
precipitate was incubated for 1 hour by gently rotating with Eppendorf disk rotator (Eins-
Sci E-RDM-A) giving enough time for phage-silica interaction. 
Washing step 
After 60 min incubation step, washing and spinning cycles were repeated 10 times for each 
biopanning round with desired TBST concentration inorder to remove weakly bound or non-
specific phages from silica surface. The concentration of the detergent Tween 20 mixed with 
TBS (TBST) was increased in the additional panning rounds to improve the washing 
condition stringency. For example, the washing buffer (TBST) concentrations used for 
rounds 1-5 panning were 0.1%, 0.3%, 0.5%, 0.7% and 0.9% (Tween 20, volume fraction) 
respectively. After each washing cycle, the phage-silica suspension was vortexed for 3 min 
followed by centrifugation at 10,000 x g for 4 min. After each spinning cycle, the supernatant 
was transferred to a fresh 1.5 ml Eppendorf microcentrifuge tube and the remaining pellet 
consisting of phage-silica precipitate washed with fresh TBST buffer solution for each wash.  
Elution step  
After the washing and spinning steps, the strongly bound phages were recovered from the 
silica surface by disrupting the strongest possible interactions present between phage and 
silica through elution. To the final phage-silica precipitate from the last washing step, added 
1 ml of elution buffer of interest (0.2 M Glycine-HCl of pH-2.2, 4 M MgCl2, pH-6.1 and 100 
mM Triethylamine, pH-11) to remove the strongly bound phages from mineral silica. This 
solution containing phage-silica precipitate in elution buffer was then vortex rotated for 5 
min and centrifuged at 10,000 x g for 4 min. Here, the supernatant eluted containing tightly 
bound silica phage was recovered and transferred to a fresh micro centrifuge tube. 
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Table 2.1. Experimental conditions used to elute silica binding peptides via 
traditional and optimised biopanning methods. Two different biopanning methods are 
presented in this table: traditional or standard (used in Chapter 3) and optimised (used in Chapter 
4) methods. Both were performed at different times using two separate batches of same library 
(#E8100S). For the standard biopanning process, three different elution buffers were used but only 
one specific elution for entire respective biopanning experiment and rounds. In contrast, the 
optimised elution biopanning process presents 2 approaches (each differ from the former): 
Approach 1 differs from the standard biopanning method as each mentioned buffers were used 
successively at every single biopanning round of elution step, as apposed to one specific buffer 
being used for all rounds in individual traditional panning experiments; Approach 2 only used the 
Glycine-HCl elution buffer but at varying pH’s.  
Experimental 
method type 
Library 
lots used 
Elution buffers 
used 
Molarity pH 
Times eluate 
(target bound 
phage) obtained 
separately at 
each elution step   
Total 
screened 
panning 
rounds    
 
Traditional 
biopanning 
Lot 1  
(0211212) 
Glycine-HCl 0.2 M 2.2 1 
1→ 5 MgCl2 4 M 6.1 1 
Triethylamine 100 mM 11 1 
Optimized 
biopanning 
Lot 2 
(0221501) 
Approach 1 
Glycine-HCl 0.2 M 2.2 
3  
(1st, 2nd and 3rd) 
1→2 MgCl2 4 M 6.1 
Triethylamine 100 mM 11 
Approach 2 
Glycine-HCl 0.2 M 
2.2 
3  
(1st, 2nd and 3rd) 
1→2 7 
11 
 
 
Neutralization step 
During this neutralization step, the supernatant recovered from the last low pH (i.e. 0.2 M 
Glycine-HCl of pH-2.2) elution step was immediately neutralized with 150 µl of 1 M Tris 
HCl of pH-9.1 by nullifying the final solution pH to approximately 7 and stored at 4º C. This 
is called B1E (Biopanning round one unamplified eluent) as shown in Figure 2.2.  While the 
neutralization step in case of elution buffers 4 M MgCl2, pH-6.1 and 100 mM Triethylamine 
was carried out by adding 50 µl of 1 M Tris HCl of pH-9.1 and 150 µl of 1 M Tris HCl of 
pH-5 respectively.  
 
 Chapter 2 : Instrumentation and Experimental Section 
 
 
68 
Phage amplification step 
900 µl of the unamplified eluate (i.e.B1E, see Figure 2.2) obtained after the neutralization 
step was added to 20 ml of LB broth inoculated in a 250 ml autoclaved conical flask with 
200 µl of 1:100 overnight grown E.coli ER2738 strain and incubation carried out by vigorous 
shaking at 37 ºC, preferably 250 x g speed for 4-5 hours until the optical density at 600 nm 
reached between 0.4 and 0.6 using a UV visible spectrophotometer. After reaching the 
desired optical density at 600 nm, the entire culture was transferred to an autoclaved 30 ml 
capacity NALGENETM Oak Ridge centrifuge tube and centrifuged at 10,000 x g for 4 min 
at 4 ºC. The supernatant was transferred to a fresh autoclaved centrifuge tube and respun at 
10,000 x g for 4 min at 4 ºC. Now, the upper 80% of the supernatant was transferred to a 
fresh autoclaved centrifuge tube and 1/6 volume (i.e. 3.3 ml) of 20% PEG/ 2.5 M NaCl stock 
solution was added. This PEG solution was allowed to precipitate the phage by leaving the 
tube overnight at 4 ºC.   
 
 
 
Figure 2.2. Diagrammatic representation of biopanning process and steps 
involved. 
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The next day, the PEG containing precipitate was centrifuged at 10,000 x g for 15 min at 4 
ºC. The supernatant was transferred to fresh 15 ml centrifuge tubes without disturbing the 
pellet. Centrifugation was performed for the pellet containing centrifuge tube and the 
supernatant containing centrifuge tubes to remove any residual supernatant present leaving 
only the pellet. The pellet present in the centrifuge tubes was suspended carefully with 1 ml 
of TBS buffer (pH-7.5) and all the material moved to a single autoclaved 1.5 ml micro 
centrifuge tube. The suspension was quickly centrifuged at 12,000 x g for 5 min at 4 ºC to 
pellet any remaining residual cells. The supernatant was transferred to a fresh autoclaved 
centrifuge tube and 1/6 volume (i.e. 160 µl) of 20% PEG/ 2.5 M NaCl stock solution was 
added and then incubated on ice for 1 hour. After incubation, the suspension was again 
centrifuged at 12,000 x g for 10 min at 4 ºC and the supernatant discarded. At this stage, the 
pellet was not clearly visible but none the less the centrifuge tube was respun to remove any 
remaining supernatant cells. The pellet which was then slightly visible when under normal 
tube light was resuspended carefully in 200 µl of 0.02% NaN3-TBS stock buffer (pH-7.5). 
To remove any insoluble material, it was then spun at 11330 x g for 1 min, transferred to a 
fresh autoclaved microcentrifuge tube and stored at 4 ºC. This suspension is called the 
biopanning round one amplified eluate (R1A, see Figure 2.2) product and would be used for 
phage titering.  
 
The whole biopanning process described above is termed biopanning round 1 and the 
amplified phage product obtained here called the amplified eluate (R1A, see Figure 2.2). 
From here on, the above biopanning process was repeated up to 3-5 biopanning rounds by 
taking R1A to get R2A, R2A to get R3A and so on until getting to a maximum of R5A 
(Figure 2.2) but by changing the washing buffer conditions. With increasing the number of 
biopanning rounds the washing detergent (Tween 20) concentration was also increased. For 
example, the washing buffer TBST (0.1% Tween 20 in TBS) concentrations used for 1-5 
panning rounds were 0.1, 0.3%, 0.5%, 0.7% and 0.9% (Tween 20, volume fraction) 
respectively. A clear picture of biopanning experimental conditions used for initial 
biopanning experiments is detailed in Table 2.2.  Also, to start the second round of panning, 
150 µl of round 1 amplified eluate (i.e amplified phage library obtained from round 1) was 
added to a fresh 1mg of silica followed by series of steps involving incubation, washing, 
elution followed by amplification (as described above) to get to round 2 amplified eluate 
R2A. The same process (i.e adding 150 µl of round 2 amplified eluate (R2A) to a fresh 1mg 
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of silica to get R3A and so on) was repeated until reaching the biopanning rounds 3-5 for 
every biopanning experiment.  
 
Table 2.2. Experimental conditions used for initial and repanning experiments 
via traditional biopanning process. The experimental conditions include the washing of 
weakly bound phages with TBST detergent (0.1-0.5% Tween 20 [v/v] in TBS); the removal of 
strongly bound binders from silica surface that isolated the silica binders using three different 
elution buffers; the dates and the order of experiments performed for normal biopanning were 
shown in the below table. 
Exp. 
Order 
Dates (month/ 
year) of 
experiments 
performed 
Wash times (cycles) and 
Tween 20 detergent 
concentration 
(v/v) in TBS. 
Elution buffer 
and Conditions 
Biopanning 
round screened 
Initial biopanning experiments 
1 07/13  
0.5%, 10 washes  
Glycine-HCl 
0.2 M, 
pH-2.2 
3  
 
07/13 
3 09/13 
4 02/14 
5 07/13 MgCl2, 
4 M, 
pH-6.1 
6 08/13 Triethylamine 
100 mM, 
pH-11 
Repanning experiments 
7 07/15 0.5-0.9% 
(10 washes with each 
detergent concentration in 
successive rounds) 
Glycine-HCl 
0.2 M, 
pH-2.2 
3-5 
8 11/15 0.7%, 10 washes Triethylamine 
100 mM, 
pH-11 
4 
 
The amplified phage obtained from the biopanning round of interest (3-5) further underwent 
phage titering, plaque amplification, DNA extraction, purification and sequencing followed 
by the interpretation and identification of target binding peptides as detailed in the following 
sections. Overall three different elution buffers (0.2 M Glycine-HCl, pH-2.2; MgCl2, pH-
6.1; TEA, pH-11) with varied pH conditions (low or high pH and neutral pH) have been used 
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separately and the biopanning process was performed for each experiment to identify silica 
binding peptides. 
 
2.1.2.1.2 Phage titering and blue-white screening  
The blue-white screening method is fast, efficient and the most commonly followed protocol 
in molecular biology to detect bacteria carrying recombinant vectors202–204. The simple 
procedure includes ligation, transformation and screening. The principle is based on α-
complementation of the lacZ gene that carries information of β-galactosidase enzyme. This 
technique entirely depends on the activity of the β-galactosidase enzyme that is present in 
E.coli thereby cleaving lactose into the products of glucose and galactose.  
When the plasmid vector carrying the lac Z gene is plated on specific antibiotic resistant agar 
medium containing E.coli (carrying lac Z deletion sequence) in the presence of X-gal 
(chromogenic substrate) and IPTG (an inducer of lac Z expression), an α-complementation 
process occurs resulting in the formation of β-galactosidase enzyme, thus hydrolysing X-gal 
and  producing blue coloured colonies. However, if the foreign DNA is taken up by the 
plasmid vector, then the α-complementation process does not occur resulting in no formation 
of the β-galactosidase enzyme producing white coloured plaques.  
 
M13 phage libraries which are made using a plasmid vector carrying the lac Z gene will 
display blue plaques, when interacting with α-complementing K12 ER2783 bacterial strain 
resistant to tetracycline, in a LB-Xgal/IPTG plate. However, the host strain in M13 PhD. -7 
phage library, E. coli ER2738, lacks the lacZ gene in its DNA and thus will not be able to 
produce β-galactosidase, resulting in a phage clones that look like blue plaques on LB-
Xgal/IPTG plate. The mechanism of blue-white screen is connected to the lac operon in E. 
coil (host cell) with a complementing subunit vector of the phage.  It is possible for the β-
galactosidase to be secreted when it is present when the recombinant E, coil DNA with the 
target vector keeps the lacZ gene. If not, the β-galactosidase secretion will get blocked if 
lacZ gene is disturbed due to foreign DNA, or repressors interact with operator. 
 
The intercellular enzyme β-galactosidase is responsible for cleaving the disaccharide lactose 
into galactose and glucose. For the detection of β-galactosidase, the indicator Xgal (modified 
galactose) is generally used. The solution changes from a colourless to blue as the Xgal 
catalyses the β-galactosidase, forming the product 5-bromo-4-chloroindole. Simultaneously, 
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the molecule β-D-1-thiogalactopyranoside (IPTG) also interacts with receptors to prevent 
the β-galactosidase secretion. The blue colour of plaques is due to the library cloning vector 
(M13KE), which is prepared from the cloning vector M13mp19 consising of the lacZ α gene 
and become easier to observe when using a strain (such as ER2738) alongside Xgal/ IPTG 
plates. Additionally, the bacterial strain for the planting in the Xgal/ IPTG plates, must be 
capable of α-complementation (lacZDM15 or equivalent), such as the strain ER2738 
supplied for the blue-white screening to work well.  
 
This experiment is done to estimate the number of phage titers at the completion of each 
biopanning round. There are three steps associates to the blue-white screen experiment: first 
is preparation of Xgal/IPTG plates, next is the serial dilution of eluted phage samples, and 
final step involving the estimation of phage titers for each biopanning round. 
 
Preparation of LB-Xgal/IPTG plates: 1ml of Xgal/ IPTG stock solution was added to the 
1 litre of freshly autoclaved liquid warm LB agar bottle and mixed gently by slowly moving 
the bottle up and down until all the added Xgal/ IPTG solution dissolved. Then, the solution 
of LB agar- Xgal/ IPTG mixture was poured onto a 60 nm sterile plastic petri dish plates and 
allowed to solidify at room temperature. These plates were with parafilm and aluminum foil 
and stored at 4℃ in the dark for a maximum of 1 month. 
 
Serial dilution of phage samples: 10 ml of LB broth was inoculated in a 250 ml autoclaved 
conical flask with 200 µl (1:100 dilutions) of overnight grown E.coli ER2738 strain and 
incubation was carried out by vigorous shaking at 37 ºC, preferably 250 x g speed for 4-5 
hours until the optical density at 600 nm observed between 0.4 and 0.6. The shaking speed 
was turned down from 250 to 100 in the last 10 minutes after reaching the desired O.D to 
make sure that none of the F-pili was lost. Now, ten 1.5 ml autoclaved microcentrifuge tubes 
were taken with 1 ml LB broth in each of the tubes and 10 µl of amplified phage eluate from 
biopanning round of interest was added to the first tube (10-2 dilution) followed by successive 
serial dilutions by transferring 100 µl from each dilution until the last microcentrifuge tube 
(10-10 dilution). While the bacteria were growing, ten 15 ml autoclaved red top tubes were 
taken with 3 ml of LB broth and LB agar (2:1 dilution) and were stored at 45 ºC -55 ºC. To 
increase the binding between phage clones and the E.coli cultures, ten 1.5 ml fresh 
autoclaved microcentrifuge tubes were taken with 10 µl of the above phage dilutions and 
200 µl of mid-log phased E.coli culture (OD600~ 0.5) ; this was then allowed to incubate at 
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37 ºC for 5 min. Then, the bound E.coli phage dilution was transferred to the red top tubes 
which were stored, vortexed for at least 10 seconds before pouring onto the freshly prepared 
X-gal/IPTG plates. These plates were kept upside down and incubated overnight preferably 
for 12-14 hours at 37 ºC. 
 
Calculation of Phage Titers: The next day, the plates with few colonies preferably last 
dilution plates containing 25~50 plaques from each eluted page solution were chosen to 
calculate the amount of phage with the equation as follow: For instance, 10 µl of diluted 
phage (from 9th dilution) was introduces to a 3 ml top agar and vortexed. The solution was 
then transferred onto LB-Xgal/IPTG plate and was kept under incubation overnight. As 10 
phage plaques were accounted for on the LB-Xgal/IPTG plate, there calculation for phage 
amount is as follows: 
 
𝑇ℎ𝑒 𝑡𝑜𝑡𝑎𝑙 𝑎𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑝ℎ𝑎𝑔𝑒 =
 10 (𝑝ℎ𝑎𝑔𝑒 𝑝𝑙𝑎𝑞𝑢𝑒𝑠)
0.01 𝑚𝐿 (𝑑𝑖𝑙𝑢𝑡𝑒𝑑 𝑣𝑜𝑙𝑢𝑚𝑒)
× 109 (𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟)     
= 1.00 × 1012 𝑝𝑓𝑢/𝑚𝐿 
pfu: plaque forming unit 
 
In accordance with the phage titers for each round, the phage amount is calculated to create 
a phage pool for the following experiments. 
 
2.1.2.1.3 Plaque amplification  
Plaque amplification is a very crucial step to obtain proper single stranded phage DNA 
sequences. Selecting improper or pooled plaques will lead to the overlapping of phage DNA 
sequences. It is always good to pick an isolated blue plaque from the last two plaque plates. 
By using 1.5 ml blue centrifuge tube tips, each single plaque was picked carefully and 
inoculated with 2 ml of LB broth containing 20 µl (1:100 dilution) of overnight grown E.coli 
culture and incubation was carried out by vigorous shaking at 37 ºC, preferably 250 x g 
speed for 4-5 hours until the optical density at 600 nm observed between 0.4 and 0.6 reached. 
It is important to turn down the shaking speed from 250 to 100 for the last 10 minutes after 
reaching the desired wavelength to make sure that none of the F-pili was lost. After reaching 
the desired optical density at 600 nm, the entire culture was transferred to 2 ml autoclaved 
centrifuge tubes and centrifuged at 12,000 x g for 30 sec. The supernatant was transferred to 
 Chapter 2 : Instrumentation and Experimental Section 
 
 
74 
a fresh autoclaved centrifuge tube and the spinning process repeated. Then, the upper 80% 
of the supernatant was transferred to a fresh autoclaved centrifuge tube. This is called the 
amplified phage stock and can be stored for several weeks (for long term storage the sample 
was mixed with an equal volume of glycerol and kept at -20 ºC to -40 ºC) at 4º C.   
 
2.1.2.1.4 Phage DNA purification (Modified procedure) 
The purity of the DNA samples to be sent for sequencing largely depends on how well the 
purification step is carried out. Autoclaved nuclease free water was used for preparing all 
the solutions for this purification step. 1000 µl of each amplified phage stock solution was 
transferred to a fresh autoclaved centrifuge tube and 400 µl of 20% PEG/ 2.5 M NaCl stock 
solution stored at 4 ºC was added to each centrifuge tube and allowed to stand for 15 min at 
room temperature. This suspension was then centrifuged at 12,000 x g for 10 min at 4 ºC. 
After discarding the supernatant, the remaining material in the microcentrifuge tubes were 
respun at 12,000 x g for 10 min at 4 ºC. Then, the phage precipitate was collected by carefully 
removing (slowly without disturbing the pellet) any remaining supernatant. At this stage, the 
pellet was not clearly visible, but the phage precipitate was first suspended with 100 µl of 
iodide buffer stock by vigorously tapping the tube and then with 250 µl of 70% ethanol. It 
was then allowed to incubate at room temperature for 15 min. This incubation step was to 
preferentially precipitate phage ssDNA leaving all the phage protein in solution. Then the 
suspension was centrifuged at 12,000 x g for exactly 10 min at 4 ºC. Longer incubation times 
or centrifugation of precipitate resulted in co-precipitation of phage proteins and salt. The 
precipitate collected was washed with 0.5 ml of 70% ice cold ethanol and respun at 12,000 
x g for exactly 10 min at 4 ºC. The precipitate which contained pure phage ssDNA was 
resuspended with 17 µl of Tris buffer of pH-8.   
 
2.1.2.1.5 Purity testing of phage DNA using a NanoDrop spectrophotometer 
A Nano Drop™ ND-8000 8-sample spectrometer was used for testing the purity of all the 
phage DNA samples. The principle behind the NanoDrop spectrophotometer is that nucleic 
acids especially nitrogenous bases absorb UV light maximally at a wavelength of 260 nm 
while proteins absorb UV light maximally at a wavelength of 280 nm205,206. After the sample 
loading surface was cleaned with nuclease free water and double distilled water, a drop 
containing 1.5 µl of phage DNA was loaded and measured. The minimum concentration 
needed for the page DNA sample was 15ng/ µl. The purity of the DNA samples was 
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evaluated by calculating the A260/A280 ratio. Ideal DNA samples have an A260/A280 ratio 
of 1.8, but samples having a value between 0.6 and 2.0 were sent for phage DNA sequencing.  
 
2.1.2.1.6 DNA sequencing and analysis 
The DNA sequencing method applied to sequence all the phage DNA samples in this work 
used a modified cycle sequencing technology on Applied Biosystems™ 3730XL sequencing 
apparatus207,208. The cycle sequencing is a modified Sanger’s dideoxy chain termination 
method which contains an additional thermo stable DNA polymerase and fluorescently 
tagged dideoxy nucleotide triphosphates (ddNTPs) unlike the traditional Sanger sequencing 
method209.  
Dideoxy nucleotides are similar to regular deoxy nucleotides, but with one key difference: 
they lack a hydroxyl group on the 3’ carbon of the sugar ring (Figure 2.3, a). In a regular 
nucleotide, the 3’ hydroxyl group acts as a “hook," allowing a new nucleotide to be added 
to an existing chain. Once a dideoxy nucleotide has been added to the chain, there is no 
hydroxyl available and no further nucleotides can be added resulting the chain to terminate 
the growing DNA strand (Figure 2.3, b). The chain ends with the dideoxy nucleotide, which 
is marked with a particular color of dye depending on the base (A, T, C or G) that it carries. 
 
Figure 2.3. Illustration depicting the normal dNTPs and fluorescently tagged 
ddNTPs and their mechanism in DNA synthesis. Panel A shows the structures of normal 
deoxy nucleotide with hydroxyl (OH) group and dideoxy nucleotide without hydroxyl group (H) at 
3’ carbon sugar ring. Panel B show how the extension of DNA strand synthesis happens upon 
addition of deoxy nucleotides (dATP, dCTP, dGTP, and dTTP) while the growing chain terminates 
with the attachment of dideoxy nuclotides (ddATP, ddCTP, ddGTP, and ddTTP) to the 3′ end. Image 
adapted from Applied Biosystems manual 210.  
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This method involves the random incorporation of ddNTPs in the place of dNTPs (deoxy 
nucleotide triphosphate) causing the growing chain to terminate during the process of DNA 
synthesis, thereby separating all the fragments by size on capillary electrophoresis which can 
then be visualised on a chromatogram. The cycle of events that occur during the sequencing 
process include denaturation, annealing, extension and separation by capillary 
electrophoresis (Figure 2.4). The cycle sequencing process starts with the addition of a 
reaction mixture consisting of thermostable DNA polymerase, sequencing primers, dNTPs, 
ddNTPs and buffer comprising of Mg++ and K+ to the original temple thereby activating the 
annealing process. During the DNA synthesis process, the fluorescently labelled ddNTPs 
(ddATP, ddTTP, ddGTP, ddCTP) terminates the reaction. 
 
 
Figure 2.4. Schematic representation of cycle of events that occur in cycle 
sequencing technology. A) Process of denaturation, annealing, extension and termination 
forming DNA fragments in thermal cycler B) Electrophoresis separation of fluorescently tagged 
DNA fragments based on molecular weight. Image adapted from Applied Biosystems manual 210. 
 
In this work, all the phage DNA samples were sent to Eurofins Genomics, UK for 
sequencing. They used a modified cycle sequencing technology and sequenced DNA 
samples via their Applied Biosystems™ 3730XL sequencing apparatus as described above. 
After obtaining the sequenced data from Eurofins, further analysis was carried out to identify 
the target binding peptides. 
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2.1.2.2 Bioinformatics  
A range of bioinformatics tools have been used to identify and analyse the authenticity of 
sequences. These include in-silico sequence convertor, peptide property calculators such as 
Innovagen and Bachem211,212 and peptide database search engine HLAB BDB (Biopanning 
data bank) or formerly called as MimoDB. Moreover, to find any sequence similarities in 
the identified silica binders, the sequence alignment was performed using MSA Viewer213.  
Interpretation of phage DNA sequence:  
The interpretation of sequenced data obtained from Eurofins has been done by primarily 
checking and selecting the good quality chromatogram peaks using Finch TV software 
(http://www.geospiza.com/Products/finchtv.shtml). Then, a series of steps that includes 
interpreting the sequenced data by identifying the anticodon, building the complementary 
strand and translating those codons to amino acid codes was done to recognize the peptide 
that bound to target material as shown below. An example of data processing and analysis 
performed to identify the peptide TVNFKLY was shown as an example in the Figure 2.5. 
 
Figure 2.5. An example of the sequencing data obtained from Eurofins (top) and 
how the peptide TVNFKLY has been interpreted (bottom) and identified. 
 
The in-silico sequence converter214 has been used to build complementary strand for 
identified DNA sequence and translate to amino acids. Innovagen and Bachem peptide 
calculators have been used to investigate the selected peptide physico-chemical properties 
such as charge, pI, amino acid groups, hydrophobicity etc211,212.   
Peptide database search engines: 
Biopanning data bank (BDB) or  formerly called as MimoDB, an online available database 
having a collection of 29,333 peptide sequences that were shown to have an affinity to 
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compounds ranging from small substances to the whole organisms isolated using phage and 
surface display methods215. Besides the peptide sequences, supplementary information that 
relates to the peptide sequences including the target material, template and type of libraries 
collected from public sources including Uniport, GenBank, published works and from 
PDBsum can be found free of cost (http://immunet.cn/bdb/index.php). All the phage 
displayed mineral binding peptides in this project have been checked against MimoDB216,217  
and BLAST218 to find the whole or exact part of phage display or surface display peptide 
sequences that were identical or similar to identified binders. As an example, a screenshot 
of MimoDB Search, Blast, Scan and TUPredict results were shown in Figure 2.6.  
 
 
Figure 2.6. A screen shot showing the result obtained for peptide GQSEKHL using 
MimoDB search, Blast, Scan and TUPredict tools.  
 
Another example includes, the phage displayed peptide sequence TVNFKLY identified as a 
silica binder in this project was found to have affinity for Fe3O4 nanoparticles indicating that 
this peptide might be having promiscuous binding nature to multi-materials. MimoDB 
database consists of few tools which include Mimo Search, Mimo Scan, Mimo Blast and 
Target un-related peptides (TUPs). The default search parameters were used by entering or 
pasting the sequence (either in FASTA format or raw sequence) in the query to obtain the 
data. The MimoSearch will search to find the similar sequence gained by other groups with 
for various targets. While the MimoScan and MimoBlast tools will check for any matched 
pattens or similar query sequences. In addition to BDB search or Blast, the acceptability of 
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the silica binding peptides from this project were checked with TUPrdecit tool from BDB 
databank. This tool was developed using machine learning algorithms and currently three 
predictors are available including PhD7Faster, SABinder and PSBinder215. For example, the 
PhD7Faster tool can be used to predict if phages bearing randomly displayed peptides from 
the Ph.D.-7 library might grow faster due to propagation advantage217,219. The predictor was 
built using Support Vector Machine, trained with peptides from the unselected Ph.D.-7 
library after one round of amplification219. Moreover, the list of peptides reported to bind to 
polystyrene-based components (i.e. TUPs) such as well plates, beads, petri dishes and films 
during biopanning the process is shown in Table 2.3. 
 
Table 2.3. List of polystyrene or plastic binding peptides identified by phage 
display process 
 
No Peptide Sequence  Target Name Phage library  Reference 
1 
PWWWVSWVDAG-
GGSLALPTQPSD 
Polystyrene and 
polyvinyl chloride 
TSAR-12 
phage display 
220 
2 
3 
4 
VDWVGWGASW 
SAWVRWGRVW 
PWNAWGRTWV 
Polystyrene/ 
polyurethane  
(magnetic beads) 
fUSE5-based 
X10 phage 
display library 
221 
5 
6 
WHRWPWLVSG 
WHWWYWALDR 
Polystyrene  
(petri dish) 
X10 phage 
display library 
222 
7 
8 
FHENWPS 
FHWTWYW 
Polystyrene  
(96-well plate) 
Ph.D.-7 223 
9 CRAKSKVAC Dysplastic skin CX7C T7  224 
10 KGLRGWREMISL 
Polystyrene  
(96-well plate) 
FliTrx 
bacterial 
display library  
225 
11 
APFYYSWFPSYM-
AEGLPSPSPLDPV-
QDNLY 
Polystyrene  
(96-well plate) 
Not known 226 
12 
13 
FFPSSWYSHLGVL 
FFSFFFPASAWGS 
Polystyrene  
(96-well plate) 
X6PX6 and 
X6YX6  
227 
14 
15 
RAFIASRRIKRP 
AGLRLKKAAIHR 
Polystyrene  
(petri dish) 
FliTrx 
bacterial 
display library 
228 
16 
17 
GETRAPL 
FPGRPSP 
Syndiotactic 
polystyrene film 
Ph.D.-7 229 
18 FKFWLYEHVIRG 
Polystyrene  
(96-well plate) 
Ph.D.-12 230 
19 
20 
HWGMWSY 
WHWRLPS 
Polystyrene Ph.D.-7 231 
21 TLHPAAD 
Polystyrene 6 well 
plate 
Ph.D.-7 232 
22 VHWDFRQWWQPS 
Polystyrene 96-well 
microtiter plate 
Ph.D.-12  233 
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2.1.2.3 Optimised Biopanning Method and Elution Strategies 
In the optimised biopanning method, a separate batch of M13 Ph.D.-7 phage display library 
(#E8100S, Lot: 0221501) has been used for panning against same batch of already 
characterized amorphous silica nanoparticles. Two alternative elution-based approaches 
(Figure 2.7) were tested. In the first approach, three different elution buffers consecutively 
one after other (Gly-HCl, pH-2.2; MgCl2, pH-6.1; TEA, pH-11) were used during each 
elution step of panning round; while, in the second approach, we used single elution buffer 
(for example, Gly-HCl) but by varying the pH one after other (pH-2.2, pH-7, pH-11) to 
eluate all the phages including the ones that might have been left attached to the silica during 
the traditional biopanning and repanning experiments. The typical protocol used for the 
optimised biopanning methods are discussed in the following sub steps. While, the details 
of phage display experiments and elution conditions used to elute silica binding peptides via 
traditional and optimized elution biopanning methods were shown in the Table 2.4. 
 
 
 
Figure 2.7. Diagrammatic representation of optimised biopanning method by 
exploring elution strategies. A separate second batch (Lot: 0221501) of M13 Ph.D.-7 phage 
display library (#E8100S) has been used for performing the optimised biopanning method. The 
optimised biopanning process presents 2 elution approaches (each differ from the traditional 
biopanning method of Chapter 3) used for Chapter 4: Approach 1 differs from the traditonal 
biopanning method as each mentioned buffers (Gly-HCl, pH-2.2; MgCl2, pH-6.1; TEA, pH-11) are 
used consecutively one after other for each screening (biopanning) round, as appose to one specific 
buffer being used for all rounds in traditional biopanning and repanning experiments (chapter 3); 
Approach 2 only used the same Glycine-HCl elution buffer but at varying pH’s (i.e. Gly-HCl of pH-
2.2; pH-7; pH-11). However, for verifying this optimised elution based biopanning experiments, 
further panning was done by taking the mixture of amplified library attained by mixing together 
the already amplified phage libraries that were obtained from the biopanning round 1 of previous 
separate experiments (Table 2.2) via using Lot 1(Lot: 0211212) of Ph.D.-7 phage display library. 
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Target cleaning step 
1 mg of target silica was washed with 1 ml 0.3% TBST concentration (0.1% 0.3% Tween 
20 in 1ml of TBS, v/v), vortex rotated for 3 min and centrifuged (eppendorf MiniSpin® 
GL010) at 10,000 x g for 4 min. The pellet was collected by removing the supernatant. The 
same process was repeated 3 times to make remove the contaminants from silica surface.   
Binding step 
10 µl of Ph.D.-7 library (Lot: 0221501) containing 1 x 1013 pfu/ml was exposed to 1 mg/ ml 
of silica nanoparticles in TBS buffer at pH-7.5. This phage library-silica precipitate was 
incubated for 1 hour by gently rotating with Eppendorf disk rotator (Eins-Sci E-RDM-A) 
giving sufficient time for phage-silica interaction. 
Washing step 
After 60 min incubation step, washing and spinning cycles were repeated 10 times for each 
biopanning round with 0.1%-0.5% TBST (v/v) concentration used for rounds 1-2 panning 
rounds respectively. After each washing cycle, the phage-silica suspension was vortexed for 
3 min followed by centrifugation at 10,000 x g for 4 min. After each spinning cycle, the 
supernatant was transferred to a fresh 1.5 ml Eppendorf tube and the remaining pellet 
consisting of phage-silica precipitate washed with fresh TBST buffer solution for each wash.  
Elution step  
Here, instead of using single elution buffer throughout out biopanning experiment as in 
traditional biopanning, all the same three elution buffers were used consecutively one after 
other in a single panning round (three step elution), to elute and recover the strongly bound 
silica binders. In the first elution step, 1ml of 0.2 M Glycine-HCl, pH-2.2 was added to the 
final phage-silica precipitate from the last washing step to elute, followed by second and 
third elution steps with 1ml of 4 M MgCl2, pH-6.1 and 100 mM Triethylamine, pH-11 
respectively to remove the strongly bound phages from mineral silica. The solution 
containing phage-silica precipitate in elution buffer was vortexed for 5 min, centrifuged at 
10,000 x g for 4 min and transferred to a fresh micro centrifuge tube. 
Neutralization step 
The supernatant recovered from the last low pH (i.e. 0.2 M Glycine-HCl of pH-2.2) elution 
step was immediately neutralized with 150 µl of 1 M Tris HCl of pH-9.1 by nullifying the 
final solution pH to approximately 7 and stored at 4º C. While the neutralization step in case 
of elution buffers 4 M MgCl2, pH-6.1 and 100 mM Triethylamine was carried out by adding 
50 µl of 1 M Tris HCl of pH-9.1 and 150 µl of 1 M Tris HCl of pH-5 respectively.  
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The above steps were repeated by adding 150 µl of round 1 amplified eluate (i.e amplified 
phage library obtained from each elution step separately) to a fresh 1mg of silica followed 
by doing a series of steps involving washing, elution followed by amplification to get to 
round 2 amplified eluate R2A and then silica binders from round 1 and 2 underwent  titration, 
plaque amplification, purification and sequence analysis as described in section 2.1.2.1.   
 
Table 2.4. Experimental conditions (washing and elution) used for optimised 
biopanning process. The experimental conditions include the number of times and washings 
performed with different concentrations of TBST detergent (0.1%-05% Tween 20 in TBS, v/v) to 
remove weakly bound or nonspecific phage binders from target silica surface; the elution of 
strongly bound phage clones from the silica surface that isolated the silica binders using alternative 
elution methods via three different elution buffers and conditions; the number of biopanning 
rounds and the way successive elution’s carried out during each elution step were shown in the 
below table. 
Biopanning 
round 
Wash times and 
TBST detergent 
concentration (v/v) 
Elution step and conditions 
Elution buffer  pH Eluent 
1 
0.1-0.3% 
5 each 
Total 10 washes  
0.2 M Glycine-HCl 2.2 1st 
4 M MgCl2 6.1 2
nd 
100 mM TEA 11 3
rd 
2 
0.3-0.5% 
5 each 
Total 10 washes 
 
0.2 M Glycine-HCl 2.2 1st 
4 M MgCl2 6.1 2
nd 
100 mM TEA 11 3rd 
 
In this optimised biopanning process, only two biopanning rounds were carried. The 
biopanning rounds were reduced to two to check the effectiveness of the optimised 
biopanning approach. The amplified phages from the biopanning rounds 1 and 2 underwent 
phage titering, plaque amplification, DNA extraction, purification and sequencing as 
described briefly under phage display process section 2.1.2.1. In order to verify the optimised 
elution process, further panning experiments were carried out by exposing fresh silica to 10 
µl of the mix of amplified phage which is prepared by mixing the amplified elute (i.e phage 
populations obtained from initial biopanning tests via using Lot 1 library) stored from each 
biopanning round 1 of traditional biopanning experiments (Table 2.2).  
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2.1.2.4 Repanning Experiments 
To cross check the reproducibility of the above phage displayed sequences, further repanning 
experiments (Table 2.5) were performed by mixing the amplified phage pool obtained from 
the panning round of interest and by taking from each different biopanning experiments. In 
this process, 50 µl from each round 2 amplified eluate (R2A) obtained from separate normal 
biopanning experiments (Exp1, 2, 4, 5 and 6) varying different elution buffers (Table 2.2) 
were mixed together in a clean 1.5 ml microcentrifuge tube and stored at -20 ºC. This mixture 
was named as ‘mix of amplified phage’. The whole biopanning process is then again 
performed starting with incubation step by exposing 50 µl of mix of amplified phages with 
fresh silica followed by repeated multiple steps involving washings (with detergent TSBT 
of 0.5%, 0.7% and 0.9% concentrations for rounds 3, 4 and 5), elution, phage amplification, 
phage titering, plaque amplification, DNA extraction/ purification and sequencing as 
described in section 2.1.2.1.  
 
Table 2.5. Schematic representation of experimental conditions used for 
repanning experiments. The amplified phages obtained from different biopanning 
experiments where a small number of sequences screened were mixed together to verify the 
reproducibility of previously identified peptide sequences. 
Experiments 
checked by 
repanning 
Amplified phage stocks taken 
and mixed together from 
Re-
panned 
till what 
round 
Experiment
al numbers 
performed 
order 
Elution 
buffers 
used 
pH 
condition 
Library 
lot 
number 
Experiment 
numbers 
Round 
Repanning experiments to check traditional biopanning method 
Initial 
biopanning 
(Chapter 3) 
Lot 1 
0211212 
1,2,4,5 and 
6 
2 3-5 7 Glycine
-HCl 
Low pH, 
2.2 
8 Triethyl
amine 
High pH, 
11 
Repanning experiments to check optimised biopanning method (Chapter 4) and as 
comparator for traditional biopanning method (Chapter 3) 
Optimised 
biopanning 
(Chapter 4) 
Lot 1 
0211212 
1,2,4,5 and 
6 
2 3 n/a Glycine
-HCl 
Low pH, 
2.2 
     MgCl2 High salt 
pH-6.1 
 Triethyl
amine 
High pH, 
11 
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Figure 2.8. Schematic representation of repanning method. The amplified phages 
obtained from different biopanning experiments where a small number of sequences screened 
were mixed together to verify the reproducibility of previously identified peptide sequences.  
 
In this study, 2 different repanning experiments were carried out with each experiment using 
one of the elution buffers (0.2M Glycine-HCl, pH-2.2 or 100 mM Triethylamine, pH-11). 
The detailed step by step phage display process was explained in section 2.1.2.1. Encouraged 
by the optimised elution biopanning approach results, we tried both elution strategies on 
M13 Ph.D.-7 phage display library (#E8100S, Lot: 0211212) by taking the previously stored 
amplified stocks from round 1 of different experiments (experiment 1, 2, 4, 5 and 6 as 
described in Figure 2.8) to check the reproducibility and to verify the optimised elution 
biopanning process.  
 
2.1.2.5 Selection of Single Phage Clones for Binding Studies 
The individual phage clones displaying peptide of interest have been selected from the above 
phage titering (blue-white screening method) and plaque amplification steps. As mentioned 
in section 2.1.2.1.3, under plaque amplification step, each single plaque from the last titering 
plates were carefully picked using 1.5 ml blue centrifuge tube tips and inoculated to an 
individual 10 ml red top tubes with 2 ml of LB broth containing 20 µl (1:100 dilution) of 
overnight grown E.coli ER2738 culture. Incubation was then carried out by vigorous shaking 
at 37 ºC, preferably 250 x g speed for 4-5 hours until the optical density at wavelength 600 
nm observed was between 0.4 and 0.6. After reaching the desired optical density at 
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wavelength 600 nm, the entire culture was transferred to 2 ml autoclaved Eppendorf tubes 
and centrifuged at 12,000 x g for 30 sec. The supernatant was transferred to a fresh 
autoclaved Eppendorf tubes and the spinning process repeated. Later, the upper 80% of the 
supernatant was transferred to a fresh individual autoclaved Eppendorf tube. This is called 
the amplified phage stock and was stored few weeks at 4 ºC. The amplified phage stock 
samples containing individual clones were divided into two lots. One lot was initially stored 
for few weeks at 40C to perform titering experiments and later moved to -20 ºC. While the 
other lot were mixed with equivalent amounts (1:1 ratio) of sterile glycerol and stored at -40 
ºC. However, the amplified phage stock solutions can be stored for several years (long term) 
by mixing the samples with an equal volume of glycerol and by storing at -40 ºC to -80 ºC. 
At this step, we have sent 1 ml for sequencing and the remaining 1 ml was marked and stored 
at 4 ºC. This amplified phage stock solution containing 1 ml of same type of single phage 
plaque underwent phage amplification, DNA extraction and sequencing as defined in 
sections 2.1.2.1.1, 2.1.2.1.4 and 2.1.2.1.6. Each single plaque will have single silica binding 
phage DNA sequence which was identified after performing the DNA extraction and 
purification (refer section 2.1.2.1.4) and sequence analysis. After identifying the peptide 
from the sequence analysis results, the selected phage clone samples of known sequences 
were further amplified in E.coli followed by purification step as mentioned earlier. The 
known peptide sequence displaying individual phage clones were further used for relative 
binding experiments and for TEM studies. 
 
2.1.2.6 Synthesis and Characterization of Silica Binding Peptides and Nanoparticles 
To avoid any inconsistent results, the same batch of amorphous silica nanoparticles of size 
82 ± 4 has been used for phage display and binding studies that were already available in the 
Perry laboratory and had been synthesized by the Stöber process and characterized using 
varied techniques4,107,234. The physical properties including surface chemistry of silica 
nanoparticles (Table 2.6) had been reported in our previous papers4,107. 
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Table 2.6. Structural properties of silica nanoparticles including surface 
chemistry. a Specific surface area was determined using the Brunauer−Emmett−Teller (BET) 
method in the range of 0.05 < P/P0 < 0.35. b Barrett−Joyner−Halenda (BJH) desorption pore volume 
and size were calculated between 2 and 300 nm. c Determined from TGA measurements. The table 
was reprinted from ACS4,107. 
sample size 
(nm) 
SSA 
(m2 /g)a 
pore volume 
(cm3 /g)b 
pore size 
(nm)b 
#OH/nm2c ζ, pH 7.4 
(mV) 
pzc 
SiO2-82 82 ± 4 65.0 ± 0.3 0.334 32 4.5 −38 ± 5 2.4 
 
 
Selected peptides (LPVRLDW, NDLMNRA, GQSEKHL, GASESYL, KIAVIST, YSLKQYQ-
OH, YSLKQYQ-NH2, ADIRHIK-OH, ADIRHIK-NH2, HYIDFRW-OH and HYIDFRW-NH2) 
identified by phage display were synthesized and chemically modified using automated 
single channel microwave assisted solid phase peptide synthesizer (CEM Corporation 
Liberty1) by following the standard peptide synthesis procedure via Fmoc chemistry as 
stated in section 2.1.2.6.1. These synthesized peptides were characterized by HPLC and mass 
spectrometry. The list of peptides synthesised including their molecular weights, the number 
of times peptides were synthesised, HPLC and Mass spectrometry measurements and the 
type of binding study they were used for can be seen from the Table 2.7. 
Table 2.7. List of silica binding peptides synthesized and their characterisation 
measurements using HPLC and Mass spectrometry. 
Peptide 
Sequence 
Mol.Wt 
of pep 
(g/mol) 
MALDI-TOF 
mass analysis 
(g/mol) 
HPLC of 
pep purity 
(%) 
Times 
peptide 
synthesized 
Type of binding 
studies peptides 
used for 
KIAVIST 730.89  731.41 93.8 1 
Verification 
(Fluorescamine 
assay and Raman 
spectroscopy) 
LPVRLDW 898.07 898.3 898.5 92 94 2  
NDLMNRA 832.94 833.3 833.3 72 80 2 
GQSEKHL 797.87 798.3 798.4 92 95 2 
GASESYL   725.75 726.06 726.2 93 94 2 
YSLKQYQ-Acid 929.03 N/A 94 1 
Verification 
(Fluorescamine 
assay and TEM) 
YSLKQYQ-Amide 928.04 N/A 93 1 
ADIRHIK-Acid 852 N/A 94  1 
ADIRHIK-Amide 851.01 N/A 98 1 
HYIDFRW-Acid 1036.14 N/A 78  1 
HYIDFRW-Amide 1035.16 N/A 73 1 
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2.1.2.6.1 Solid phase peptide synthesis (SPPS) 
Solid phase peptide synthesis (SPPS) has become an essential day to day laboratory tool for 
constructing synthetic peptides under controlled chemical conditions due to their vast usage 
in academia and industry. In 1963, Merrifield revolutionised peptide science by synthesizing 
a tetra peptide using a cross linked polystyrene solid support that allowed the anchoring of 
Nα-amino acids resulting C to N terminus peptide formation235. The principle (Figure 2.9) 
of SPPS is based on the acid liable attachment of C-terminal amino acid to an insoluble 
polymeric solid support (resin) and subsequently extending the length of the peptide chain 
by a series of repeated chemical steps including deprotection, activation and coupling236,237. 
Once the desired peptide synthesis is completed, the unwanted resin and side chain 
protecting groups are removed by simultaneous deprotection and cleavage steps. Further, 
these cleaved and deprotected free peptides are filtered and washed before freeze drying. To 
cleave the Nα-protecting groups, either mild or harsh chemicals are used. Usually, free 
peptides are precipitated and washed in chilled suitable organic solvents (eg. diethyl ether).  
This SPPS method is suitable to synthesize small proteins and in particular peptides due to 
convenience of using excess reagents, easy removal of any unreacted products or by products 
and no need of purification and characterization steps each time after the addition of new 
amino acid and most importantly minimal loss of peptide due to peptide being anchored to 
solid support during the entire synthesis process238–240. The most commonly used chemistries 
to protect Nα-amino acid (AA) side chain groups include 9-fluorenylmethoxycarbonyl 
(Fmoc)241 and t-butyloxycarbonyl (Boc)242. Here, N-terminus Fmoc amino acid groups are 
acid stable but base liable while the temporary side chain protecting groups are acid liable 
and base stable. 
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Figure 2.9. General principle and scheme of solid phase peptide synthesis via 
Fmoc chemistry. First, the Nα- protected C-terminal amino acid is anchored to the insoluble 
solid supported resin with the help of linker. Subsequently, the desired peptide will be assembled 
by elongating the length of the peptide chain by a cycle of repetitive chemical steps involving 1) 
deblocking of the temporary Fmoc protecting amino acid group 2) activation of carboxy group of 
new incoming amino acid 3) coupling.  Once the chosen peptide length is achieved, the unwanted 
resin and side chain protecting groups will be removed by performing final deprotection and 
cleavage steps. Later, these cleaved and deprotected free peptides will be washed and purified. 
Image reproduced from Sigma Aldrich website. 
 
However, the success of SPPS depends upon the choice of selecting the right resins, linkers, 
and protected groups and using suitable chemical reagents at appropriate times either to 
activate or remove specific side chain amino acids during the activation, deprotection,  
coupling, cleavage and purification steps236,243. Harsh acids like trifluoroacetic acid (TFA) 
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and hydrofluoric (HF) are used to release Boc-protected groups and completed peptide from 
the solid support242. While, Fmoc protected groups can easily be removed under mild 
conditions using a combination of piperidine and N, N-dimethylformamide (DMF)241. 
Solvents such as DMF, N-methyl-2-pyrrolidone (NMP), are used for coupling and removing 
Fmoc protected groups under microwave energy244. While N,N-dicyclohexyl-carbodimide 
(DCC) or diisopropylcarbodiimide (DIC), N,N-diisopropyl-ethylamine (DIEA) along with 
a combination of DMF, HBTU or Hydroxybenzotriazole (HOBt) helps in swelling resins 
and activating incoming acid by reacting with carboxylic acid group thereby improving 
coupling reaction240.  
Protocol: 
In this study, selected peptides identified by phage display have been synthesized using an 
automated single channel microwave assisted solid phase peptide synthesizer (CEM 
Corporation Liberty1) by following the standard peptide synthesis procedure via Fmoc 
chemistry as described above. These peptides have been programmed in such a way that C-
terminal end group ended up with either acid (OH) or amide (NH2) groups. Preloaded Wang 
resins protected with Fmoc chemistry have been used as a solid support and for initiating the 
peptide synthesis reaction in a vessel. For example, 7-mer peptide ADIRHIK was preloaded 
with Fmoc protected lysine (K) Wang resin as a starting point to initiate peptide synthesis 
reaction and ended up recovering final peptide as ADIRHIK-OH or ADIRHIK-NH2. The 
other chemicals that were used in this process include DMF for swelling resin and as a 
system solvent for rinsing, piperazine mixed with DMF for removing N-terminal protected 
groups, HBTU mixed with DMF for coupling reactions, DIEA mixed with DMF for 
activating the new incoming amino acid, TFA mixed with thianisole (TIS), 3,6-Dioxa-1,8-
octanedithiol (DODT) and ddH2O for cleaving and removing unwanted protected side 
groups of final peptide and diethyl ether for precipitating and filtering pure peptide.  
The first list of peptides synthesised was selected mainly based on experimental phage 
display results that include LPVRLDW, NDLMNRA, GQSEKHL, GASESYL and KIAVIST. 
The second list of peptides such as YSLKQYQ, ADIRHIK, HYIDFRW were selected by taking 
various parameters into consideration including phage experimental results, physo-chemical 
properties and bioinformatics analysis. Additionally, these peptides were synthesized by 
chemically modifying the C-terminal end groups with amide (i.e YSLKQYQ-NH2, 
ADIRHIK-NH2, HYIDFRW-NH2).  
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2.1.2.6.2 High performance liquid chromatography (HPLC) 
Chromatography is the process of separating or isolating a compound from a mixture. This 
is a powerful and versatile single-step process for modern analysts. There are many forms 
of chromatography depending on the phase of the sample (gas, liquid or solid) and the type 
of analyte (enantiomer, ionic and etc.) required for isolation245. The Russian botanist M.S. 
Tswett was among the first scientist to recognise the separation method, as he used a 
rudimentary form of liquid-solid chromatography to separate the plant pigments246,247. Also, 
this seems to be the origin for the prefix ‘chroma’ in the word chromatography; although 
color has little to do with separation, the word has persisted246,247. High-performance liquid 
chromatography (HPLC) is a leading technique for chemical analysis to separate, analyse 
and/or purify almost any sample. HPLC begins by placing the sample in a tray for automatic 
injection into a packed column (usually silica). A solvent is pumped constantly into the 
column resulting in compounds to separate according to their affinity to the packing (Figure 
2.10). The separated compounds are then sensed by the detector as they leave the column. 
The coupling of HPLC with MS allows for the further separation and detection as the 
fragmented analytes are detected according to their m/z ratio248–250. A significant 
development has been made in the types HPLC, yet reverse-phase chromatography (RPC) 
is the most widely used for the sample preparation or separation. This techniques has a 
significant impact of proteomics where enriched, trapped, pre-fractionated or desalted 
peptides can be eluted and separated on column251. 
 
Figure 2.10. Illustration depicting the instrumentation principle and working 
mechanism of HPLC. 
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Protocol: 
In this peptide study, RP-HPLC (Dionex) equipped with a UV detector fixed at 214 nm and 
Phenomenex made reverse phase porous column (Jupiter® 4 µm Proteo 90 Å C12) has been 
used to detect the purity of lyophilized (VirTis® 110 freeze dryer) peptides. The stationary 
phase in the column is tightly packed with porous silica particles that are functionalized with 
hydrophobic groups which can help in binding to an analyte. While, for eluting the analyte, 
a mixture of solvents has been used to construct two different mobile phase gradients 
comprising of HPLC graded acetonitrile and water. First mobile phase (highly polar) consists 
of a mixture of 95% acetonitrile, 5% water and 0.01% TFA, whereas for second mobile 
phase, the nature of polarity decreased by changing the acetonitrile and water percentages to 
5% and 95% respectively. Priming and degassing was performed for both mobile phase 
solvent mixtures to adjust the column by clearing the impurities present earlier. The Peptide 
sequence along with a multitude of other factors will influence the retention time of the 
analyte on the column, this may result in a higher/ lower affinity for a non-silica binding 
sequence but then this is silica with C12 groups and capped silanols on the surface so no 
significant amounts of free SiO2 groups are present for binding to silica binding sequences. 
Also, the electrostatic interactions with the silica surface is reduced by running in TFA 
(0.01% TFA pH ~ 1.8 – 2.0) which would provide slightly protonated silica by allowing only 
hydrogen bonding and van der waals interactions with the peptides. In addition to this, the 
column used has been end capped with TMS (trimethyl silane) which effectively blocks 
access to the silica surface to the peptides by replacing any residual Si-OH with Si-methyl 
groups. As a result, the silica binding peptides were eluted out without binding to the column 
that is packed with silica. 
For comparison, a blank sample consisting of 50% HPLC graded water, acetonitrile and 
0.01% TFA was run before and after each peptide sample run. Furthermore, Chromeleon® 
software has been used for processing the data peaks thereby analyzing the purity of the 
peptide samples. The purity of first list of peptides LPVRLDW, NDLMNRA, GQSEKHL, 
GASESYL and KIAVIST was measured as 94%, 80%, 94%, 95% and 94% respectively 
(Appendix 2.1). On the other side, the purity of second list of synthesized peptides 
YSLKQYQ-OH, YSLKQYQ-NH2, ADIRHIK-OH, ADIRHIK-NH2, HYIDFRW-OH and 
HYIDFRW-NH2 was measured as 93.8%, 92.9%, 94.1%, 97.7%, 77.3% and 72.9% 
respectively (Appendix 2.2). 
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2.1.2.6.3 Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) 
mass spectrometry  
Mass spectrometry (MS) is an analytical technique for studying masses of atoms, molecules 
or fragment of molecules such as proteins and peptides. The instrument (Figure 2.11) 
consists of an ion source to produce ions from the sample, a mass analyser for the separation 
of the various ions according to their m/z ratio and the detector. Mass spectrum is obtained 
when gas-phase ions of compounds are produced by ionising the condensed phase. The 
molecular ions undergo fragmentation252. The ions are accelerated by an electric field, then 
through a magnetic field where ions are separated according to their mass-to-charge ratio, 
m/z. The area of peak in each mass spectrum is proportional to the abundance of each 
isotope. The magnet within the mass spectrometer, deflects the ions towards the detector; 
where the trajectory of each ion varies with their respective mass and magnetic field 
strength253–255. Mass spectrometry has been used to classify amino acid sequences in 
proteins, nucleic acids in DNA and structure of complex carbohydrates256,257. MALDI 
requires less sample preparation and is popular for the analysis of biomolecules such as 
oligonucleotides, proteins and glycoproteins258–261. 
 
 
Figure 2.11. Illustration describing the principle and mechanism of MALDI-TOF 
mass spectrometry. 
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The technique ‘Matrix-Assisted Laser Desorption’ was first mentioned in the paper by Karas 
et al. 1985262. MALDI-MS samples are prepared by embedding the analyte in a matrix 
(crystalline structure of small organic compounds) and deposited on a conductive sample 
support. This forms a co-crystal which is then irradiated with a high energy (commonly UV) 
laser pulse with a wavenumber of 266 or 337 nm. The bombardment of the laser causes a 
structural decomposition of the cocrystal and generates a plume of particles from which ions 
are extracted travelling by the electric field. The mechanism (Figure 2.11) for the process of 
desorption is best described as the conversion of the laser energy into vibrational oscillation 
of the crystal molecules. After acceleration of the ions through the electric field, the ion drifts 
through a field-free path and reaches the detector 263,264. The pulse generation of ions in the 
MALDI technique lent itself to be used in combination with time-of-flight (TOF) mass 
analysers 265. 
Protocol:  
For this peptide study, an automated matrix-assisted laser desorption ionization time-of-
flight (Bruker Ultrflex III TOF/TOF) mass spectrometer has been used to characterize the 
quality of lyophilized (VirTis® 110 freeze dryer) peptides based on the molecular mass of 
the peptides. The fragments separated based on mass to charge ratio (m/z) with MALDI-
TOF/TOF and MS/MS spectrums have been considered for identifying the peptides. The 
data for these peptides was performed and collected at Van Geest Cancer Research Centre, 
NTU by Dr. Graham Hickman (postdoc within the Perry group) with a resolution mass in 
between 700 and 6000 Da as well as using Bruker Daltonicflex analysis software. A mixture 
of mass spectrometry and HPLC graded solvents comprising of a mixture of 50% 
acetonitrile, 50% water and 0.1% formic acid has been used to run peptide samples (1mg/ 
ml). A blank sample consisting of the same mixture (prepared for peptides) was run before 
running each peptide sample. The Bruker Ultraflex MS system is calibrated with 
ProteoMass™ Peptide Calibration Kit (Sigma) which includes a series of calibration 
standards across the range of 756.3997 to 3,494.6513 Da. The molecular weight of the 
peptides LPVRLDW, NDLMNRA, GQSEKHL, GASESYL and KIAVIST was measured as 
898.5 g/mol, 833.3 g/mol, 798.4 g/mol, 726.2 g/mol and 731.41 g/mol respectively 
(Appendix 2.3).  
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2.1.2.7 Silica-Peptide Binding studies 
2.1.2.7.1 Fluorescence spectroscopy  
Fluorescence spectroscopy is a special type of electromagnetic spectrofluorometry 
commonly used to measure the emitted fluorescence from a sample266. The principle of 
fluorescence can easily be explained using Jablonski diagram (Figure 2.12, a). When a light 
hits the molecule, the electrons get excited by reaching a higher energy level. An excited 
state of any molecule is short-lived, the electrons from higher energy state can undergo non-
radiative transition or vibration relaxation. Furthermore, the electrons from excited 
vibrational level state slowly reaches to the lower vibration state and making it possible for 
the electron to return to the ground state. This flow of emission is termed as fluorescence.  
On the other hand, fluorescamine, a non-fluorescent dye reacts rapidly with primary amine 
groups of proteins or peptides that are found attached to terminal amino acids or positively 
charged ε-amino group of lysine, thereby forming a fluorescent compound that can be 
measured using fluorescence spectroscopy (Figure 2.12, b).   
 
 
Figure 2.12. Illustration depicting the working principle of absorption and 
fluorescence spectroscopies and fluorescamine binding mechanism to proteins. 
a) Jablonski diagram depicting the mechanism of absorption and fluorescence emissions including 
their electronic and vibrational transitions of a molecule and the transition between them 267. b) 
Reaction mechanism of fluorescamine and primary amine groups of terminal amino acids 268. 
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Several assays based on fluorescence have been established for quantifying the proteins or 
peptides in an effort to improve the absorbance-based assays such as Bradford and Lowry269. 
Fluorescamine is a non-fluorescent compound upon interaction with peptides rapidly reacts 
with primary amines that are present attached to the terminal end of biomolecule or with ε-
amino side chain residue of lysine, hence forming a fluorescent product which can be 
measured by Fluorescence Spectroscopy270. This assay measures the fluorescence intensity 
of total protein content present in the samples using fluorescamine assay protocol. Thus, 
provided that calibration data is available for the particular protein/ peptide and can be used 
in our peptide-silica binding studies. Note, the amount of peptide remaining in solution at 
specific time points is measured and the amount of peptide adsorbed to silica surface 
calculated by difference to the amount present at the start of the reaction.  
The limitations or issues with method include i) The reagent is unstable (i.e) non-fluorescent 
compound fluorescamine reacts readily with the primary amino groups in milliseconds, 
thereby forming a fluorescent compound. However, the unreacted compound gets 
hydrolysed in seconds and removing the fluorescamine from the reaction. Hence, the 
measurements were taken immediately after adding fluorescamine to samples. ii) The assay 
is not well-suited with amine-containing buffers. Hence, phosphate buffer saline was used 
not TBS which can interfere with the experiment. iii) Sensitivity depends on the number of 
amines present and is limited to solution-based studies. 
Protocol: 
For studying the peptide-silica binding, samples prepared on 96-well plate (Corning® black 
polystyrene) using fluorometric quantification assay method271,272 were stained with 
fluorescamine dye which effectively binds to primary amine groups of peptides273. This non-
fluorescent upon interaction with peptides rapidly becomes fluorescent in nature by forming 
fluorophore270. The procedure used for preparing sample was schematically shown in Figure 
2.13. A calibration line was initially plotted by preparing a series of dilutions of the peptide 
of interest with the known concentrations of peptide ranging from 0.2-1.6 mM in phosphate-
buffered saline buffer of pH-7.5. 
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Figure 2.13. Schematic representation of fluorescamine assay protocol used for 
preparing samples.  
 
On the other hand, a series of samples were prepared in individual 2 ml Eppendorf tubes by 
adding suspension of silica nanoparticles (1 mg/ ml) in phosphate-buffered saline buffer and 
sonicated for 1 hour to uniformly disperse the particles. To the sonicated suspension, suitable 
amounts of peptide (concentration ranging from 0.2-1.6 mM) was added to all the Eppendorf 
tubes containing PBS dispersed silica nanoparticles to achieve the desired initial peptide 
concentration. These mixtures were then shaken vigorously and left them for incubation for 
1 hour at room temperature. At this point centrifugation was performed at 11330 x g for 5 
min. Then the supernatant was transferred to a new clean Eppendorf tube followed by 
quantifying the amount of peptide left in the solution. Thereafter, 180 μl of the supernatant 
solution along with 20 μl of fluorescamine (5 mg/ ml) in acetonitrile was added to a 96-
wellplate (Corning® black polystyrene) and the fluorescent intensity of the samples was then 
measured using fluorescence multiplate reader (TECAN Infinite® M200 PRO) by setting 
excitation and emission wavelengths at 360 nm and 465 nm respectively4,107.  The 
concentration of each peptide was measured using a peptide calibration curve, and the 
amount of peptide adsorbed was calculated by the difference from the initial peptide 
concentration. To attain the best signal-noise ratio, the gain was set at 60 a.u. All assays were 
repeated for 2-3 times to get reliable and best fitting data. 
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2.1.2.7.2 Raman spectroscopy 
Raman spectroscopy is a scattering technique, commonly used to detect vibrational, 
rotational and low frequency movement of molecules in the system. Over the past decades, 
it has become a versatile research or analytical tool for applications ranging from biomedical 
to pharmaceutical and even for analysing nanomaterials274–277. The principle is based on 
inelastic scattering of light (Figure 2.14). When a monochromatic incident light hits the 
molecule or crystal, the photons of light get scattered in all directions. Most of the scattered 
light has a frequency (wavelength) equal to that of the incident light and is called Rayleigh 
scattering. A tiny fraction of the scattered light has a frequency different from that of the 
incident laser light and is called Raman Scattering. The difference in the energy frequency 
of the incident and the scattered light represents the characteristics of the molecule vibrations 
or bonds and is used to construct a Raman spectrum. If the scattered light has a frequency 
lower or higher than the incident light, Anti-Stokes and Stokes Raman appear respectively.   
 
 
Figure 2.14. Working principle of Raman spectroscopy. Raman scattering is based on 
the frequency of incident and scattered radiations upon laser hitting the sample forcing the sample 
to vibrate forming Rayleigh, anti-stokes and stokes Raman spectrum. Image adapted from HORIBA 
Scientific webinar 278. 
 
Raman spectroscopy is well suited for solid and liquids due to its advantages. i) Minimum 
sample preparation is needed, for example 1mg for solids and 50-100 μl for liquids. ii) 
suitable for both solids and liquids iii) has much weaker signal for water than any other 
materials, hence the analysis of solids or particles becomes easy with no interference of 
water. iv) non-destructive and quick. However, using an intense laser power can destroy the 
samples and is not suitable for studying of metals or metal composites275.  
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Protocol: 
In this work, Raman spectroscopy has been used for the identification of peptide LPVRLDW 
and to probe its interaction with silica particularly to see the changes in the amino acid 
residues. For analysing the sample, the Nicolet iS50 spectrometer equipped with a 785 nm 
near infrared laser with power 2.5 Watt has been used. While, Thermo Scientific OMNICTM 
software was used for fitting the mixture spectra. The samples prepared for Raman analysis 
include solid samples of silica alone (1 mg), peptide LPVRLDW alone (1 mg), and the mixture 
of peptide LPVRLDW-silica samples including liquid air-dried (1mg of peptide-silica 
suspension in 1ml in water w/v), solid powdered (1 mg of peptide with 1 mg of silica w/w) 
and the samples from fluorescamine assay (1mg of peptide-silica suspension in 1ml in PBS 
w/v). The precipitated peptide samples (adsorbed to silica nanoparticles) obtained from the 
fluorescamine assay (after the centrifugation step) were washed twice with water, air-dried 
and investigated using Raman spectroscopy to see if change in the peptide structure on 
binding could be identified. 
 
2.1.2.7.3 Transmission electron microscopy (TEM) 
Transmission electron microscope (TEM) is one type of electron microscope. It operates in 
the same manner as a light microscope but uses electron as opposed to light. The electron 
within the TEM is generated by the source. The source contains an anode and a cathode, 
which when heated, emits electrons which are then accelerated toward the specimen (Figure 
2.15, a). Electrons at the rim of the beam will plunge onto the anode while the others will 
pass through the centre small hole of the anode. Electrons become scattered as the beam of 
electrons pass through the thin section of the specimen. A series of electromagnetic lenses 
focus the scattered electrons into an image or diffraction pattern (Figure 2.15, b), or a nano-
analytical spectrum, depending on the operating mode. TEM has application in various 
diagnostic fields such as cancer research, virology, pathology and material science and 
pollution279–281.  
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Figure 2.15. Diagrammatic representation of TEM working principle and 
mechanism a) The schematic outline of a TEM b) A ray diagram from the diffraction mechanism 
in TEM. Image adapted from 279,282. 
 
For studying the peptide-silica interactions, TEM (JEOL JEM-2010) equipped with LaB6 
emitter (filament) and with 80-200 kV operating voltage range was used. TEM grids used 
for sample analysis were coated with Poly-L-lysine and/ or paraformaldehyde. A non-
radioactive dye EM Stain 336 (Uranyl Acetate Alternative) purchased from agar scientific, 
diluted 4x times in double distilled water (ddH2O) was used to stain the peptide-silica 
complex affixed on TEM grid. The uranyl type acetate ions present in the dye binds to 
peptides which can be visualized under TEM. Furthermore, the stained samples were washed 
with ddH2O and air dried at room temperature before analyzing with TEM. For comparison, 
silica alone, silica with dye and Ph.D.™-7 phage display peptide library (New England 
Biolabs) with dye was observed under TEM. 
Protocol: 
The JEOL 2010 TEM has been used to examine the phage bound to silica and observe the 
surface morphology of the silica particles. The amplified phage clones displaying the 
selected peptides YSLKQYQ, ADIRHIK and HYIDFRW were mixed with silica nanoparticles 
(1mg/ ml) and incubated on either Poly-L-lysine and/ or paraformaldehyde coated TEM 
grids. The TEM grid containing silica-phage suspension was washed thrice with distilled 
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water to remove weakly bound phages followed by adding a drop (roughly 5 μl) of EM stain 
336 diluted in water (purchased from Agar Scientific) and left for 30 min at room 
temperature for the dye to stain phage peptides. Then the grids were air dried before washing 
three times with distilled water by adding drop by drop leaving 10 sec intervals between 
each drop (roughly 5 μl). These air-dried samples were visualised under TEM by setting the 
voltage as 2000 volts and using LaB6 filament to confirm the phage-silica binding. The 
known peptide sequence displaying YSLKQYQ, ADIRHIK and HYIDFRW single phage 
clones were selected for probing phage-silica binding studies using TEM. The process by 
which these phage clones were prepared has already been described in section 2.1.2.5. 
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Chapter 3: Selection and Screening of Silica Binding Peptides 
by Phage Display Process 
 
3.1 Introduction 
Over the last two decades, silica has attracted considerable interest because of its developing 
use in bio- and nano-technology. Silica is commonly found in nature as quartz, which is in 
crystalline form but with metal impurities thereby limiting its usage in scientific and 
industrial applications283. Thus, to meet the rising demand of pure silica nanoparticles with 
controlled size and shape, synthetic routes are being used to synthesize silica nanoparticles 
with improved physical, chemical and functional properties106,133,284. 
In recent years, amorphous silica nanoparticles have gained tremendous attention for their 
growing applications in biomedical285 and nanomedical applications286, mainly due to its 
distorted structure, comparatively higher surface area, decent permeability with cell or 
plasma membranes, very low to no toxicity compared with crystalline silica nanoparticles. 
The unique characteristics of amorphous SiNPs including biocompatibility and 
biodegradation with biological or cellular systems combined with functionalisation makes 
them unique candidates for nanomedical applications286. The toxicity of amorphous SiNPs 
in biological systems is directly dependant on various physical, chemical and environmental 
factors such as the particle size, shape, crystallinity, surface functionalisation, chemical 
composition, dosage, time and type of organism or cell lines exposed in vitro or in vivo 
conditions64,287–291. For instance, studies have shown that with decrease in the size or surface 
area of the SiNPs (< 20 nm) the toxicity was increased causing cytotoxic damage to cells 
thereby affecting the cellular uptake process292–294.  
To date, a wide range of synthetic SiNPs have been generated by tuning their chemical and 
functional properties either by directing silica nanoparticles themselves or by modifying 
them with inorganic or organic molecules. For example, the abundant number of hydroxylic 
groups on the silica surface allows them to be used for further functionalization, including 
moieties such as carboxyl295, amine296,297, methyl296,297 phenyl298 or thiol299 groups leading 
to functionalized silicas. Furthermore, SiNPs have also been functionalized with dye 
molecules to generate fluorescent silica NPs in order to study biological processes and 
conduct cell imaging assays300,301. A study carried out by Ha et al. showed that fluorescent 
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SiNPs can increase thermal, photochemical, and pH stabilities as well as its biocompatibility 
for in vivo assays302.  
The organic molecules reported to bind to silica NPs include proteins (silica binding 
peptides, antibodies or antibody fragments, enzymes and streptavidin or avidin BPs4,12,303–
306, cells (bacterial or viral)134,307,308, nucleic acids (DNA or RNA)135,309 and other targeting 
molecules (ligands and peptide motifs)310,311. Although nanomaterials have been designed 
and produced decades ago, their utilization in nano- or bio-technology is limited due to poor 
solubility, stability and biocompatibility issues. Several strategies have been developed to 
overcome the potential safety concerns including poor solubility, stability and 
biocompatibility issues; and eventually, phage display technology was able to provide 
greater control over the nanomaterials.  
Phage display technique, initially developed for screening biological targets (as mentioned 
in section 1.1.1, Chapter 1) has now become ubiquitous in selecting and screening peptides 
having high affinity towards a range of inorganic material surfaces. Until now, a range of 
biomimetic peptides displaying  specific affinity and molecular recognition for metals 
(Ag142–144, Au7,19, Pt66, Pd142), metal oxides (SiO2
4,10,24,65,145, ZnO146,147, TiO2
8,59,148, 
Fe2O3
149,150, IrO2
151, Al2O3
10,152, Cu2O
146), minerals (calcite, hydroxyapatite, graphite, mica, 
sapphire)153–155, semiconductors (CdS, GaN, GaAs and ZnS)23,86,156, carbon materials 
(graphene, carbon nanotubes)157,158 and polymer materials159,160 have been isolated.  
 
Further, these material specific peptides have been used as creators and builders for 
synthesizing simple to complex bio- or nano-materials, mediating the controlled 
biomineralization process147,312,313, directing self-assembly and nanofabrication of ordered 
structures93,125,153,186,189,314–316, facilitating the immobilization of functional biomolecules and 
for constructing inorganic-inorganic or organic-inorganic nano hybrids6,8,151,181,317. More 
details of inorganic material binding peptides and their applications were discussed in 
section 1.4.  
 
In the recent years, several groups have identified silica binding peptides using Ph.D.-7 and 
Ph.D.-12 random peptide display libraries as shown in Table 3.1. Further, these peptides 
were utilised in various applications including nanomaterial synthesis24,65,192 and to 
understand the mechanisms involved at silica-biomolecule interface4,59,107,124,132. Further 
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details of silica-biomolecule interactions and their applications have been discussed in 
section 1.2.2.   
 
Table 3.1. List of silica binding peptides reported in literature that were 
identified by phage display technique. 
No Peptide Sequence Target 
info 
Biopanning 
round 
screened 
Phage peptide 
library type 
Reference 
1 
 
APPGHHHWHIHH 
MSASSYASFSWS 
KPSHHHHHTGAN 
Silica 
 
3 Ph.D.-12 24 
2 
 
MSPHPHPRHHHT 
MSPHHMHHSHGH 
LPHHHHLHTKLP 
APHHHHPHHLSR 
RGRRRRLSCRLL 
Silica 
 
4 Ph.D.-12  
3 
 
HPPMNASHPHMH 
HTKHSHTSPPPL 
SiO2 
films 
(100 nm) 
3 Ph.D.-12 65 
4 CHKKPSKSC SiC1 6 Ph.D.-7 145 
5 CTSPHTRAC 
CSYHRMATC 
Ge-on-Si 3 Ph.D.-C7C 318 
6 
 
RLNPPSQMDPPF 
QTWPPPLWFSTS 
Quartz-
binder 
3-5 Ph.D.-12 319 
7 YITPYAHLRGGN Silica 
(15 nm) 
 
5 
Ph.D.-12 10 
 KSLSRHDHIHHH (82 nm) 5 Ph.D.-12  
 LDHSLHS  5 Ph.D.-7  
 MHRSDLMSAAVR (450 nm) 5 Ph.D.-12  
8 
 
KLPGWSG 
AFILPTG 
(82 nm) 3-5 Ph.D.-7 4 
9 LSNNNLR SiO2  Ph.D.-7 320 
10 
 
AAPSHEHRHSRQ 
ALAHNPKTTHHR 
ERPLHIHYHKGQ 
TTHSKHHFPSSA 
Siliceous 
spicules 
3 Ph.D.-12 321 
 
However, very few studies were reported identifying heptapeptides displaying affinity to 
silica using Ph.D.-7 library. As mentioned in chapter 1, the PhD.-12 library contain 1.9 x 109 
independent clones, or only a small fraction of the 2012= 4.1 x 1015 possible sequences and 
useful for targets requiring 7 or fewer defined residues for binding but cannot be present in 
the PhD.7 library. Although, 12-mer is long enough to fold into short structural elements, 
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which may be useful when panning against targets requiring structured ligands. The 
limitation of this library is that the increased length of randomised segment may allow for 
the selection of sequences with multiple weak binding interactions, instead of a few strong 
interactions. However, the PhD.-7 library which contain 2.8 x 109 independent clones, 
enough to encode most of the 207= 1.28 x 109 possible 7-residue sequences are useful for 
targets requiring binding elements concentrated in a short stretch of amino acids.  Also, these 
short heptapeptides peptides are easy to work with and can simply be exposed to solvents 
during the phage display process unlike larger peptides which are easily degradable, 
problematic to purify and are unstable at higher temperature and pH changes.  
 
In this study, we used a traditional biopanning process using three different chemical elution 
buffers (low pH, high pH and high salt) with specific elution conditions that removed unique 
heptapeptide binding phages from amorphous silica nanoparticles via disrupting the 
electrostatic and non-electrostatic interactions. Moreover, a repanning method to biopanning 
reported here has reproduced more or less the same silica binders alongside identifying/ 
recovering additional sequences that may have missed in the previous biopanning 
experiments. Furthermore, selected silica binding peptides isolated from both biopanning 
and repanning processes have been artificially synthesized and their binding to silica verified 
using fluorometric quantitative assay and Raman spectroscopy.   
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3.2 Materials and Methods 
 Materials 
Chapter 2, section 2.1.1 provides details of materials used for adsorption studies. 
 Methods 
3.2.2.1 Phage display protocol 
For this phage display study, the typical protocol applied for the initial (traditional) and 
repanning biopanning experiments are discussed in methods sections 2.1.2.1 and 2.1.2.4. 
While, the details of phage display experiments and elution conditions used to elute silica 
binding peptides via initial and repanning methods can found in the Tables 2.1, 2.2 and 2.5.  
3.2.2.2 Relative binding affinity method  
To assess the binding of phage clones to silica, the individual phage clones were amplified 
and selected as described in methods section 2.1.2.5. A total of 15 different individual phage 
clones identified from both initial and repanning experiments were chosen. The silica 
nanoparticles (1mg) were washed 10 times with TBST (0.3% Tween 20 [v/v] in 1ml of TBS) 
at pH-7.5, incubated with equivalent selected phages (2.5 x 1010 pfu/ml) separately and then 
washed 10 times with TBST. Bound phages were eluted by three step elution process, 
neutralised (section 2.1.2.3), mixed together and determined by phage titer assay and 
blue/white screening methods (section 2.1.2.1.2). Out of the 15 individual phage clones 
selected, six individual clones which were identified less frequently (QQTNWSL, QLAVAPS and 
VGSYLGI) or only once (GTGSQAS, ETALIAA and SQTFTSD) in either of the initial and 
repanning experiments were randomly picked as controls along with M13KE (wild type). 
The M13KE phage with no random peptides displayed on pIII coat protein was chosen as a 
main control. By caluclating the ratio of bound or output to input amounts of phage clones 
the binding ratio for phage clones were estimated. The phage titer calculations including the 
number of input to output phages and the binding ratios from two separate experiments 
(repeats) can be seen in Appendix 3.1. 
3.2.2.3 Bioinformatics searching  
Chapter 2, section 2.1.2.2 provides details of materials used for bioinformatics analysis. 
3.2.2.4 Silica-peptide interaction studies 
Two techniques, including fluorescamine assay and Raman spectroscopy has been used to 
verify silica-peptide binding. Five peptide sequences LPVRLDW, NDLMNRA, GQSEKHL, 
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GASESYL and KIAVIST synthesized (section 2.1.2.6.1) and characterized (sections 
2.1.2.6.2 and 2.1.2.6.3) were selected for fluorometric fluorescamine based quantification 
assay. The protocol and materials used for this assay are described in chapter 2, section 
2.1.2.7.1. While for Raman spectroscopy analysis the peptide LPVRLDW was chosen. The 
protocol and materials used for this assay are described in chapter 2 under section 2.1.2.7.2. 
 
3.3 Results and Discussion 
For the entire phage display study, the same batch of amorphous silica nanoparticles of size 
82 nm prepared in the Perry laboratory and previously characterised4,107,234 has been used as 
a target to avoid any inconsistencies that might occur due to differences in the surface 
properties of inorganic material. More information about the properties and measurements 
of silica particles is described in Table 2.6 under the section 2.1.2.6. Similarly, the results 
presented in this chapter, used the same batch of M13 Ph.D.-7 phage display peptide library 
kit (#E8100S, Lot: 0211212) for all phage display experimentations including initial 
biopanning and repanning methods, as described in Chapter 2 under materials section 
2.1.1.1). Three different elution buffers (0.2 M Glycine-HCl, pH-2.2; MgCl2, pH-6.1; TEA, 
pH-11) with varying pH 2-11 were randomly chosen for this chapter, to elute and collect the 
phages that bound to the target material. The list of phage display experimental conditions 
including experimental numbers, three different elution buffers and conditions (i.e pH and 
number of times elution and screening rounds performed) used in the initial biopanning and 
repanning experiments are shown in Tables 2.1, 2.2 and 2.5. More details including step by 
step biopanning protocol used to isolate silica binders was described in chapter 2, under 
methods section 2.1.2.1.  
 
 Silica binders identified from initial (traditional) biopanning  
Here, a total of six separate biopanning experiments, and for each biopanning experiment, 
three panning rounds were performed. In each panning round, phage binding, washing, 
elution and amplification steps were carried out. At the end of third round, blue/white 
screening method was used to select phage plaques. A total of 79 individual phage plaques 
were selected randomly from third round of different panning experiments (Table 3.2, 1-6) 
and analysed by DNA sequencing. Out of 79 individual phage plaques picked for sequence 
analysis, 52 plaques (eluted via Glycine-HCl, pH-2.2) were selected from four separate 
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panning experiments (Table 3.2, 1-4). While, 14 and 13 phage plaques (eluted via MgCl2, 
pH-6.1 and TEA, pH-11) were picked from panning experiments 5 and 6 respectively (Table 
3.2, 5-6).  
 
In the very initial biopanning tests (Table 3.2, 1-2), a small number of individual phage 
plaques (i.e 3 and 4 plaques for the panning experiments performed in the years 2013 and 
2014; three being the lowest number) obtained from third round of biopanning were selected 
for sequencing, which resulted in variable peptide sequences showing no or single similar 
binder SAAWNKS (two out of three from experiment 2, Table 3.2) being repeated. Research 
groups differ in their selection of phage plaques for identifying inorganic material binding 
peptides 10,24,69,322,323. It was reported in the literature that 15-20 phage plaques selected from 
biopanning rounds 3-5, displayed peptide sequences with high affinity for silver 24, silica 4,10 
and metallic boride322 nanoparticles. According to NEB manual, 10-20 clones selected from 
third round are recommended to detect a consensus binding sequence. However, Donatan 
and co-workers, at the end of each panning rounds 1-4, five individual phage plaques were 
chosen out of a large amplified pool of binders and were able to isolate mica binding peptide 
sequences69. This variation in selection of clones in terms of numbers can be due to the 
limitations of experimental process (blue/white screening) used for selecting plaques (i.e 
only a few clearly visible individual plaques can be picked at a time from plaque plates for 
sequencing) and the expense of sequencing66. Although it is not clear how many clones are 
needed to isolate the high affinity target binders; from previous studies4,10,185, it is 
appreciated that the larger the number of phage clones selected, the better the results in terms 
of identifying reliable target binders. To further improve the selection process, we gradually 
increased the number of phage plaque selection to 13 (experiment 6, 2013), 14 (experiment 
5, 2013), 20 (experiment 4, 2014) and 30 (for all other panning experiments including 
repanning and three step elution biopanning methods) in the subsequent phage display tests.  
 
In the biopanning experiments, after performing three rounds of selection, the phage clones 
obtained from third round displayed a range of silica binding peptide sequences (Table 3.2) 
due to the progressive enrichment of phage clone population. Biopanning rounds should not 
be repeated more than five times because too many rounds of selection tends to collect phage 
that elute or amplify better than the strong target binders24,146. A summary of peptide 
sequences (repeated, identical and dissimilar) identified from third round of biopanning to 
amorphous silica using three different elution buffers is shown in Table 3.2. Overall, 21 
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peptide sequences were isolated coding for 7 identical repeats and 14 different silica binding 
sequences.   
 
Table 3.2. Schematic representation of experimental conditions (washing and 
elution) used for routine biopanning that isolated the silica binders from third 
panning round using three different elution buffers. Experimental conditions include 
the order of experiments performed and their dates (month/ year); washing detergent TBST (TBS 
with 0.5 % (v/v) Tween 20) concentrations for removing non-specific binders from silica surface; 
elution buffers and conditions (low pH, high salt and high pH) to elute tightly bound phage clones 
from silica nanoparticles; selected rounds at which sequences were screened and the most 
frequently identified silica binders. Identical sequences repeated in one or more panning 
experiments are presented in a unique colour for clarity.  
Exp. 
order 
Date 
Wash 
TBST 
Elution buffer 
and condition 
Round 
screened 
Displayed sequence and 
frequency of appearance 
Frequently 
observed 
peptides 
1 07/13 
 
0.5% 
Glycine HCl, 
0.2 M, pH-2.2 
 
3 
 
SSFRLDW 1/4 
SSNQFHQ 1/4 
WSLSELH 1/4 
ETTLITA 1/4 
LPVRLDW 
GQSEKHL 
GASESYL 
NDLMNRA 
VSRDTPQ 
 
 
 
2 07/13 VGSYLGI 1/3 SAAWNKS 2/3 
3 09/13 LPVRLDW 25/25 
4 02/14 
GASESYL 6/20 
VSRDTPQ 3/20 
QQTNWSL 2/20 
WQWPARV 2/20 
NDLMNRA 1/20 
GQSEKHL 1/20 
QLAVAPS 1/20 
ETALIAA 1/20 
GTGSQAS 1/20 
ALQPQKH 1/20 
VASHSKP 1/20 
5 07/13 0.5% 
MgCl2, 4 M, 
pH-6.1 
3 
LPVRLDW 5/14 
NDLMNRA 4/14 
GQSEKHL 2/14 
QQTNWSL 1/14 
VGSYLGI 1/14 
QLAVAPS 1/14 
6 08/13 0.5% 
Triethylamine,
100 mM,  
pH-11 
3 
GQSEKHL 7/13 
ELTPLPL 2/13 
NDLMNRA 1/13 
VSRDTPQ 1/13 
KIAVIST 1/13 
QHMPQPR 1/13 
 
 
From the above findings, it was found that five phage clones displaying peptide sequences 
LPVRLDW (25/25, 100%), GQSEKHL (10/47, 21%), GASESYL (6/20, 30%), NDLMNRA 
(6/47, 13%) and VSRDTPQ (4/33, 12%) appeared as the most frequently occurring silica 
binders (i.e more abundantly observed sequences from a randomly selected few phage clones 
after third panning round) within the small sequenced population from separate panning 
experiments (Table 3.2, 1-6). While, some sequences were displayed more than once 
(highlighted in a unique color) in separate experiments within the biopanning process. The 
list of repeated silica binders identified from three different elution buffers (0.2 M Glycine-
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HCl, pH-2.2; MgCl2, pH-6.1; TEA, pH-11) include LPVRLDW, GQSEKHL, NDLMNRA, 
VSRDTPQ, QQTNWSL, QLAVAPS and VGSYLGI. The peptide sequences GQSEKHL (1/20, 
2/14 and 7/13) and NDLMNRA (1/20, 4/14 and 1/13) were displayed in all the three elution 
buffers used; whereas the LPVRLDW (25/25, 5/14 and 0/13), QQTNWSL (2/20, 1/14 and 
0/13), QLAVAPS (1/20, 1/14 and 0/13) and VGSYLGI (1/3, 1/14 and 0/13) peptides were 
identified from two elution buffers (Glycine-HCl, pH-2.2 and MgCl2, pH-6.1). In contrast, 
the peptide VSRDTPQ (3/20, 0/14/ and 1/13) was eluted from low and high pH buffers 
(Glycine-HCl, pH-2.2 and TEA, pH-11) respectively. It must be noted that, all the above-
mentioned peptide sequences were found at least once in the Glycine-HCl buffered 
biopanning experiments (Table 3.2, 2-4). However, no apparent sequence similarity peptides 
were observed from the very initial biopanning experiment 1, using elution buffer 1 (0.2 M 
Glycine-HCl, pH-2.2). Note that, the term ‘tightly bound’ silica binders as stated in this 
thesis refers to the sequences that appeared most frequently from the small number of phage 
clones that were randomly selected for sequencing out of a large amplified population 
obtained during multiple rounds of phage display experiments.  
 
The most frequently observed individual silica binding peptide sequences LPVRLDW, 
GQSEKHL, GASESYL, NDLMNRA and VSRDTPQ shows the total number of functional 
amino acid groups involved in binding to silica and the percentage of eluted amino acid 
residue distribution. The peptide LPVRLDW which appeared as the main silica binders in the 
experiments 3 (25/25), and 4 (5/14) consists of 72% hydrophobic (LPVLW), 14% each acidic 
(D) and basic (R) amino acid composition. Whereas, the GQSEKHL and NDLMNRA peptide 
sequences identified in experiments 4 (1/20), 5 (2/14, 4/14) and 6 (7/13, 1/13) distributed 
33% and 43% hydrophobic and 57% each hydrophilic amino acid residues. However, the 
peptides GASESYL (found only in experiment 4, 6/20) and VSDRTPQ (found in experiments 
4 (3/20) and 6 (1/13)) displayed 57% and 43% hydrophilic residues.  
 
The distribution of the total number of amino acid groups present in the isolated silica 
binders from all 6 panning experiments and eluted by three different elution buffers were 
shown in the Figure 3.1. The low pH elution buffer (0.2 M Glycine- HCl, pH-2.2) from 
experiments 1-4 eluted clones consisting of 42% hydrophobic and 41% polar uncharged 
groups in addition to the acidic (8%) and basic (9%) residues. Thus, indicating the low pH 
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elution buffer might have eluted phages bound to silica mostly by interactions involving 
electrostatic alongside hydrophobic forces. 
 
 
 
 
Figure 3.1. Comparison of functional amino acid groups distributed specific to 
elution buffer. All the phage clones identified from panning experiments 1-4 (Glycine-HCl, pH-
2.2), 5 (MgCl2, pH-6.1) and 6 (Triethylamine, pH-11) are considered while plotting the pie diagrams.  
 
Interestingly, the high salt magnesium chloride elution buffer (4 M MgCl2, pH-6.1) from 
experiment 5 eluted the phage clones displaying peptide sequences containing 49% of 
hydrophobic amino acids, in contrast to 34% and 42% using high pH triethylamine (100nM 
Triethylamine, pH-11) and low pH (0.2 M Glycine- HCl, pH-2.2) respectively. However, 
the total number of functional amino acid groups present in the isolated peptide sequences 
eluted by high pH triethylamine showed both hydrophobic (34%) and polar (30%) side 
chained groups alongside removing more acidic (13%) and basic (23%) residue composition 
than the other two elution buffers. Also, an increase in the acidic and basic charged amino 
acid residue composition was noticed with increase in the pH of the elution buffers. For 
instance, the phage clones eluted from elution buffer 1 (low pH) exhibited 8% acidic and 9% 
basic amino acid groups. While, the same acidic and basic charged residue composition 
gradually increased to 11% and 15% for the clones identified from elution buffer 2 (high 
salt, near neutral pH) and 13% and 23% with elution buffer 3 (high pH) respectively.  
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 Repanning to check the reproducibility of silica binders identified in 3.3.1 
Repanning experiments were carried out to check the reproducibility of the identified 
sequences, as described in Chapter 2 under methods section 2.1.2.4 by exposing the mixture 
of amplified phage pool from the initial tests with fresh silica. This amplified phage mixture 
was prepared by mixing the round 2 amplified phage samples stored from initial biopanning 
experiments 1, 2, 4, 5 and 6. Experiment 3 is not taken into account (or excluded) for 
repanning, as it was thought that the sequence may represent a fast grower (due to panning 
advantage), as the same peptide sequence was identified repeatedly in rounds 2 (4/4) and 3 
(25/25). However, the experiment 5 is included for repanning exercise, where the same 
peptide was also observed as one of the main silica binders (5/14). More detailed description 
about the fast growers and their ability to get selected in the further bioapanning rounds due 
to bias in the amplification process was explained in the following discussion. The 
experimental conditions used for repanning experiments including which amplified phage 
stocks were taken and then how far carried forward in subsequent biopanning rounds can be 
found in Table 2.5.  
 
The results of the repanning experiment reproduced similar silica binders (Table 3.3) as were 
identified previously in the above initial biopanning experiments (Table 3.2) along with few 
new peptide sequences. Out of 120 phage clones sequenced from two separate repanning 
experiments (7 and 8) and rounds (3-5), 102 phage clones were reproduced indicating 85% 
reproducibility. However, 18 new phage clones (15%) were also isolated. The silica binders 
reproduced which were also isolated previously include LPVRLDW, KIAVIST, GQSEKHL, 
NDLMNRA, VSRDTPQ, ELTPLPL, QLAVAPS, QQTNWSL, ETALIAA, WSLSELH and 
GTGSQAS. Also, four peptide sequences that had displayed as tight silica binders 
(LPVRLDW, GQSEKHL, NDLMNRA, VSRDTPQ) in the initial bioapanning experiments 
(Table 3.2) are reproduced and repeated with in two separate experiments that are eluted by 
two different elution buffers (Table 3.3, 7-8). While, the peptide sequence GASESYL that 
had identified only in experiment 4 (six times out of twenty sequenced clones), has not 
appeared in the repanning method. However, the same sequence KIAVIST that had found 
only once in previous routine biopanning experiment 6, re-appeared as the main abundant 
silica binder in both repanning experiments 7 and 8 in all the rounds sequenced (i.e 3-5). 
Therefore, this repanning process may be used as an obvious way to check the 
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reproducibility of target binders as well as to recover or identify new binders; and thus, 
representing a larger fraction of the population. 
 
Table 3.3. Results of repanning experiments showing both silica binders that 
were found previously identified and further new silica binders. The silica binders 
found previously in the initial biopanning procedure and reproduced in this repanning method can 
be found under the sub-heading ‘previous binders’. The new binders appearing only in the 
repanning experimental process are shown as ‘entirely new’. Sequences repeated during different 
experiments as different round only in this series of repanning experiments are highlighted colour.  
Exp. 
order 
Date 
Wash 
TBST 
Elution  
condition 
Rou
nd 
Displayed peptide sequence and frequency 
 Previous binders Entirely new 
7 
07/15 0.5% 
Glycine-
HCl 
0.2 M, 
pH-2.2  
3 
KIAVIST 7/30 
QLAVAPS 3/30 
ETALIAA 2/30 
GQSEKHL 2/30 
VSRDTPQ 1/30 
LPVRLDW 1/30 
ELTPLPL 1/30 
HYIDFRW  2/30 
HVPRAMA  1/30 
07/15 0.7% 4 
KIAVIST 10/30 
VSRDTPQ 7/30 
LPVRLDW 2/30 
GQSEKHL 1/30 
ELTPLPL 1/30 
QQTNWSL 1/30 
WSLSELH 1/30 
GTGSQAS 1/30 
HVPRAMA  4/30 
HYIDFRW  1/30 
SQTFTSD  1/30 
 
07/15 0.9% 5 
KIAVIST 22/30 
NDLMNRA 8/30 
 HYIDFRW 1/30 
 
8 11/15 0.7% 
Triethyl 
amine 
100 mM, 
pH-11 
4 
KIAVIST 12/30 
GQSEKHL 4/30 
ELTPLPL 3/30 
VSRDTPQ 1/30 
NDLMNRA 1/30 
QQTNWSL 1/30 
 
HYIDFRW 3/30 
SFPLSKY  3/30 
TVNFKLY 1/30 
HGGVRLY  1/30 
 
 
Interestingly, a few sequences HYIDFRW, HVPRAMA, SQTFTSD, SFPLSKY, TVNFKLY 
and HGGVRLY appeared only in this repanning process. The isolation of new peptide 
sequences only in this repanning process could perhaps be due to two possible reasons. As 
they were not identified before in the initial biopanning experiments suggests that these 
entirely new peptide sequences are the ones that might have been missed probably due to 
too few phage clones being picked randomly from the large pool for sequencing. In the 
repanning experiments representing a larger proportion of the initial population was 
recovered. In other terms, only a subset of sequences within the small proportion of clones 
sequenced were identified via the initial biopanning process. In performing repanning 
experiments, some clones have been further selected due to the conditions used. The other 
possible reason might be that these phage clones are the ones that perhaps have selected in 
the repanning experiments due to their amplification advantage (encouraged by propagation 
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preferences of phage in bacteria) or binding to other components of the screening process 
including the blocking agents, contaminants and other reagents 1,2,324.     
 
However, the recurrence of the phage clone displaying the peptide LPVRLDW in this series 
of repanning experiments, also proves the sequences that appeared as tight silica binders 
have not undergone any propagation advantage in the biopanning rounds which is a common 
problem in phage display1,233. For instance, the reappearance of LPVRLDW peptide sequence 
in the repanning experiments suggests this phage clone does not have any propagation 
advantage which implies this peptide sequence is not a fast grower but a genuine target 
binder. The sequences holding proliferation advantage have the capacity to select as main 
target binders even after the first round of biopanning during the amplification step which 
can be very notorious and ruin the entire phage display work by hiding the actual binders, 
thus giving false results325. Several databases have been designed to identify fast growers 
and/or target unrelated peptide binders (TUPs). The PepBank and MimoDB was designed 
based on published experimental results and as well as theoretical predications knowing that 
the 7-mer phage library having 2×1011 phages should theoretically contain 2×109 peptide 
sequences55,216,217,326. Other web-based tools like SAROTUP have been built to aid in the 
identification of peptides that bind to unrelated target materials that were used during the 
biopanning process327. For example, a list of phage displayed peptide sequences identified 
to have affinity for plastic or polystyrene based components such as well plates, beads, petri 
dishes and films during biopanning process are shown in Table 2.3, section 2.1.2.2, Chapter 
2. Although, the results of these databases are mainly constructed based on already published 
sequences and theoretical predictions, the repanning method may experimentally verify your 
own target binding results giving information about any possible non-specific binding due 
to panning limitation or amplification bias and thereby checking the direction of the ongoing 
phage display work. Thus, the repanning method reported for the first time for silica binders 
appeared to be a straight forward approach to verify all phage display experimental results 
simply by mixing phage clones from different biopanning experiments and rounds. 
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 Relative binding affinity experiment to evaluate phage binding to silica 
The phage clones that appeared and were identified as main silica binders in all phage display 
experiments (i.e. initial and repanning tests) were further analysed by performing the relative 
binding affinity assay306,322,323. It is important to note that the phage clones isolated as main 
binders (i.e most abundantly occurred) in the bioapnning experimental rounds do not 
necessarily have to be a strong binder to the target material. It could also be due to 
propagation advantage or binding to other components of the screening system1,2,324. 
Although the repanning method was carried to check the reproducibility of the phage clones, 
this method is limited to testing the overall experimental process, thereby examining the 
direction of the ongoing phage display work. Thus, the relative binding affinity assay was 
used to assess the binding capability of each of the 15 different phage clones to silica 
nanoparticles by phage titer assays at pH-7.5 (Figure 3.2). In addition to the nine phage 
clones selected as main silica binders (highlighted in asterisk), six individual clones which 
were identified less frequently (QQTNWSL, QLAVAPS and VGSYLGI) or only once 
(GTGSQAS, ETALIAA and SQTFTSD) in either of the initial and repanning experiments 
were randomly picked as controls along with M13KE (wild type). The M13KE phage with 
no random peptides displayed on pIII coat protein was chosen as a main control. Calculating 
the ratio of bound or output to input amounts of phage clones has been known as a 
comparatively simple and quick method to evaluate the target binding ability of the displayed 
sequence. Consequently, a higher binding ratio signifies the higher binding ability of phage 
or recovery rate of phage to substrate silica nanoparticles.  
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Figure 3.2. Binding ratio (bound/input) of each of the 15 different phage clones 
to silica nanoparticles. The relative binding affinity of the phage clones isolated from both 
initial and repanning experiments was determined by titer assay at pH-7.5. The asterisk (*) 
indicates the phage clones displayed most frequently (abundantly observed) and repeated in the 
screening rounds 3-5. The sequences QQTNWSL, QLAVAPS and VGSYLGI were identified in more 
than one experiment but not repeated so often. The M13KE (wild type) phage with no random 
peptides displayed on pIII coat protein was chosen as a main control. In addition, the phage clones 
GTGSQAS, ETALIAA and SQTFTSD were randomly picked as they found only once in either of the 
initial and repanning experiments. The assay was repeated twice for each phage clone and the 
explained phage amounts were arithmetically averaged. The errors bars indicate the standard error 
obtained from the two separate experimental repeats.  
 
As presented in the Figure 3.2, all the 15 phage clones showed higher binding than the 
control M13KE, which did not show any plaques at 10-4 dilution but observed binding ratio 
at 10-3 dilution as 0.0072 (see Appendix 3.1). Thus, verifying the binding of the phage clones 
displaying the peptides to the silica was a result of the randomly displayed peptide sequence 
and not due to non-specific coat proteins interactions. While, the nine phage clones picked 
as tight silica binders (highlighted in asterisk) from initial and repanning results showed 
dissimilar binding to silica but greater binding than the other six phage clones that were 
selected randomly as secondary controls except for GASESYL and VSRDTPQ. The phage 
clones GQSEKHL, VSRDTPQ and GASESYL that had appeared more frequently in the 
biopanning experiments (initial and repanning) displayed less binding to silica in relative 
binding studies. However, the phage clones displaying peptides LPVRLDW, HYIDFRW and 
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KIAVIST have emerged as the top three strong binders for amorphous silica nanoparticles 
followed by NDLMNRA and ELTPLPL out of the nine phage clones that had displayed most 
frequently and repeatedly observed in the screening rounds 3-5 from initial and repanning 
results. Interestingly, the ELTPLPL sequence that was isolated a few times in both initial 
(2/79) and repanning (5/120) experiments 6, 7 and 8 has exhibited a higher binding ability 
to silica nanoparticles.  
 
 Prediction and bioinformatics analysis of silica binders: Comparison studies   
It has been an accepted way to predict the likely type of interactions through which the 
peptides bind to silica nanoparticles by analysing the physico-chemical properties such as 
the charge, pI and functional amino acid groups of the isolated peptides from phage 
display124,328. These interactions include electrostatic (ion pairing and hydrogen bonding), 
hydrophobic and other weak binding forces. The selected silica binding peptides that 
displayed binding to silica nanoparticles in biopanning (initial and repanning) and relative 
binding experiments exhibit a range of physicochemical properties (Table 3.4).  
 
The peptide KIAVIST which appeared as the main silica binder in all biopanning rounds of 
repanning and relative binding affinity experiments exhibited high pI (10.1) with net positive 
charge 1. At the same time, the peptides GQSEKHL, LPVRLDW, NDLMNRA, VSRDTPQ, 
QLAVAPS and QQTNWSL showed a close range of neutral pI (6-7) values with overall neutral 
charge, while the GASESYL and ELTPLPL showed acidic pI-3-4 with net negative charge 
1. However, the GQSEKHL, VSRDTPQ and GASESYL that appeared more frequently in the 
biopanning experiments (initial and repanning) displayed less binding to silica in relative 
binding studies.  
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Table 3.4. Physico-chemical properties of selected silica binding peptides 
displayed from routine biopanning process and repanning method. aPhysico-
chemical properties of all the sequences were obtained from Innovagen and Bachem peptide 
property calculator211,212. Highlighted in bold are the sequences that appeared as the most 
frequently occurring silica binders repeated in one or more panning experiments (both initial and 
repanning). An asterisk (*) indicates the peptides sequences that exhibited higher binding 
capability to silica in relative binding affinity assay. The amino acids that contain amine side chain 
(N, Q, P, W) and hydroxyl side chain (S, T, Y) containing groups in a peptide, which can help in 
forming hydrogen bonding between silica-peptide or among themselves are shown. 
 
Peptide 
sequence 
pIa 
Net charge 
@pH 7a 
Functional amino acid residue compositiona 
Polar 
(-ve, +ve and uncharged) 
Hydrop 
-hobic  
Amine 
side chain  
(N,Q,P,W) 
Hydroxyl 
side chain 
(S,T,Y) Acidic Basic Uncharged 
KIAVIST* 10.1 1 0 1 2 4 0 2 
GQSEKHL 7.82 0.1 1 2 2 1 1 1 
HYIDFRW* 7.8 0.1 1 2 1 3 1 1 
LPVRLDW* 6.78 0 1 1 0 5 2 0 
NDLMNRA* 6.78 0 1 1 2 3 2 0 
VSRDTPQ 6.78 0 1 1 3 2 2 2 
QLAVAPS 6.01 0 0 0 2 5 2 1 
QQTNWSL 6.01 0 0 0 5 2 3 2 
ELTPLPL* 3.3 -1 1 0 1 5 2 1 
GASESYL 3.3 -1 1 0 3 3 0 3 
 
 
From the results, the physico-chemical properties (i.e charge, pI and functional groups) of 
the isolated silica binders suggest that the three different elution buffers (0.2 M Glycine-
HCl, pH-2.2, 100 mM Triethylamine, pH-11 and 4 M MgCl2, pH-6.1) used have extracted 
phage clones displaying peptides of both electrostatic and non-electrostatic interactions. It is 
not surprising that the isolated silica binders differ in their charge (i.e positive, neutral and 
negatively charged) and amino acid composition (Table 3.4). From the previous studies, it 
was evidenced that the groups have isolated peptide sequences with dissimilar physico-
chemical properties including both positive, neutral and negatively charged sequences by 
panning against same inorganic nanoparticles such as silver24 and metallic boride 
nanoparticles322. In particular, a range of peptide sequences varying in charge and functional 
amino acid groups have been identified by phage display against silica nanoparticles24 of 
same size10 and same batch4,44. In a recent contribution, Patwardhan and colleagues, have 
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shown that synthetically synthesized (Stöber process) amorphous silica nanoparticles with 
even comparable size reported minimal binding to highly dissimilar peptide sequences, 
mainly due to changes in the degree of surface ionization on nanoparticles of slightly 
different sizes10. Thus, this variation in peptide selection to the same inorganic nanoparticles 
is thought to be due to the complex amorphous structures, degree of surface ionization and 
minor differences in size of the nanoparticles synthesized by Stöber process4,10,44,107. 
Moreover, to find any sequence similarities in the identified silica binders, the multiple 
sequence alignment was performed using MSA Viewer213. A total of 77 different silica 
binding peptide sequences were taken for this sequence alignment. All these silica binders 
were isolated from three different sets of biopanning experiments but using the same aliquot 
of NEB Ph.D.-7 phage library (Lot: 0211212). The three-separate series of biopanning tests 
include the initial or traditional biopanning (section 3.3.1), repanning experiments 
performed to check the reproducibility of traditional biopanning (section 3.3.2) and the 
optimised biopanning methods (section 4.2.2, discussed in Chapter 4). From the multiple 
sequence analysis (Figure 3.3), it was found that the sequence (VSTPLLA) has been emerged 
as a consensus silica binder.   
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Figure 3.3. Multiple sequence alignment of silica binders. All the silica binding 
peptides used for generating this figure were isolated from three sets of biopanning experiments. 
A total of 77 dissimilar sequences were chosen and analysed. An identified consensus peptide 
sequence (VSTPLLA) from the multiple sequence alignment was also highlighted and shown.  The 
sequence alignment was generated by using the freely available MSA viewer 
(https://toolkit.tuebingen.mpg.de/#/tools/alnviz) from the Max Planck Institute website. Label 
indicate the position and number of the peptide sequences. The small logo (figure) that is present 
on top of the ‘label’ indicate the number of times the amino acids have appeared in that specific 
position. The larger the size of the amino acid the higher the times the amino acid have appeared in 
that specific position of the peptide sequences. For example, the amino acid V (valine) was the most 
frequently observed residue (14 times), followed by S (serine, 12 times) as second, Q (glutamine, 8 
times) and so on in the first position of all the 77 silica binders. Thus, V (valine) has appeared larger 
in the first column followed by second bigger S (serine) and so on.     
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This consensus sequence was then compared with all the silica binders identified in this and 
previous studies to find any similarities. Interestingly, the motif LP was commonly found in 
most of the peptide sequences that were reported to be the strong silica binders. Also, these 
peptides were identified in bioapanning experiments against silica and reported in the 
literature (Table 3.5). 
 
Table 3.5. Identification of amino acid motif (LP) by comparing the silica binders 
of this study with the peptide sequences published in literature. An asterisk (*) 
indicates the sequence displayed as one of the most abundant silica binders in bioapanning 
experiments or in silico designed and was shown to exhibit strong binding to substrate in binding 
studies. All the silica binders isolated from three sets of biopanning experiments (77 dissimilar 
sequences) are checked and the sequences having motif (LP) were shown in the first row of the 
table. While, the other sequences were displayed only once in different panning experiments in this 
study. The amino acid motif (LP) was shown highlighted in bold and underlined.   
Peptide 
sequence 
Target binder Library 
type 
Panning 
round 
Reference 
LPVRLDW* 
ELTPLPL* 
GISDLPS 
QLAPLMQ 
SFNPLAY 
SFNPLAY 
SFPLSKY 
VKMESPL 
VPLTEVR 
Silica nanoparticles 
(82 nm) 
Ph.D.-7 3-5 Identified in this 
study 
KLPGWSG* 
AFILPTG* 
Silica nanoparticles 
(82 nm) 
Ph.D.-7 3-5 4,44 
LPHHHHLHTKLP* 
 
Silica Ph.D.-12 4 24 
HTKHSHTSPPPL* SiO2 films 
(100 nm) 
  3 65 
QTWPPPLWFSTS* 
VPHPPFPHLPPH* 
Quartz only 
Quartz and 
Hydroxyapatite 
 3-5 319 
LPPPPLPLQPLP* 
PPPWLPYMPPWS* 
SPPRLLPWLRMP* 
LPDWWPPPQLYH* 
Quartz (100) 
 
 
 
in silico 
designed 
n/a 42,43 
 
In a recent contribution, Oren et al. reported a bioinformatics approach and generated quartz 
binding peptides with a predictable binding affinity for silica using the experimental results 
of combinatorial selection and characterization studies of quartz binding peptides42. To 
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achieve this, the total similarity scores were calculated using BLOSUM 62, PAM 250 and 
QUARTZ I scoring matrices and generated 1000000 peptides having the highest similarity 
scores from PhD-7 and 12 libraries42,43. The sequences with the highest similarity scores 
representing the strongest four quartz silica binders were identified and reported (Table 3.6). 
The amino acid proline (P) has been reported as a major constituent responsible for specific 
binding of peptide to silica167. Proline (P) followed by hydrophobic amino acid residues like 
Leucine (L) and Tryptophan (W) were shown to have the strongest affinity to quartz silica43. 
Using this knowledge, an amino acid motif (LP) that may be responsible for higher binding 
to silica has been identified.  
 
Furthermore, all peptides displayed against SiO2 were initially checked against MimoDB 
and BLAST database to find the whole or exact part of phage display or surface display 
peptide sequences that are similar to the identified silica binders. The analysis of MimoDB 
and BLAST results showed no hits for all the silica binders with the exception to the peptides 
shown in Table 3.6. The sequences that appeared as tight binders to silica such as QLAVAPS, 
GQSEKHL HYIDFRW, VSRDTPQ and GASESYL were found to have affinity for one or more 
than one different targets (Table 3.6) including Fe3O4 nanoparticles, Human prostate cancer 
cell line PC3,  Sera of peanut-tolerant subject 2, Sera of peanut allergic patient 1, 3, 4, Plasma 
of peanut allergic patient 4 and Anti-TIM polyclonal antibody323,329–331, while other peptide 
sequences appeared to have some affinity for silica in one of the biopanning rounds were 
found to have attraction for other targets (Table 3.6). This suggests that peptides isolated 
mostly were target-related sequences and rather true silica binders without any human or 
pathogen or sample contamination, whereas the peptide sequences that were found to have 
exact or part of motif similarity for other targets indicate the possibility of promiscuous 
binding behaviour to multitude of materials. 
 
From the previous studies, it is important to note that certain sequences having affinity to 
more than one material have been identified and explored for their ability to bind to different 
inorganic molecules. For example, the sequence KSLSRHDHIHHH has been identified 
against FePt nanoparticles332, titania333 and 82nm silica nanoparticles10. In addition, the same 
sequence searched against MimoDB database appeared to bind to organic molecules such as 
lipopolysaccharide334 and Anti-PRRSV monoclonal antibody335 and would appear to be 
‘target unrelated peptide’. 
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Table 3.6. MimoDB search/ scan/ Blast analysis results of phage displayed silica 
binders found to have affinity for other materials indicating that they might be 
promiscuous binders. Peptide sequences highlighted in bold are the phage clones that 
appeared as highly abundant or tight binders to silica in initial biopanning and/ or repanning 
methods.  
Peptide Target Found Matched 
Sequence 
Library 
type 
Biopan-
ning 
round 
Reference 
QLAVAPS 
TVNFKLY 
Fe
3
O
4 
Nanoparticles Full 
sequence 
Ph.D.-7 4, 5 323 
HYIDFRW Fe
3
O
4 
Nanoparticles, 
Plasma of peanut 
allergic patient 4 and 
Human prostate cancer 
cell line PC3 
“ 
 
Ph.D.-7 2-5 323,329,330 
GQSEKHL 
 
Fe3O4 Nanoparticles, 
Sera of peanut-tolerant 
subject 2 
“ 
 
Ph.D.-7 2-5 323,330 
HGGVRLY Agrobacterium vitis 
polygalacturonase, 
Plasma of peanut 
allergic patient 4 
“ 
 
Ph.D.-7 2, 3 330,336 
VSRDTPQ 
 
Sera of peanut allergic 
patient 1-4, and 
tolerant subject 2 
“ 
 
Ph.D.-7 1-3 330 
ETALIAA Plasma of peanut-
tolerant subject 3 
“ Ph.D.-7 2, 3 330 
WSLSELH 
SSNQFHQ 
SAAWNKS 
GTGSQAS 
Sera of peanut allergic 
patient 1, 3, 4 
“ 
 
Ph.D.-7 1-3 330 
GASESYL Sera of peanut allergic 
patient 1, Anti-TIM 
polyclonal antibody 
“ 
 
Ph.D.-7 2, 3 330,331 
IDNSHTH Agrobacterium vitis 
polygalacturonase, 
“ 
 
Ph.D.-7 3 336 
SWTALGP E3 ubiquitin-protein 
ligase Mdm 
TWLDNIWT
TLGP 
Ph.D.-
12 
3 337 
TTQVLEA Mouse brain 
microvasculature 
CTGRMTXQ
XXXA 
CX10C 5 338 
 
 
However, the same sequence has been well studied both experimentally and in silico and 
have shown to be a better binder to the above mentioned inorganic molecules10,332,334,335,339. 
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Some more examples include the peptide sequences DRPWMFPPHWSV (gold, quartz and 
hydroxyapatite) and VPHPPFPHLPPH (Quartz and Hydroxyapatite) identified from 
biopanning against one of the above mentioned inorganic materials but displayed binding 
towards multitude of materials60,189,340.  
 
Also, the binding of short peptides to different targets depends on the number of defined 
binding sites available on substrate surface for binding, thus proving information about the 
diversity being eluted324. For instance, If the target molecule has a single well-defined 
binding site for binding (eg. monoclonal antibodies) then one can expect low number of 
sequences. Whereas the targets holding multiple binding sites (polyclonal antibodies) or less 
defined sites (proteins with greater binding interfaces or inorganic particles) to thousands of 
sites (organs or cells) available for binding will result in identifying relatively higher number 
of sequences324. 
 
Recently, the artificial binding proteins have become popular due their ability to bind 
specifically to different target molecules like peptides, proteins or small molecules, leading 
to different applications by engineering or modifying these small molecules341–344. In a recent 
contribution, a small protein (Adhiron) displaying variable binding loops was developed  and 
designed Adhiron library345. Using this this adhiron technology, few groups have designed 
Adhiron library and identified binders to more than 100 target molecules including a receptor 
(CD31), 12 mer peptide, yeast SUMO proteins, fibroblast growth factor (FGF1), platelet 
molecule (PECAM-1) and the SH2 domain Grb2346–348.   
 
The most commonly reported problems for identifying the peptide sequences that show 
affinity to other targets (unrelated targets) likely arise due to amplification bias such as the 
binding of phage to E.coli pili, rare mutations in the regulatory region of phage genes and 
interference with infection2,325,349. However, these effects are generally lesser for the pIII or 
smaller display systems compared with the pVIII systems. It is more common to observe a 
loss in the sequence diversity for the peptide libraries displayed on pVIII than pIII coat 
proteins350,351.  To minimise this unspecific binding, few solutions have been reported. These 
include i) use of buffers with detergents and by increasing the washing stringency and 
number of wash cycles. This process will supress the nonspecific binding. ii) competitive 
elution to remove the wanted (target) or unwanted (unrelated) binders using binder specific 
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proteins (eg. Biotin can act as specific binder to streptavidin) or by excess target 
concentration. iii) to eliminate the amplification step to reduce the nonspecific binding.  
 
Even after minimising the nonspecific binding, there is chance that few peptides might show 
binding to other materials due to close structural or chemical characteristic similarities 
between different inorganic material surfaces318,323,352. Also, it is possible that short peptides 
specifically 7 mers could show binding to different molecules exact or part of the similar 
sequences could be matched towards different molecules due to the absence of defined 
tertiary structure353. However, the working of each method can differ depending on the target 
substrate. So, there is a need to design washing or elution buffers and conditions that 
specifically suite the target materials.  
 
Nonetheless, the target unrelated peptides can be identified by performing relative and 
competitive binding experiments, thus showing that these TUPs do not have true affinity for 
the target substrate. In addition, many databases are available to check the authenticity of 
the target binders. Nevertheless, the BLAST search alignment results might end up finding 
random hits due to the short length of the peptide sequences that are being searched with the 
typical large proteins and the entire genome of the organisms218. Therefore, using both 
experimental binding results along with bioinformatics checking will help to identify a true 
binder from nonspecific binders. 
 
Therefore, to confirm that most of the sequences identified for silica are not target unrelated 
peptides, a number of steps were followed. These include increasing the washing stringency 
and number of wash cycles; repanning and relative binding experiments complemented by 
bioinformatics verification. 
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 Assessment of silica-peptide interactions 
3.3.5.1 Fluorometric quantification of peptide adsorbed to silica 
A fluorometric method, based on the use of fluorescamine4,10,271,272,354 was carried out to 
check and test the ability of the peptide sequences obtained from the experimental phage 
display processes to bind to silica. This quantitative assay was performed in PBS buffer by 
maintaining the similar environment (i.e. media condition at pH-7.5 and same batch of silica 
nanoparticles) employed previously during the biopanning process. The approach used 
enabled quantitation of the amount of peptide adsorbed on the surface of the silica as a 
function of peptide concentration by measuring the amount of peptide left unattached to 
silica in the supernatant4. The procedure including the materials used for this assay was 
already described in Chapter 2, section 2.1.2.7.1. 
The molecular mechanism between peptide-protein or peptide-solid surface has been shown 
to be a complex process and is highly dependent on electrostatic, hydrogen bonding, 
hydrophobic and other weak interaction like van der Waal forces4,129,234,355–357. Five peptides 
were selected for experimental binding studies to study their binding behaviour with silica 
nanoparticles under in vitro conditions. At the solid-peptide interface, the complex 
adsorption chemistry is not only dependent on the nature of inorganic material surface but 
also on other factors like the binding environment (eg. pH, buffer and temperature)107,333,356; 
peptide sequence and conformations (eg. size, structure and orientation)9,10,129,234; peptide 
kinetics (eg. atomic level movement involving binding forces and energies)7,13,44,355,357 
together with their physico-chemical properties4,132 and motifs43. Thus, all the peptides 
selected were derived using result of the biopanning approach, binding assay, pI values and 
net charge at pH 7 (Figure 3.4). For this binding study, five peptides were chosen. Four out 
of five peptides such as KIAVIST (high pI value and net positive charge), LPVRLDW, 
NDLMNRA and GQSEKHL (neutral pI and charge) selected were identified (most frequently 
observed) in both initial (traditional) biopanning and repanning experiments; while peptide 
GASESYL (low pI and net negative charge) was only found in one experiment (4) of initial 
routine biopanning process. However, in relative binding studies, the LPVRLDW, KIAVIST 
and NDLMNRA exhibited higher binding, while, the GQSEKHL and GASESYL displayed 
medium to low binding to amorphous silica nanoparticles (Figure 3.4). 
 
As it is very difficult to find a peptide that truly does not bind to silica, the peptide GASESYL 
was chosen as a control peptide for the binding studies described in this thesis. Also, from 
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our previous studies, it was evident that the peptide LDHSLHS with nearly similar properties 
in terms of charge and composition to GASESYL showed less binding to silica nanoparticles 
at pH-7.5 compared with other peptide sequences4,107. In addition, the same peptide 
GASESYL displayed less binding to silica in relative binding studies. 
 
Firstly, all the five peptides selected for this adsorption studies showed distinctive binding 
to silica nanoparticles as shown in Figure 3.4. Secondly, the KIAVIST peptide which has 
been identified as a silica binder (only once out of thirteen peptides sequenced) in experiment 
6 of routine biopanning but displayed in all the panning rounds of repanning experiments 
(i.e 3-5 screened rounds in experiments 7 and 8) appeared as the best binder to silica 
nanoparticles at higher peptide concentrations (1.2 and 1.6 mM) compared with the other 
four peptides used in this study. Thus, confirming the repanning process may be used for 
recovering the target binders that might have been missed (due to selecting a small number 
of clones for sequencing) in the routine biopanning process and by representing a larger 
population now. Also, with increasing the pI and net charge of peptides, the binding 
behaviour towards silica increased at pH 7.5 (Figure 3.4 and 3.5). For example, the peptide 
KIAVIST with high pI (10.1) and net positive charge (+1) showed high binding to silica, 
while the peptides LPVRLDW and NDLMNRA having neutral pI values (6.8) and net charge 
(0) showed low binding than KIAVIST peptide. However, the peptide LPVRLDW displayed 
better binding than that of KIAVIST at lower concentrations (i.e up to 1mM). In contrast, 
the peptide GQSEKHL with nearly similar pI (7.8) and net neutral charge (0.1) values to that 
of the peptides LPVRLDW and NDLMNRA, exhibited lower binding to silica nanoparticles. 
The peptide GASESYL with low pI (3.3) and net negative charge (-1), which was selected 
as a control for this adsorption investigations showed least binding to silica nanoparticles. 
Note, the isoelectric point of silica pH was determined to be present at pH-2-3 and with 
increasing the pH of the solution, the silica attains more negative charge due to the rapid 
deprotonation of silanol (Si-OH) groups4,10,107. Therefore, the silica was negatively charged 
during these binding events at pH-7.5. 
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Figure 3.4. Adsorption behaviour of peptides on the surface of hydrophilic silica 
nanoparticles at pH-7.5. The y-axis represents the amount of peptide adsorbed to silica in mM, 
while the x-axis shows the initial peptide concentration or peptide added in mM. The theoretical 
100% peptide adsorption is shown in black dotted line. The error bars represent the standard 
deviation error calculated as a result of the assay being repeated in triplicate. Based on the above 
data, the binding order of the peptides was ranked as KIAVIST>LPVRLDW> NDLMNRA> GQSEKHL 
and GASESYL.  
 
 
 
Figure 3.5. Analysis of the above peptides displayed in Figure 3.4. The graph showing 
the peptides and their binding (%) amounts to silica at four different peptide concentrations. The x 
and y-axis represent the peptide added and percentage of peptide adsorbed to silica in mM. 
   
The isolation and high binding of peptide KIAVIST to silica surface is not surprising due to 
the fact that biomolecules including peptides or proteins or even individual amino acids 
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comprising of positively charged groups have been found to display high binding behaviour 
to negatively charged silica surfaces at neutral or high pH; mainly due to the likely 
involvement of ion pairing mechanism complemented by hydrophobic interactions10. The 
likely electrostatic mechanism that directed the peptide to bind to deprotonated silanol sites 
on the silica surface might have come primarily from the positively charged sites of lysine 
(i.e due to the presence of positively charged lysine (K) at both N terminus and the side chain 
comprising a basic amino group with pKa=10.4); thus giving the peptide KIAVIST a 
constant net positive charge (+1), resulting in the strongest possible ionic interactions. This 
is supported by the results from our previous studies4,107, where it was evident that the 
peptide KLPGWSG with similar properties (i.e same pI-10.1, +1 net charge at pH-7, position 
of lysine and composition) to KIAVIST showed identical binding to the same batch of silica 
nanoparticles4,107. This study also described that with increase in the pH of the system, the 
peptides possessing positive charge tend to increase the strength of their interaction to 
negatively charged silica surface due to an increase in the overall charge of the system; 
thereby confirming the role of electrostatic interactions in solution4.  
 
The peptide LPVRLDW, which appeared as the second-best binder from the above adsorption 
studies, showed high binding until 1.2 mM concentration and saturation remained constant 
thereafter (Figure 3.5). In this case, a non-electrostatic interaction mechanism is likely to 
happen. This type of binding behaviour of LPVRLDW peptide may perhaps be due to the 
presence of five non-polar residues (Leu, Pro, Val and Trp) in the sequence resulting in an 
increase in the hydrophobic character, leading to hydrophobic interactions at the peptide-
silica surface4. Although, hydrophobic interactions are the key forces likely to be responsible 
for LPVRLDW peptide adsorption9,43;  it might be also be due to the presence of a high binding 
motif LP (Leucine followed by Proline)42,43,167. Note, although, quartz silica is pure SiO2, 
amorphous silica nanoparticles synthesised by Stöber process display dissimilar chemistries. 
For instance, a significant increase in the surface acidity and in the area density of ionic 
groups due to little differences in the size of the silica nanoparticles was reported10.  
 
The peptide NDLMNRA showed reasonable binding at lower concentrations (0.4 and 0.8 mM) 
but with drastic increase in binding at higher concentrations from 1.2 to 1.6 mM with no sign 
of saturation. This sort of binding behaviour of peptide NDLMNRA to silica surface is likely 
to be due to the presence of polar and non-polar amino acids. The polar uncharged amino 
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acids Asn (N) present at the N-terminus and at 5th position along with other charged polar 
residues including Asp (D) and Arg (R) are likely responsible for initiating hydrogen 
bonding due to increased binding at a higher peptide concentration with no sign of saturation 
resulting in multilayers connected by hydrogen bonds4. Also, the possibility of hydrophobic 
interactions cannot be ruled out due to the presence of hydrophobic groups at 3rd position 
(Leucine) and at the carboxyl end (Alanine). In contrast, the GQSEKHL peptide with nearly 
neutral pI (7.8) and neutral charge (0.1) similar to the pI and charge of peptides LPVRLDW 
and NDLMNRA, exhibited low binding to silica nanoparticles. This might be due to the 
presence of weaker interactions such as hydrogen bonding and van der Waals forces. 
Nonetheless, the peptide GASESYL with low pI (3.3) and net negative charge (-1), which 
was selected as a control for this adsorption studies showed least binding to silica 
nanoparticles. The possible reason that prevented binding of peptide GASESYL to silica 
might be due to the involvement of electrostatic repulsions between the negatively charged 
peptide and silica under these pH conditions4. As a result, the minimum binding to silica 
occurred only due to the participation of weaker hydrogen bonding (serine and tyrosine) and 
hydrophobic interactions.  
 
Based on the above peptide-silica adsorption findings, the likely type of interactions that 
aided in binding of specific peptides to silica nanoparticles at pH-7.5 are shown in Table 3.7. 
Additionally, the probable effect of increasing pH and particle size on binding to silica was 
predicted by comparing the peptide sequences of this adsorption study with previous 
studies4,44,107, where peptides of similar properties (eg. peptide length, net charge of peptide 
at pH-7 and same batch of silica nanoparticles) were investigated and assessed based on 
adsorption studies4,44,107. It must be noted that the pH range and nanoparticles size considered 
for these studies include pH-3 to pH-8.5 and 28 nm, 82 nm and 210 nm respectively4,44,107. 
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Table 3.7. Physico-chemical properties and adsorption of silica binding peptides:  
aPhysico-chemical properties of all the sequences were obtained from Innovagen 
(https://pepcalc.com/) and Bachem (http://www.bachem.com/) peptide property calculator. 
Type of interactions likely be responsible for peptide-silica binding and their effect on increasing 
pH and particle size were shown. The asterisk (*) represents the probable effect of increasing pH 
and particle size on binding to silica was estimated and predicted by comparing the peptide 
sequences of this findings with previous studies, where peptides of similar properties (eg. peptide 
length, net charge of peptide at pH-7 and same batch of silica nanoparticles) were investigated and 
assessed based on adsorption studies4,44,107. 
Peptide 
sequence 
pIa 
Net 
charge 
@pH 7 
Functional groups and composition 
of peptide sequencea Likely key type of 
interactions liable 
for binding to silica 
Expected effect 
of increasing 
pH and particle 
size on 
binding* 
Acidic 
(-ve) 
Basic 
(+ve) 
Hydrop
hobic 
Polar 
Uncha
rged 
Average 
Hydro- 
philicity 
KIAVIST 10.1 +1 0 1 4 2 -0.4 
Electrostatic/ 
Hydrophobic 
↑ 
LPVRLDW 6.8 0 1 1 5 0 -0.4 Hydrophobic = 
NDLMNRA 6.8 0 1 1 3 2 0.4 
H-bonding/ 
Hydrophobic/ van 
der Waals 
= 
GQSEKHL 7.8 0.1 1 2 2 2 0.6 
H-bonding/ van der 
Waals 
= 
GASESYL 3.3 -1 1 0 3 3 -0.1 
Electrostatic 
repulsion/ H-
bonding 
↓ 
 
Therefore, these results indicate that peptide adsorption to silica surfaces may exhibit more 
than one type of interaction and can be influenced by the experimental conditions such as 
pH, subject to the peptide charge and pI in solution-based assays. 
  
3.3.5.2 Raman spectroscopy for probing peptide-silica interactions 
In this study, Raman spectroscopy has been used for the identification of peptide structure  
and to probe their interaction with silica particularly to see small conformational changes 
(due to their sensitivity to microenvironment) in some amino acid residues in aqueous and 
solid states274–277. These minor shifts has been used as a marker to assess the 
microenvironment (i.e hydrophobicity or hydrophilicity)274,275,278. The sequence LPVRLDW 
was chosen for this Raman study due to the peptide composition (i.e the variation in 
functional amino acid residues) representing hydrophobic (Leu at N terminus and at 5th 
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position), polar basic (Arg), polar acidic (Asp) aromatic (Trp) and motifs (LP) that are crucial 
to identify the likely type of binding to silica. In addition, the sequence contains special 
amino acid (pro) at 2nd position of the peptide sequence. The peptide samples in different 
formats including solid, liquid air-dried, solid powdered samples were used. In addition, the 
residual pellet (peptide adsorbed to silica) collected from the fluorescamine assay were 
washed twice with water, air-dried and investigated using Raman spectroscopy to see if 
change in the peptide structure on binding could be identified. The crowded Raman shift 
region also known as finger print region (500-1600 cm-1) was taken to uniquely identify 
specific amino acids or any other structural conformations of the peptide274. For all these 
peptides, the Raman spectra was collected from 100 cm-1 to 3600 cm-1 but only the finger 
print region from 500 cm-1 to 1600 cm-1 was used for this analysis, as this area is of focal 
interest for both peptide and silica. 
 
 
Figure 3.5. Raman spectrum of amino acids identified in LPVRLDW peptide. A 
strong signal has been noticed for Tryptophan (W) at 756 cm-1 and 1010 cm-1. 
 
A few amino acids present in LPVRLDW peptide such as Trp (W), Leu (L), Pro (P) and Asp 
(D) gave strong to medium signals while the Val (V) gave medium range signals and for the 
remaining amino acid Arg (R) did not give any sign of peak or band signals (Figure 3.5).   
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Figure 3.6. Raman spectrum showing the LPVRLDW peptide alone, silica alone and 
when peptide adsorbed to silica particularly for the aromatic amino acid 
tryptophan. Asterick * represents the silica bands found at around 440, 732 and 1390 cm-1. A) 
Symmetric benzene/pyrrole in-phase breathing mode of Trp at 756 cm-1 B) Indole ring vibration 
with NH bending mode of Trp 880 cm-1 C) Symmetric benzene/pyrrole out-of-phase breathing 
mode of Trp at 1012 cm-1 D) Pyrrole C2-C3 stretching mode of Trp found at 1551 cm-1. 
 
 
Figure 3.7. Raman spectra obtained from different samples of peptide (LPVRLDW) 
and silica. Five different samples such as peptide alone, silica alone, peptide adsorbed to silica 
(solid powered and dried pellet from solution) and the dried peptide-silica pellet obtained from the 
fluorescamine assay showing the variation and shifts in the Raman spectra. Asterick * represents 
the silica bands found at around 440, 732 and 1390 cm-1.  
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In silica alone samples, the Raman bands were found at around 440, 732 and 1390 cm-1 
respectively129, while strong bands of Trp (W) were observed in LPVRLDW peptide alone 
samples at 756 cm-1 and 1010 cm-1274,277 (Figure 3.6).  These strong signals are due to the 
symmetric benzene in and out phase breathing mode of Tryptophan358. The LPVRLDW 
peptide adsorbed silica samples (mixed solid and dried pellet) showed signals at 440 cm-1, 
732 cm-1, 1390 cm-1, 756 cm-1 and 1010 cm-1 respectively but slightly lower signals (Figure 
3.7). This clearly indicates that changes in vibrational shifts or signals for particularly 
aromatics occur in solids (strong) and solutions (weak) but showing some signals for peptide 
backbone. However, only silica bands were found in case of dried peptide-silica pellet after 
fluorescamine assay by masking the peptide bands with silica (Figure 3.7). The possible 
reasons for masking of peptide signals with silica may be due to not enough peptide required 
for obtaining Raman signals because of fluorescamine experimental sample limitation. Thus, 
verifying the peptide LPVRLDW binding to silica by Raman spectroscopy revealing the 
differences in the spectrum may be due sensitivity of microenvironment at peptide-silica 
interface in solids and solutions. The binding signal observed was mainly from aromatic Trp 
(W) amino acid; indicating this technique has potential to be used for identifying the peptides 
or specific amino acids and use them as markers to assess the local environment in silica-
peptide composites.    
 
3.4 Conclusion 
In summary, heptapeptides having affinity for amorphous silica nanoparticles (hydrophilic, 
82 nm) have been identified. To achieve this, elution buffer conditions (low pH, high pH 
and high salt) and the elution buffer itself were changed to remove peptide binding phages 
from silica surface during the phage display process. The experimental results gave 
information about the tight peptide silica binders eluted and the functional amino acid groups 
may be responsible for electrostatic and non-electrostatic interactions. Also, complementary 
bioinformatics results prove that most of the sequences checked do not exist in MimoDB 
database and are not identified as contaminants. This demonstrates that peptides isolated 
were not target-unrelated sequences but rather genuine target binders without any human, 
pathogen or sample contamination. 
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A repanning method has been reported to recheck the phage display process and verify silica 
binders by checking the reproducibility of the process. The repanning method may 
experimentally verify your own target binding results giving information about any possible 
non-specific binding due to panning limitation (amplification bias), thereby checking the 
direction of the ongoing phage display work. Thus, the repanning method reported for silica, 
appeared to be a straight forward approach to verify phage display experimental results by 
mixing phage clones from different biopanning experiments and rounds. The results of the 
repanning experiment reproduced mostly similar silica binders that were identified 
previously along with additional peptide sequences which were hidden in the previous 
biopanning experiments. The tightly bound silica binders reproduced which were also 
isolated previously include LPVRLDW, GQSEKHL, NDLMNRA, VSRDTPQ, ELTPLPL and 
QLAVAPS gave us indication of reproducibility of material binding peptides by verifying 
the experimental biopanning process. Additionally, this experiment also prove that no 
possible human, pathogen and sample contamination was present. While the sequences such 
as HYIDFRW, HVPRAMA, SQTFTSD, SFPLSKY, TVNFKLY and HGGVRLY appeared only 
in this process but were not identified before via traditional biopanning process suggest that 
these entirely new peptide sequences are the ones that might have been missed in the few 
phage clones that were selected from a large pool for sequencing. The KIAVIST peptide 
sequence in repanning process appeared as a main silica binder which has been identified in 
both elution experiments (0.2 M Glycine-HCl, pH-2.2 or 100 mM Triethylamine, pH-11) 
and has displayed in all rounds sequenced; while the same sequence was found only once in 
previous traditional biopanning experiments. Therefore, this verification process may be 
used to identify the tight silica binder (KIAVIST). The reappearance of LPVRLDW peptide 
sequence in repanning experiment prove that this phage clone does not have any propagation 
advantage, which means this peptide sequence is not a fast grower but a genuine target 
binder. The results and physico-chemical properties of isolated silica binders suggest that 
the three different elution buffers (low pH, high salt and high pH) used have isolated peptides 
of both electrostatic and non-electrostatic interactions. 
 
The phage clones displaying peptides LPVRLDW, HYIDFRW and KIAVIST that occurred 
more frequently in the phage display experiments, showed higher binding to amorphous 
silica nanoparticles. However, the phage clones GQSEKHL, VSRDTPQ and GASESYL that 
had appeared frequently in the biopanning experiments (initial and repanning) displayed less 
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binding to silica in relative binding studies. While, the ELTPLPL sequence that was isolated 
a few times in both initial and repanning experiments has exhibited a higher binding ability 
to silica nanoparticles. In addition, the multiple sequence analysis was performed for all the 
silica binding peptide sequences and a sequence (VSTPLLA) has been emerged as a 
consensus silica binder. This consensus sequence was then compared with all the silica 
binders identified in this and previous studies and the motif LP was commonly found in most 
of the peptide sequences that were reported to be the strong silica binders. 
 
Furthermore, selected silica binding peptides (LPVRLDW, NDLMNRA, GQSEKHL, GASESYL 
and KIAVIST) identified from experimental biopanning (traditional and repanning) and 
relative binding methods were chemically synthesized and characterized for studying the 
peptide-silica interactions using fluorescamine assay and Raman spectroscopy. All the five 
peptides selected for adsorption studies (fluorescamine based quantification assay) showed 
distinctive binding to silica nanoparticles. The peptide KIAVIST with high pI (10.1) and net 
positive charge (+1) showed high binding to silica, while the peptides LPVRLDW and 
NDLMNRA having neutral pI values (6.8) and net charge (0) showed lower binding than 
KIAVIST peptide. However, the peptide LPVRLDW displayed better binding than that of 
KIAVIST at lower concentrations (i.e up to 1mM). In contrast, the peptide GQSEKHL with 
nearly similar pI (7.8) and net neutral charge (0.1) values to that of the peptides LPVRLDW 
and NDLMNRA, exhibited lower binding to silica nanoparticles. The peptide GASESYL with 
low pI (3.3) and net negative charge (-1), which was selected as a control for this adsorption 
investigations showed least binding to silica nanoparticles. Also, these results indicated that 
peptide adsorption to silica surfaces may exhibit more than one type of interaction and can 
be influenced by the experimental conditions such as pH, subject to the peptide charge and 
pI in solution-based assays. Besides, complementary binding studies of LPVRLDW using 
Raman spectroscopy exposed that there are differences in the spectrum after binding of 
peptide with silica. The binding signal observed was mainly from aromatic Trp (W) amino 
acid; indicating this technique has potential to be used for identifying the peptides or specific 
amino acids and use them as markers to assess the local environment in silica-peptide 
composites. 
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Chapter 4: Isolation of Silica Binders by Optimised Biopanning 
Method and Bioinformatics 
4.1 Introduction 
With increase in the demand of using biopanning to display material specific peptides and 
then to synthesize the biobased materials in vitro and in vivo, it is very important to 
efficiently elute and recover the strongly bound phage from the inorganic material surfaces 
without degenerating the material or the phage peptide. In general, to elute strong binders a 
single elution buffer is used and to isolate the best consensus binders, the number of 
biopanning rounds are increased24. During the successive controlled washing steps, mostly 
any binder unrelated to the target should have been removed, leaving only the target selective 
phage to remain68.  Moreover, the non-specific binding of peptides to materials is an issue 
that can nurture the wrong results. The non-specific peptides may have affinity for the 
chemicals or substrates including plastic tubes or plates or films or petri dishes, washing or 
elution buffers and their components and blocking or coating agents that are used during the 
biopanning process. This type of non-specific binding behaviour can hide the actual binders 
thereby promoting the wrong or untargeted binders or fast growers. A full list of peptides 
reported to bind to polystyrene based components such as well plates, beads, petri dishes 
and films during biopanning process was shown in Table 2.3, Chapter 2. Considerable effort 
has been made to isolate material binding peptides by targeting washing and elution 
strategies. Elution for target-binding phage can be done using various methods, as shown in 
Figure 4.1.  
 
Chemical based elution methods are more traditionally used, which can involve eluting the 
stronger binders using buffer conditions, such as extreme pH, salts (ionic strength) or 
reductants such as DTT69,359. During the biopanning procedure, the extreme low pH elution 
or high salt buffers tend to cause changes in the phage-target interface, or sometimes degrade 
or denature either the substrate or phage surface. As a result, they may become inactive or 
may change the original reaction between the inorganic surface and the phage peptide. 
Because of these modifications, strong binders may be removed incompetently; 
consequently, a large number of strongly bound phages can be left on the material 
surface4,153. Washing and elution steps in the phage display process are key to know whether 
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all the strong binders are eluted completely from the available phage library; alongside 
removing the loosely bound phage clones using appropriate detergents and elution buffers. 
 
 
 
 
Figure 4.1. Schematic representation of different types of elution methods. a) Chemical 
elution: The non-specific or weakly bound phage are first washed away, and the remaining strongly bound 
phage are eluted by low or high pH or high salt buffer b) Physical elution: The strongly bound phage is 
eluted either by using sonication or ultrasound or with a combination a) and b). c) Enzymatic elution: 
enzymes (such as trypsin or protease) are used to cleave phage bodies at specific sites (capsid or scFv). 
Only the immobilized phage bound to the bait (target material or antigen) will be eluted. Any non-specific 
phages present will be marginalized during several panning rounds. d) Competitive elution: high 
concentration target antigen is introduced to elute bound phage, with the material binding phage still 
bound to surface. 
 
The phages clones which are eluted using high or low pH solutions often display just low to 
medium affinity to the target360. Suggestions for the improvement of this procedure, for the 
selection of high affinity clones include: gradually decreasing in pH of the elution buffer 
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during the last biopanning round361, using target protein as the elution buffer362 and eluting 
the bound phage with triethylamine over multiple time359,363.  
 
In another article, the selection of high affinity binders was improved from a 7-mer peptide 
phage library, using a strategy know as an alternating elution procedure.  In this elution 
procedure, solutions of low pH buffer (glycine buffer) and target protein (at higher 
concentration) were used in turns as eluting reagents for all the panning rounds, and by the 
third round were able to select high affinity clones for sequencing. Lysozyme was here used 
as model protein to evaluate the selection strategy. It was established that the using low pH 
buffer alone is not enough to remove the high affinity binders due to propagation effect of 
the atoms close to the affinity site. Using alternating elution from the initial round can 
prevents the loss of strong phage binders in the start of biopanning359. Similarly, another 
article has also commented on the problem with using conventional pH (acid and alkali) 
washing regimes which in previous studies has resulted in the loss of high affinity binder. 
With the intention to maximise recovery of binding sequence, Rawlings et al. at end of the 
selection rounds would use the eluted phage, and the remaining magnetic nanoparticle with 
any attached residual phage, to directly infect the E. coli cells364. 
 
Cell bound phage in general are eluted using acidic buffers, but recent studies have suggested 
that low pH may not be enough as significant amount of phage remains bound with the cell 
pellet post centrifugation365–367.  A possible alternative method for improving phage recovery 
maybe to use higher pH (alkali) solution or to infect the cell-bound phage directly with 
growing E. coli bacterium368,369. Certain studies have suggested that some phages may be 
internalized into the cell before binding to the cell surface antigen, thus using a combination 
of low pH solution, regardless the presence of a non-denaturing detergent (such as Tween 
20 or NP-40), will enhance the phage recovery dramatically370,371 
 
Recent research showed some advancement by using ultrasonication based physical elution 
combined with chemical elution and can be used as an alternative to the traditional chemical 
elution method69. In this biopanning approach, 100% of selected strong binders to solid 
materials have been recovered, by firstly eluting the peptides through chemical elution and 
followed by an additional step of 30 seconds physical elution by passing the ultra-sonic 
energy via ultrasonication69. Whereas, by using only single physical elution step, they 
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managed to recover  45% of the selected peptides from solution by ultra-sonication and also 
only a few numbers of clones were identified69. Likewise, in another study, inorganic 
binding peptides with electroactive properties were eluted by using a tiny electronic device 
in the biopanning media92,372,373. As a result of electric field application, the reversible electro 
activated peptides that have sensor applications were desorbed from the material surface 
after the chemical elution step92,372,373. However, the high power ultrasonication causes the 
production of cavitation bubbles which cause hydrodynamic sheering stress and helps in 
dissociating the phage68. 
 
Enzymatic elution method involves using an enzyme such as trypsin or protease to cleave 
the link between the phage capsid and the library protein. Trypsin cleaves between the scFV 
and pIII phage (phage coat protein) thus, any scFV-attaching phage (surface binding and 
antigen binding) will be eluted, except for the phage-head-attaching phage which will still 
be bound to the surface. For the manipulation of the scFV phage, a helper protein is required. 
Engineered pIII has a helper phage known KM13 which also has a trypsin specific cleavage 
site, which post trypsin treatment is non-infective. However in the case of scFv-pIII fusion 
will lose the scFv protein post trypsin treatment, but still will remain infective374. Any non-
specific binders in the eluted phage is reduced in phage display panning rounds with trypsin 
treatment compared to conventional elution methods (such as triethylamine elution)375,376. 
3C protease has shown effective cleavage of phage proteins at 4°C, allowing the specific 
elution of phages bound to the bait (target material or antigen). The results showed that 3C 
protease treatment at 4°C elutes ~80 times more bound phage compares to traditional elution 
method with 1% SDS T7 phage349. 
 
Within competitive binding elution methods, there are some strategies which use specific 
blockers and biological ligands to elute bound phages. As an example, Hageman et al. has 
used CCL22 and CCL17 (G-protein coupled chemokine receptor (CCR4)-specific 
chemokines) to determine anti-CCR4 mAbs that were able oppose receptor specific 
ligands377. Competitive elution methods are certainly useful for experiment that require the 
panning of native cell lines, as it is capable for expressing many antigens on the surface. A 
good example of this property would be the competitive elution of CK 8 and T4 cell line 
targeted phage binders, using anti-CK8 mAbs (RCK 102)378,379. However with this elution 
method, to achieve the desired outcome, optimisation of the incubation period and 
concentration of eluent agents is vital378. Competitive elution is an alternative elution method 
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which can be useful in experiments where the ligands of the certain target are known and 
accessible68. 
 
Some literature suggests that scientists have tried to overcome the elution and recovery 
problems by two approaches. The bound phage recovery method93,319 is one of the solutions, 
where the phage still remains bound to the surface of the material which is then amplified 
and sequence analysis is performed following PCR. A second approach is the PCR derived 
phage display153. In this method, the bound phages were eliminated, amplified and the phage 
DNA isolated through lysis buffer, followed by sequence analysis of the binders following 
PCR; however, under some harsh chemical conditions, the question concerning the materials 
stability remains unsolved and also there still remains the laborious labor-intensive nature of 
the process of biopanning. Taylor and co-workers achieved some success by introducing two 
new variations to the phage display technology380. Firstly, they introduced 10% wild–type 
phages and phage library into the panning mixture which enabled them to identify phage 
DNA for both non-specific and specific binding. Secondly, they used rolling circle 
amplification with polymerase phi29 where phage DNA bound to substrates after a series of 
washings for direct amplification380. 
 
A study has also developed a phage display strategy for Affimer phage library that uses 
comparatively low amounts of target and non-target homologous antigen, thus making this 
a suitable method for proteins that are difficult to express or are expensive. The highly 
specific selected Affimer clones can distinguish between protein isoforms with similar 
structures. The method also allows for negative selection by which a small amount of 
homologous protein is premixed with the phage library from the round two of panning 
onward. Round two onward of panning involves the phage population to be initially 
incubated with homologous proteins to the target protein to eliminate any phage that binds 
to the closely related homologs, after which it is incubates with the planned target. This 
process may also be able to block or capture the cross-relative Affimer-displaying phage, 
thus allowing the enrichment and isolation of highly selective Affimers in the successive 
panning rounds. The method can potentially be suitable for any phage library for similar 
highly selectivity and for developing reagents to study signalling cascade by blocking of 
protein-protein interactions381.  
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Although various alternative elution strategies (eg. physical based such using as sonication, 
ultrasound etc.) are being tested to improve the elution step in biopanning process, the 
popularity of using chemical buffers (eg. low or high pH and salts) to elute the strongly 
bound target binders from material surfaces is still on rise and most preferred means.  
 
 
 
Figure 4.2. Schematic representation of peptide/ phage adsorption or desorption 
onto silica nanoparticle surface and intrinsic bias during biopanning due to pH 
or charge. Image adapted4. 
 
From our previous biopanning studies4, it is evident that at pH 7.4, silica binding peptides 
identified by the phage display process, exhibit different binding patterns to the silica surface 
and are directly dependent on the sequence and charge specific interactions. However, when 
a low pH (2.1) elution buffer is used, the strong binders are eluted from the silica surface by 
disrupting the electrostatic interactions present at peptides-silica interface, thereby 
efficiently removing the electrostatically bound peptides from the silica surface and leaving 
the non-electrostatically (hydrogen or hydrophobic or van der Waals) bound consensus 
peptides on the material surface resisting detection as shown in Figure 4.2. Due to this 
behaviour of peptides during biopanning process, some silica binders that are bound by non-
electrostatic interactions are being lost and the information about their diversity is unknown. 
This intrinsic bias of the biopanning process is due to the elution step. Also, the peptides 
adsorbed to silica nanoparticles in this study were pH dependent and found to be sequence 
dependent subject to the peptide charge. Therefore, any changes in washing and elution steps 
will affect the adsorption or desorption of peptide on silica surface. 
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Therefore, we have used an alternative elution strategy by using more than one elution 
buffers varying elution conditions to effectively elute and recover most phage clones from 
the available library. In this study, an optimised chemical elution to biopanning method 
reported here, has identified and recovered more silica binders from the phage pool in just 2 
biopanning rounds. Although the approach is tested with silica, it could perhaps be applied 
other inorganic materials that resemble silica properties. Moreover, complementary 
experimental and bioinformatics methods are used to check and test the authenticity of true 
silica binders.  
 
4.2 Materials and Methods 
 Materials 
Chapter 2, section 2.1.1 provides details of materials used for adsorption studies. 
 Methods 
4.2.2.1 Phage display protocol 
The typical protocol applied for optimised biopanning and repanning biopanning 
experiments are discussed in methods sections 2.1.2.3 and 2.1.2.4. The details of phage 
display experiments and elution conditions used to elute silica binding peptides via 
optimised and repanning methods can found in the Tables 2.1, 2.4 and 2.5.  
4.2.2.2 Relative binding affinity method  
For this chapter, 14 different individual phage clones isolated from optimised biopanning 
process were chosen for the relative binding assay. The protocol used for this assay are 
described in Chapter 3, section 3.2.2.2. The phage titer calculations including the number of 
input to output phages and the binding ratios from two separate experimental repeats was 
added in Appendix 4.1. 
4.2.2.3 Bioinformatics searching  
Chapter 2, section 2.1.2.2 provides details of materials used for bioinformatics analysis. 
 
 
 
 Chapter 4 : Isolation of Silica Binders by Optimised Biopanning Method and Bioinformatics 
 
 
143 
4.3 Results and Discussion  
In this chapter, the same batch of amorphous hydrophilic silica nanoparticles (as for chapter 
3) of size 82 nm prepared in the Perry laboratory and previously characterised4,107,234 has 
been used as a target. Further details about the properties and measurements of silica 
nanoparticles is described in Table 2.6 under the section 2.1.2.6. However, as the first batch 
of library (Lot: 0211212) was finished for more panning experiments, a second batch (Lot: 
0221501) ordered and used for the optimised biopanning process (alterative three step 
chemical elution method). It is known that most of the phage clones eluted by either low or 
high pH buffers via traditional elution methods often displayed low to medium affinity for 
the target360,382. Few studies reported improved procedures by gradually decreasing the 
elution buffer pH361 and constantly eluting the substrate bound phage with high pH 
triethylamine363 in the successive biopanning rounds for selecting high affinity clones. Also, 
from the results of Chapter 3, the physico-chemical properties (i.e charge, pI and functional 
groups) of the isolated silica binders suggested that the three different elution buffers (0.2 M 
Glycine-HCl, pH-2.2, 100 mM Triethylamine, pH-11 and 4 M MgCl2, pH-6.1) used have 
extracted phage clones displaying peptides of both electrostatic and non-electrostatic 
interactions. Hence, by using the same three elution buffers consecutively one after other in 
a single panning round (described in methods section, Chapter 2), we expect to elute and 
recover elution and /or charge specific silica binders that are bound to silica by both 
electrostatic and non-electrostatic interactions; thereby improving the elution procedure 
previously used in Chapter 3. The optimised biopanning approach differs from the traditional 
biopanning method as each mentioned buffer (Gly-HCl, pH-2.2; MgCl2, pH-6.1; TEA, pH-
11) are used consecutively one after other in a single screening (biopanning) round, as 
appose to one specific buffer being used for all panning rounds including elution steps in 
traditional biopanning and repanning experiments (Chapter 3). 
 
Despite obtaining a new aliquot of library, we did not repeat traditional biopanning 
according to Chapter 3 as a comparator with the work described in Chapter 4 because of the 
similarity of elution buffers (Gly-HCl, pH-2.2; MgCl2, pH-6.1; TEA, pH-11) and pH 
conditions that were used for Chapters 4 (optimised panning method) and 3 (traditional 
panning method). Nevertheless, for testing the optimised biopanning method, repanning 
experiments were carried out by exposing the mixture of amplified phage pool (prepared by 
mixing together the round 1 amplified phage pool samples stored from initial panning 
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experiments as shown in Table 2.5) from the initial (traditional) biopanning tests with fresh 
silica. The reason for taking all the separate amplified phage stocks from round 1 is to i) test 
the optimised chemical elution method with the first aliquot of library (Lot: 0211212, 
Chapter 3) as a comparator with the work described in Chapter 4 (new library, Lot: 
0221501). ii) use this repanning test as a repeat for the traditional biopanning method as 
described in Chapter 3, because of the similarity of elution buffers and pH conditions.  
 
 
 Silica binders isolated from optimised biopanning method 
Details including step by step optimised biopanning procedure used to isolate silica binders 
is described in Chapter 2, under methods section 2.1.2.3. Similarly, the experimental 
conditions (washing and elution) used for optimised biopanning process are shown in Table 
2.4. In the optimised biopanning experiment, a few phage clones selected from the early 
panning rounds (1-2) displayed a range of silica binding peptides including the most 
frequently repeated sequences in all three sequentially used elution buffers as shown in Table 
4.1. Here, a single biopanning experiment involving two panning rounds were performed. In 
each panning round, phage binding, washing, three step elution and amplification steps were 
carried out. At the end of first and second rounds, phage titering and blue/white screening 
method was used to select individual phage plaques. A total of 180 phage clones were 
selected randomly from first and second rounds (30 clones each from the three elution 
buffers separately) and analysed by DNA sequencing.  
 
The phage clones obtained from the first and second biopanning rounds displayed a range of 
silica binding peptide sequences as shown in Table 4.1. Overall, 47 peptide sequences were 
isolated coding for 15 identical repeats and 32 different sequences. The sequences identified 
from the second round of panning showed more repeating peptide sequences that appeared 
in first round. Also, some phage clones selected in first round were further selected in second 
panning round due to the progressive enrichment in the phage clones displaying the same 
peptide sequences. The possible reason for an increase in enrichment in the early panning 
rounds itself (second panning round) might be due to i) the stepwise increase in the detergent 
concentration (for every 5 washes, out of 10 wash cycles performed for a single panning 
round) in the washing step and ii) the additional elution steps (three step elution) covering a 
pH range 2-11 including high salt in a single panning round unlike single elution step in 
Chapter 3. 
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Table 4.1. Silica binding peptides identified from optimised biopanning process. 
A total of two screening rounds were performed, the phage clones eluted separately after each 
elution step in a three-step elution process using three different elution buffers for each panning 
round were shown. To improve the screening stringency, the Tween 20 detergent (0.1-0.5% Tween 
20 [v/v] mixed in TBS) concentration and wash times gradually increased as shown. NIL are the 
phage clones which were excluded from results due to the insertless or absence of any sequence, 
as the inherent rate of insertless phages in the NEB Ph.D.-7 library was about 5%. Frequently 
occurring sequences within the biopanning rounds are presented in a unique colour for clarity. 
Biopanning 
(screened) 
round 
Wash 
TBST 
Elution conditions 
Peptide sequence and frequency 
Frequently 
observed 
peptides Buffer pH Eluent 
1 
0.1-0.3% 
5 each 
Total 10 
washes  
Glycine-
HCl, 
0.2 M  
2.2 1st  MPRLPPA 3/30 
ADIRHIK 2/30 
SILPVTR 2/30 
MQEMRQM 2/30 
LMPGYQL 1/30 
LTQQLHT 1/30 
LETVVSS 1/30 
TAVTYKS 1/30 
VITLDTY 1/30 
QMQTGKL 1/30 
KSLWTYP 1/30 
SLETMSN 1/30 
ALVSLSQ 1/30 
SVDIWTI 1/30 
AGHVVPR 1/30 
EVISAAW 1/30 
LLALPYW 1/30 
VDTSIFN 1/30 
YPWQSDN 1/30 
TNLHINP 1/30 
ADARYKS 1/30 
LLAPPYW 1/30 
MHEAVLN 1/30 
NIL     2/30 
 
MPRLPPA 
ADIRHIK 
SILPVTR 
MQEMRQM 
  
MgCl2 
4 M 
6.1 2nd ADARYKS 4/30 
MPRLPPA 4/30 
HDSPTAA 3/30 
HWNTVVS 2/30      
ANPTFFS 2/30 
ADIRHIK 1/30 
DNDLSLS 1/30 
HDVMWQR 1/30 
 
LETVVSS 1/30 
ASMNQGG 1/30 
SFLVTRN 1/30 
SPSTNPS 1/30 
GPLIWFS 1/30 
GSTSFSK 1/30 
ASSHIHH 1/30 
ANLPQLL 1/30 
NIL     4/30 
 
ADARYKS 
MPRLPPA 
HDSPTAA 
HWNTVVS 
ANPTFFS 
TEA 
100 mM 
11 3rd ANEDTGT 13/30 
FGGPTTR 3/30 
EGWIQTF 2/30 
VWQPELQ 1/30 
FVMSDPI 1/30 
TGASQFP 1/30 
 
LNGNWTR 1/30 
VDTSIFN 1/30 
VDGARTH 1/30 
SPLHSNY 1/30 
TNLHINP 1/30 
SSTPANL 1/30 
NIL     3/30 
ANEDTGT 
FGGPTTR 
EGWIQTF 
 
2 
0.3-0.5% 
5 each 
Total 10 
washes 
 
Glycine-
HCl, 
0.2 M 
2.2 1st 
 
SILPVTR 18/30 
ADIRHIK 4/30 
ANPTFFS 4/30 
ADARYKS 1/30 
MVQSPRD 1/30 
NIL     2/30 
SILPVTR* 
ADIRHIK* 
ANPTFFS* 
MgCl2 
4 M 
6.1 2nd HWNTVVS 16/30 
SPLHSNY 3/30 
ADARYKS 2/30 
ADIRHIK 2/30 
 
ANPTFFS 2/30 
SILPVTR 2/30 
NIL     3/30 
  
HWNTVVS* 
SPLHSNY 
ADARYKS* 
TEA 
100 mM 
11 3rd ANEDTGT 22/30 
EGWIQTF 5/30 
SPLHSNY 2/30 
FGGPTTR 1/30 
ANEDTGT* 
EGWIQTF* 
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From the results, it was found that ten phage clones displaying peptide sequences ANEDTGT 
(22/30, 73%), SILPVTR (18/30, 60%), HWNTVVS (16/30, 53%), EGWIQTF (5/30, 17%), 
ADIRHIK (4/30, 13%), ADARYKS (4/30, 13%), MPRLPPA (4/30, 13%), ANPTFFS (4/20, 
13%), FGGPTTR (3/20, 10%) and SPLHSNY (3/30, 10%) appeared as the most frequently 
occurring silica binders (i.e more abundantly observed sequences from a randomly selected 
few phage clones) eluted from the first and second panning rounds via three different elution 
buffers (Table 4.1). While, some identical sequences were displayed more than once but less 
frequently within the three different elution steps (highlighted in a unique colour). It is 
important to note that, no single peptide sequence was present in all the three different elution 
steps.  
 
More importantly, the sequences isolated in this optimised biopanning process (using second 
batch of same library (Lot: 0221501) showed no identical sequences compared with 
sequences identified from first batch in Chapter 3 (traditional and repanning experiments via 
Lot:0211212). Although, this batch-to-batch variation has been frequently reported as a 
problem in the antibody production200,372,383, there is no evidence for lot-to-lot variation for 
M13 phage display, specifically for Ph.D-7 libraries. However, this could happen possibly 
depending on how the outgrowth and amplifications in a larger scale proceed in the bacteria 
in the initial preparation of phage library 384,385. The other possible reasons might be due to 
performing extended amplifications or many rounds of selections during the biopanning 
resulting mutations in E.coli leading to insert less clones. However, according to NEB 
Manual, no mutations were reported for Ph.D-7 phage display library so far.  Hence, limited 
information is known about the full diversity of the phage libraries, more experimental 
evidence would be needed to determine if this PhD.-7 library system leads to lot-to-lot 
sequence variability. Nevertheless, it must be noted that only two panning rounds were 
performed in the optimised biopanning process suggesting very low chance of amplification 
bias could have happened within the experiment. In addition, a similar trend in the 
distribution of amino acid residue occurrences for all the peptide isolates eluted and 
identified from two separate lots of library against silica was observed (Figure 4.9) after 
analysing all the sequences from both batches (described in the following section 4.3.4). 
Furthermore, the two consensus sequences identified from both lots of library showed 
similar trend towards silica surfaces (Figure 4.8). Thus suggesting, this dissimilarity in the 
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isolated sequences may be due to the selection of few clones from a large phage pool for 
sequencing.  
 
The amino acid distribution of the isolated silica binders from optimised bioapnning process 
were shown in the Figure 4.3. A total of 47 peptide sequences identified from both first and 
second panning rounds displaying 15 identical repeats and 32 different sequences were 
analysed and separated specific to the elution step and/ or buffer.  
 
 
 
Figure 4.3. Distribution of functional aminoacids of silica binders eluted from 
three step elution (optimised biopanning) process. All the phage clones identifed from 
first and second panning rounds (Table 4.1) using three different elution buffers for each panning 
round were considered while plotting the pie diagrams. 
 
The high salt magnesium chloride elution buffer (4 M MgCl2, pH-6.1) eluted the phage 
clones displaying peptide sequences containing 50% of hydrophobic amino acids, in contrast 
to 44% and 28% using low pH (0.2 M Glycine- HCl, pH-2.2) and high pH triethylamine 
(100 mM Triethylamine, pH-11) respectively. It is noteworthy that the high salt elution 
buffer showed similar pattern for the phage clones eluted in the initial biopanning 
experiments (Chapter 3). Thus, indicating the high salt buffer may be used for eluting the 
phage clones mostly bound to silica by hydrophobic interactions. It has been reported that 
the peptide sequences removed from indium zinc oxide (IZO) surface eluted via high salt 
elution buffer (4 M MgCl2, pH-6.1) showed more blocks of hydrophobic amino acids than 
the low pH buffered solution92,373.  
 
Besides, an increase in the acidic (-) and polar uncharged amino acid residue composition 
was noticed with step wise increase in the pH of the elution buffers. However, a reversed 
trend was observed for the for the groups with basic (+) charged. For example, the phage 
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clones eluted from elution buffer 1 (low pH) exhibited 6% acidic and 33% polar uncharged 
amino acid groups. While, the same acidic and polar uncharged residue composition 
gradually increased to 7% and 34% for the clones eluted from second elution step (4 M 
MgCl2, pH-6.1) and 23% and 43% with elution buffer 3 (high pH) respectively. Hence, 
indicating the single elution buffer used for eluting the phage clones (Chapter 3) may have 
resulted in incomplete removal of all strong binders and resist detection to substrate silica69. 
By using sequential three step elution process (optimised biopanning) varying elution buffers 
and pH condition in a single panning round, the phage clones that resist detection in single 
elution step may have eluted in the other successive elution steps. Also, the increase in the 
acidic amino acid composition for the phage clones eluted by high pH triethylamine (100 
mM Triethylamine, pH-11) may be due the electrostatic repulsions resulting in the removal 
of strong silica binders. 
 
Moreover, Gly-HCl at low pH has eluted 63% of peptides with net positive charge, while 
58% and 79% of peptides eluted in the second elution (4 M MgCl2, pH-6.1) and third elution 
(100 mM Triethylamine, pH-11) steps displayed net neutral and negative charged sequences 
respectively (Table 4.2 and Figure 4.3). The percentage of the peptide sequences eluted was 
calculated by counting and averaging the number of sequences and times identified in both 
first and second panning rounds. Also, it was noticed that as the pH condition of the elution 
buffers increase in the elution steps, the net charge of the sequences being eluted from silica 
surface change from positive to negative. For example, the sequences SILPVTR (20/60), 
MPRLPPA (3/60), ADIRHIK (6/60) and ADARYKS (2/60) having high pI (11.1 to 9.7) and 
net positive charge (+1) were eluted mostly in the first elution (high pH) step. While, the 
peptides HWNTVVS (18/60), SPLHSNY (3/60) and ANPTFFS (4/60) holding near neutral pI 
(7.8 to 6) and charge (0); as well as sequences ANEDTGT (35/60) and EGWIQTF (7/60) 
possessing low pI (3) and net negative charge (-1 to -2) were eluted mostly in the second 
(high salt) and third (high pH) elution steps (Table 4.2 and 4.3). However, a few sequences 
that were isolated in the first elution (MPRLPPA 4/60, ADIRHIK 3/60 and ADARYKS 6/60) 
also appeared in the second elution step. Similarly, the sequence SPLHSNY (3/60) that was 
eluted in the second elution step, reappeared in the third elution step, but fewer times. This 
may suggest that the residual sequences remaining from the previous elution steps were 
carried forward sequentially. 
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Table 4.2: Silica binders identified in Table 4.1 and their elution, pI and charge 
based appearance. The pI and net charge values for all the sequences were obtained from 
Innovagen and Bachem peptide property calculator (INNOVAGEN, 2014; Bachem, 2017). Blue 
colour indicates high pI and positive charge values of peptides at pH-7; no colour directs neutral 
charge and pI values and red colour indicates low pI and negative charge values.  
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Figure 4.4. Charge based distribution of peptides eluted in Table 4.2. The 
percentage of peptides eluted was calculated by taking the net charge (at pH-7) values for all the 
peptides (Table 4.2) eluted in three elution buffers separately.  For example, A total of 56, 53 and 
57 peptide sequences were identified from first (Gly-HCl, pH-2.2), second (MgCl2, pH-6.1) and third 
elution steps counting both panning rounds (R1A and R2A). Out of 56 sequences from first elution, 
35, 13 and 8 sequences, showed net positive charge, neutral and net negative charge values. Then 
diving the 35/56*100 will give 63% of peptides eluted in the first elution step using Gly-HCl, pH-
2.2, displayed net positive charge. The same claculation were repeted to get other values. 
 
Table 4.3: Physico-chemical properties of selected silica binding peptides 
displayed in Tables 4.1 and 4.2. aPhysico-chemical properties of the sequences were 
obtained from Innovagen and Bachem peptide property calculator (INNOVAGEN, 2014; Bachem, 
2017). Highlighted in bold are the sequences that appeared as the most frequently occurring silica 
binders repeated in first and second panning rounds. The amino acids that contain amine (N, Q, P, 
W) and hydroxyl side chain (S, T, Y) containing groups in a peptide that may help in forming 
hydrogen bonding between silica-peptide or among themselves are shown. 
Peptide 
sequence 
pIa 
Net charge 
@pH 7a 
Functional amino acid residuesa 
Polar 
(-ve, +ve and uncharged) 
Hydrophobic 
Amine 
side chain  
(N,Q,P,W) 
Hydroxyl 
side chain 
(S,T,Y) Acidic Basic Uncharged 
SILPVTR 11.1 1 0 1 2 4 0 2 
MPRLPPA 11.1 1 0 1 0 6 3 0 
ADIRHIK 10.18 1.1 1 3 0 3 0 0 
ADARYKS 9.7 1 1 2 2 2 0 2 
SPLHSNY 7.8 0.1 0 1 4 2 2 3 
HWNTVVS 7.8 0.1 0 1 3 3 1 2 
ANPTFFS 6 0 0 0 3 4 2 2 
ANEDTGT 3 -2 2 0 3 1 1 2 
EGWIQTF 3 -1 1 0 2 2 2 1 
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Figure 4.5: Percentage of hydrophobic v/s hydrophilic and amine containing side 
groups present in selected silica binding peptides mentioned in Table 4.3. The 
percentage of functional amine groups calculated by considering amino acids containing amine 
groups at side chain or N-terminus of the peptide. 
 
The reappearance of MPRLPPA in the second elution step (high salt) may also be due to 
having six hydrophobic (MPLPPA, 86%) and four amine side chain (PRPP, 57%) containing 
groups representing the phage clone bound to silica by hydrophobic and hydrogen bonding 
were fully recovered by high salt buffer (Figure 4.5). Similarly, the recurrence of SPLHSNY 
in the third elution step (high pH) might be due to the presence of only polar uncharged 
(SHSNY, 71%) or amine side chain (PHSN, 57%) containing groups representing the phage 
clone bound to silica by hydrogen bonding were fully recovered by high pH buffer. While 
the high pH elution buffer eluted and recovered peptides ANEDTGT and EGWIQTF mostly 
with low pI (3) and net negative charge ( -2 and -1) in final elution step, indicating the peptide 
bound to silica by electrostatics may have been removed as a result of electrostatic repulsions 
between negatively charged peptides and silica. Similarly, the high salt elution buffer eluted 
peptides with close neutral pI and charged peptides that could be responsible for 
hydrophobic/ hydrogen bonding or van der Waals forces.  
 
Furthermore, the appearance of peptide sequences in second and third elution steps show 
that we are not eluting and recovering most of the silica binders by traditional elution process 
(i.e. only one elution buffer throughout panning experiment and rounds). By using sequential 
three step elution process (optimised biopanning) varying elution buffer pH condition in a 
single panning round, the phage clones that resist detection in one elution step may have 
eluted in the other successive elution steps. Hence, suggesting the efficiency of the method 
to elute and isolate most of the silica binders in the early rounds of biopanning, removing 
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the sequences that resist detection during traditional bioapnning method; thereby by reducing 
the number of biopanning rounds, saving time, cost and effort. In addition, these three 
different elution buffers could be used to remove interaction or charge specific peptides 
subject to change in elution and pH condition.  
    
 Experiment to check the optimised biopanning process 4.3.1 
Encouraged by the optimised elution approach results, we tried optimised elution (three step 
elution) process in two different strategies (as described in methods section 2.1.2.4). The 
first strategy differs from the traditional biopanning method as each mentioned buffers (Gly-
HCl, pH-2.2; MgCl2, pH-6.1; TEA, pH-11) are used consecutively one after other in a single 
screening (biopanning) round, as appose to one specific buffer being used for all panning 
rounds including elution steps in traditional biopanning and repanning experiments (Chapter 
3); Second strategy only used the same Glycine-HCl elution buffer but at varying pH’s (i.e. 
Gly-HCl of pH-2.2; pH-7; pH-11). 
The repanning experiment reproduced more or less the same silica binders (Table 4.4) as 
were identified previously in the above initial biopanning experiments (Tables 3.3 and 3.4, 
Chapter 3) along with few new peptide sequences. Some silica binders reproduced which 
were also isolated previously include VSRDTPQ, GQSEKHL, TVNFKLY, LPVRLDW, 
WSLSELH, NDLMNRA, QQTNWSL, KIAVIST, ELTPLPL and WSLSELH. All the main 
silica binders identified in Chapter 3 using three different elution buffers from separate 
biopanning experiments reappeared in this repanning experiment. Also, a few sequences 
YSLKQYQ, YSFKQYQ, YNGSANG, VENVHVR, and FASRSDT appeared in this repanning 
process.  
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Table 4.4: Repanning experimental results to check the optimised biopanning 
approach and reproducibility. Selected tight silica binders were shown here and full list of 
sequences can be found in appendix 4.2 and 4.3. Note: Black coloured sequences are found in both 
initial and repannning methods (Chapter 3). While, the red coloured sequences are the ones 
appeared in this repanning experiment. ‘All 3 mix’ are the phage clone samples that are mixed 
together from all 3 elution steps and pH within elution strategy 1 and 2.  
 
Table 4.5: Physico-chemical properties of selected silica binding peptides of 
identified in Table 4.4. aPhysico-chemical properties of all the sequences were obtained from 
Innovagen and Bachem peptide property calculator 211,212. Highlighted in bold are the sequences 
observed as most frequently repeated peptides. An asterisk (*) represents the sequences that were 
present previously from initial and repanning experiments using lot 1 library (Chapter 3) and 
reappeared here. The amino acids that contain amine side chain (N, Q, P, W) and hydroxyl side chain 
(S, T, Y) containing groups in a peptide, which can help in forming hydrogen bonding between silica-
peptide or among themselves are shown. 
Peptide 
sequence 
pIa 
Net 
charge 
@pH 7a 
Functional distribution of amino acid residuesa 
Polar 
(-ve, +ve and uncharged) 
Hydrophobic 
Amine 
side chain 
(N,Q,P,W) 
Hydroxyl 
side chain 
(S,T,Y) Acidic Basic Uncharged 
KIAVIST* 10.1 1 0 1 2 4 0 2 
TVNFKLY* 9.7 1 0 1 2 3 1 2 
YSLKQYQ 9.33 1 0 1 3 1 2 3 
YSFKQYQ 9.33 1 0 1 3 1 2 3 
VSRDTPQ* 6.78 0 1 1 3 2 1 2 
GQSEKHL* 7.82 0.1 1 2 2 2 1 1 
LPVRLDW* 6.8 0 1 1 0 5 0 0 
NDLMNRA* 6.8 0 1 1 2 3 2 0 
ELTPLPL* 3.3 -1 1 0 1 5 0 1 
 Chapter 4 : Isolation of Silica Binders by Optimised Biopanning Method and Bioinformatics 
 
 
154 
Additionally, the reappearance of these peptide sequences in the current approach prove that 
this phage clone does not have any propagation advantage during biopanning rounds which 
means this peptide sequence is not a fast grower but a genuine target binder. The physico-
chemical properties of isolated silica binders suggest that the three different elution buffers 
(0.2 M Glycine-HCl, pH-2.2, 100 mM Triethylamine, pH-11 and 4 M MgCl2, pH-6.1) used 
have eluted peptides of both electrostatic and non-electrostatic interactions (Table 4.5).  
A similar trend in terms of eluting the sequences in the first two sequential elution steps 
using low pH, high salt buffers that had eluted mostly positively and neutral charged in 
optimising biopanning process was observed in this repanning experiment (Table 4.4). For 
example, the frequently repeated sequences TVNFKLY (8/30, 4/30), KIAVIST (2/30) and 
YSLKQYQ (2/30) with high pI (10.1 to 9.3) and net positive charge (+1) were mostly eluted 
and recovered in the first elution step in both strategies. While, the neutral pI and charged 
sequences VSRDTPQ (12/30, 5/30), GQSEKHL (6/30, 3/30) occurred more frequently were 
recovered in the second elution step for two strategies. It must be noticed that the low pH 
and high salt elution buffers showed similar pattern for the phage clones eluted in the 
optimised biopanning process. However, the peptides YSLKQYQ (12/30, 1/230) and 
YSFKQYQ (5/30) displaying high pI (9.3) and net positive charge (+1) were identified and 
mostly recovered in the last elution step using high pH condition.  
 
Thus, indicating these two positively charged phage clones may have bound strongly to 
negatively charged silica surface and were not able to elute and recover in the first and 
second successive elution steps resisting detection. Hence, in the third and final elution step 
(high pH elution buffer) the two phage clones were fully recovered, and this may be due the 
electrostatic repulsions between the negatively charged silica and positively charged phage 
clones at high pH resulting in the removal of strong silica binders. Thus, verifying the 
optimised biopanning process using the first aliquot of library (Lot: 0211212, Chapter 3) as 
a comparator with the work described in section 4.2.1; and further confirming the 
reproducibility of the repanning method, because of the similarity of elution buffers and pH 
conditions and importantly same aliquot of library. 
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 Relative binding affinity assay to assess phage binding to silica 
The relative binding affinity assay was carried out to evaluate the binding capability of each 
of the 14 different phage clones isolated by optimised biopanning process against silica 
nanoparticles. This phage-silica binding was determined by phage titer assay at pH-7.5306. 
Nine phage clones, that were isolated as main silica binders (highlighted in asterisk) and 
displayed repeatedly (abundantly observed) in the first and second screening rounds of 
optimised biopanning method (three step elution process) and two phage clones YSLKQYQ 
and YNGSANG displayed as new sequences in the repanning experiment of optimised 
biopanning process were chosen for binding assay. While, three individual clones were 
identified only once (LETVVSS, ASMNQGG and VDTSIFN) in the first or second screening 
round of the optimised biopanning method were randomly picked in addition to control 
M13KE.  
 
Figure 4.6. Binding ratio (bound/input) of each of the 14 different phage clones 
to silica nanoparticles. The relative binding affinity of the phage clones isolated from three 
step elution process (11 phage clones) and repanning experiment (2 phage clones) was determined 
by titer assay at pH-7.5. The asterisk (*) indicates the phage clones displayed most frequently 
(abundantly observed) and repeated in the first and second screening rounds. The assay was 
repeated twice for each phage clone and the explained phage amounts were arithmetically 
averaged. The errors bars indicate the standard error from the two separate experimental repeats. 
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It can be seen from the Figure 4.6, that all the 14 phage clones selected for binding assay 
showed higher binding than the control M13KE. The same readings that were obtained for 
M13KE in Chapter 3 are considered while plotting the graph. Eleven phage clones picked as 
tight silica binders (highlighted in asterisk) from optimised biopanning findings showed 
higher binding than M13KE and the other three phage (LETVVSS, ASMNQGG and 
VDTSIFN) clones that were selected randomly. Hence, checking the binding of the phage 
clones displaying the peptides to the silica is due to the randomly displayed peptide sequence 
and not due to non-specific coat proteins interactions. The phage clones displaying peptides 
SILPVTR, ADIRHIK and YSLKQYQ showed higher binding ratio to silica nanoparticles 
than the rest. Interestingly, the phage clones displaying MPRLPPA and SPLHSNY sequences 
that were isolated a few times in the first (7/60) and second round (5/60) of optimised 
biopanning showed better binding than the ANEDTGT (35/60) HWNTVVS (18/60), ADARYKS 
(6/60), ANPTFFS (6/60) sequences. This higher binding to silica might be due to the 
presence of motif (LP) in both the sequences. It must be noted that the motif LP was 
previously found in the identified consensus binder (VSTPLLA) to silica and in the literature 
(Table 3.5).  To further confirm the phage clones are truly binding to silica and not to any 
other target unrelated materials, all the silica binders isolated from optimised biopanning 
(via Lot 2 library) were checked against MimoDB database alongside comparing with the 
sequences identified from traditional and repanning experiments (via Lot 1 library). 
 
 Bioinformatics analysis to check authenticity of target binders 
MimoDB database, an online available bioinformatic tool has been used to identify and 
analyse the authenticity of silica binding sequences216,217. This mimotope peptide database 
search engine also called as HLAB BDB (Biopanning data bank) or formerly called as 
MimoDB. All peptides displayed against SiO2 were checked against MimoDB to find the 
whole or exact part of phage display sequences that resemble the silica binders identified 
from both library lots. Interestingly, the MimoDB results did not show any no hits for all the 
silica binders that were identified from optimised biopanning approach (via using Lot 2 
library) with the exception to the part of motif (GWXQT) being matched for the peptide 
EGWIQTF as shown below in Table 4.6. 
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Table 4.6: Mimo search/ scan/ Blast analysis results of silica binders identified 
from both lots of same phage library and the differences in lot to lot behaviour. 
The phage displayed silica binders that showed hits for other materials indicating that they might 
be promiscuous binders. Peptide sequences highlighted in bold are the phage clones that appeared 
as most abundant binders (within the small population sequenced) to silica in initial biopanning 
and/ or repanning methods (Chapter 3). 
Library 
lot used 
Peptide Target Found Matched 
Sequence 
Library 
type 
Biopa-
nning 
round 
Reference 
Lot 2 
(0221501) 
EGWIQTF Anti-T7·Tag 
monoclonal 
antibody 
NSLSMAP
QQGWVQ
TG 
  386 
Lot 1 
(0211212) 
QLAVAPS 
TVNFKLY 
Fe3O4 
Nanoparticles 
Full 
sequence 
Ph.D.-7 4, 5 323 
HYIDFRW Fe3O4 
Nanoparticles,  
“ Ph.D.-7 2-5 323,329,330 
GQSEKHL Fe3O4 
Nanoparticles, 
Sera of peanut-
tolerant subject 2 
“ Ph.D.-7 2-5 323,330 
VSRDTPQ Sera of peanut 
allergic patient 1-
4, and tolerant 
subject 2 
“ Ph.D.-7 2, 3 330 
ETALIAA Plasma of peanut-
tolerant subject 3 
“ Ph.D.-7 1-3 “ 
WSLSELH 
SSNQFHQ 
SAAWNKS 
GTGSQAS 
FASRSDT 
Sera of peanut 
allergic patient 1, 
3, 4 
“ Ph.D.-7 2, 3 “ 
GASESYL Sera of peanut 
allergic patient 1, 
Anti-TIM 
polyclonal 
antibody 
“ Ph.D.-7 1-3 330,331 
HGGVRLY Agrobacterium 
vitis 
polygalacturonase
, Plasma of peanut 
allergic patient 4 
“ Ph.D.-7 2, 3 330,336 
IDNSHTH Agrobacterium 
vitis 
polygalacturonase 
“ Ph.D.-7 3 336 
SWTALGP E3 ubiquitin-
protein ligase 
Mdm 
TWLDNI
WTTLGP 
Ph.D.-
12 
3 337 
TTQVLEA Mouse brain 
microvasculature 
CTGRMT
XQXXXA 
CX10C 5 338 
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As discussed in Chapter 3,  the silica binders recovered from biopanning experiments (initial 
and repanning) via using Lot 1 library showed peptide sequences such as QLAVAPS, 
GQSEKHL, HYIDFRW, VSRDTPQ and GASESYL were found to have affinity for one or more 
than one different targets (Table 4.6) including binding to Fe3O4 nanoparticles, Human 
prostate cancer cell line PC3,  Sera of peanut-tolerant subject 2, Sera of peanut allergic 
patient 1, 3, 4, Plasma of peanut allergic patient 4 and Anti-TIM polyclonal antibody323,329–
331. While other peptide sequences appeared to have some affinity for silica in one of the 
biopanning rounds were found to have some affinity for other targets. Details about the silica 
binders that showed hits for other targets was explained in Table 3.6, section 3.3.4, Chapter 
3. 
 
In addition to BDB search or Blast, the acceptability of the silica binding peptides from this 
project were checked with TUPrdecit tool from BDB databank. This tool was developed 
using machine learning algorithms and currently three predictors are available including 
PhD7Faster, SABinder and PSBinder215. For example, the PhD7Faster tool can be used to 
predict if phages bearing randomly displayed peptides from the Ph.D.-7 library might grow 
faster due to propagation advantage217,219. The predictor was built using Support Vector 
Machine, trained with peptides from the unselected Ph.D.-7 library after one round of 
amplification219. The silica binders identified in this study were checked by entering the 
sequence data either in FASTA or raw sequence data format. The threshold to distinguish 
between predicted positives and negatives (tp) was fixed ranging from 0 to 1. However, it 
was set to 0.5 by default. A peptide will be predicted to be a target unrelated peptide (TUPs) 
if the probability is 0.5 or higher.  
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Figure 4.7. Prediction of probability of target unrelated peptides or target 
binders. The probability values for silica binders were generated using TUP predict tool 
(http://immunet.cn/bdb/index.php/site/tools?type=TUPredict) from BDB or MimoDB database 
and plotted. Silica binders identified from A) Lot 1 library (initial biopanning and repanning 
methods) and B) Lot 2 library (optimised biopanning process) were analysed to check the 
probability of silica binders to non-targets. In addition, the silica binders identified from C) previous 
studies were also checked for comparison 4,10. An asterisk (*) indicate the sequences appeared as 
tight binders to silica in experimental phage display. From the analysis, the sequences appeared to 
be likely silica binders and target unrelated peptides were highlighted in blue and red colours.   
 
From the prediction results (Figure 4.7), most of the silica binders appeared to be the true 
sequences having affinity for silica and not target unrelated peptides. Some sequences 
QLAVAPS, TVNFKLY, ANPTFFS and SPLHSNY that were observed less frequently in the 
phage display work found to be likely TUPs. However, the sequences ANPTFFS and 
SPLHSNY displayed to have some binding to silica in the relative binding assays (Figure 
4.6) predicted to be likely fast growers or target unrelated peptides in this analysis. Even so, 
these sequences likely have some degree of ‘function’ against the screened material but also 
probably have some target-unrelated advantage over other library members219.  
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Interestingly, the silica binders KLPGWSG and AFTLPTG identified by our previous group 
members4 via traditional biopanning approach and were shown to have high binding affinity 
for silica nanoparticles in both experimental and computational studies4,107,124 appeared to 
be likely untargeted binders or fast growers. This clearly shows that both experimental phage 
results along with the theoretical databases should be used during the selection or validation 
of isolated peptides but should not rely solely on theoretical databases even though they give 
useful information about the possibility to predict fast growers. Thus, suggesting majority of 
the peptides isolated were target-related sequences and rather true silica binders without any 
human or pathogen or sample contamination, whereas the peptide sequences that were found 
to have exact or part of motif similarity for other targets indicate the possibility of 
promiscuous binding behaviour to multi-materials and more importantly the differences in 
selection of library to library.   
 
Additionally, to find any sequence similarities in the identified silica binders, the multiple 
sequence alignment was performed using MSA Viewer213. A total of 77 and 47 different 
silica binding peptide sequences identified from two different aliquots of same NEB Ph.D.-
7 phage library were taken for this sequence alignment. All the silica binders were isolated 
from four different sets of biopanning experiments using two different aliquots (Lot 1: 
0211212 and Lot 2: 0221501). Using the Lot 1 library, three-separate series of biopanning 
tests include the initial or traditional biopanning (section 3.3.1), repanning experiments 
performed to check the reproducibility (section 3.3.2) and the optimised biopanning method 
(section 4.3.2, discussed in Chapter 4). While, the optimised biopanning process was carried 
out using second lot (section 4.3.1). From the multiple sequence analysis (Figure 4.8), two 
consensus sequences (ADLSVTS and VSTPLLA) were identified from the all the silica 
binders. Although, there is a huge difference in the aliquot to aliquot library in terms of 
isolating sequences, the two consensus sequences identified from both lots showed lot of 
similarities (Table 4.7).  
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Figure 4.8. Multiple sequence alignment of silica binders isolated from two 
different master lots (aliquots) of library. The silica binding peptides used for generating 
these two figures were isolated from two different lots (Lot 1: 0211212 and Lot 2: 0221501) of 
same library. A total of 77 (Lot 1) and 47 (Lot 2) dissimilar sequences were chosen and analysed. 
The identified consensus peptide sequences (ADLSVTS and VSTPLLA) from the multiple sequence 
alignment was highlighted and shown. The sequence alignment was generated by using the freely 
available MSA viewer (https://toolkit.tuebingen.mpg.de/#/tools/alnviz) from the Max Planck 
Institute website. Label indicate the position and number of the peptide sequences.  The small logo 
(figure) that is present on top of the ‘label’ indicate the number of times the amino acids have 
appeared in that specific position. The larger the size of the amino acid the higher the times the 
amino acid have appeared in that specific position of the peptide sequences. For example, in the 
library lot 1 image, the amino acid V (valine) was the most frequently observed residue (14 times), 
followed by S (serine, 12 times) as second, Q (glutamine, 8 times) and so on in the first position of 
all the 77 silica binders. Thus, V (valine) has appeared larger in the first column followed by second 
bigger S (serine) and so on.     
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Table 4.7. Physico-chemical properties of two consensus silica binding 
sequences identified in Figure 4.8. aPhysico-chemical properties of the sequences were 
obtained from Innovagen and Bachem peptide property calculator (INNOVAGEN, 2014; Bachem, 
2017). The amino acids that contain hydroxyl side chain (OH) containing groups (S, T, Y) which may 
help in forming hydrogen bonding between silica-peptide or among themselves are shown. 
Consensus 
sequence 
Mol.wt 
(g/mol) 
Library 
Lots 
pIa 
Net 
charge 
@pH 7a 
Functional amino acid residuesa 
Polar 
(-ve, +ve and 
uncharged) 
Hydrophobic 
Hydroxyl 
side chain 
(S,T,Y) Acidic Basic Uncharged 
VSTPLLA 699 Lot 1 6 0 0 0 2 5 2 
ADLSVTS 691 Lot 2 3.1 -1 1 0 3 3 3 
 
 
More importantly, six out of seven (ALVST) amino acid groups are similar in both the 
sequences with either Leucine (L) or Serine (S) repeating twice in each peptide sequence. 
The functional amino acids present in both sequences have hydrophobic (ALV) and polar 
uncharged (ST) amino acids. Thus, indicating that all the three different elution buffers (0.2 
M Glycine-HCl, pH-2.2; MgCl2, pH-6.1; TEA, pH-11) used for biopanning experiments 
including three step elution process (optimised biopanning) may have eluted phage clones 
that are bound to silica mainly by the hydrophobic and hydrogen bonding at pH-7.5. Besides 
this, a block of three (SVT), two (ST), (SV) amino acid groups were noticed present next to 
each other in both the sequences (ADLSVTS and VSTPLLA). 
 
To further confirm the similarities, in terms of the functional amino acid groups and 
composition present in all the eluted silica binders from two different aliquots of library, 
three graphs (Figure 4.9) were plotted. The first (Figure 4.9. A) and second plots (Figure 4.9. 
B) were drawn by taking 77 and 47 peptide sequences that were identified from Lot 1 and 
Lot 2 of same library against same 82 nm sized amorphous silica nanoparticles. However, 
the third graph (Figure 4.9. C)  was plotted by mixing both 77 and 47 silica binders altogether 
(total 124 sequences). A similar trend in the distribution of amino acid residue occurrences 
for all the peptide isolates eluted and identified from two separate lots of library was 
observed (Figure 4.9).  
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Figure 4.9. Comparison of observed frequency of amino acid residues across all 
124 peptide isolates identified from two separate lots of same library. A) 77 peptide 
isolates from Lot 1, B) 47 peptide isolates from Lot 2 and C) 124 peptide isolates (by mixing 77 and 
47 separate peptide isolates) identified from both lots 1 and 2 library. The X and Y-axis indicate the 
amino acid residues and the number of occurrences of each amino acid residue in the peptide 
isolates. All the amino acids residues are categorised and separated into 5 parts showing non-polar 
(black), polar uncharged (green), basic (blue), acidic (red) and special (magenta) amino acids in 
different colours.  
 
The blocks of hydrophobic and polar uncharged groups were frequently distributed 
throughout in both lots of libraries. Primarily, the hydroxyl containing residues (S, T) 
occurred more frequently and distributed throughout all the silica binders than other residues. 
Similarly, the hydrophobic block (AVLP) displayed more frequently. While, the basic 
residues (R, H) elevated slightly higher than the basic residues (D, E). However, the amino 
acid Cysteine (C) was not found in any of the sequences identified from both lots of library. 
This might be due the interference of single amino acid Cysteine with the secretion of pIII 
protein and phage infectivity387. It must be noted that the peptide sequences isolated by 
optimised biopanning process (three step elution) using Lot 2 library showed no similar 
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sequences compared with the traditional biopanning and repanning experiments that used 
Lot 1 library. Although, there is a huge difference in the aliquot to aliquot library in terms 
of isolating sequences, the two consensus sequences and the amino acid occurrences 
identified from both lots showed similar trend towards silica surfaces. Thus, suggesting the 
optimised biopanning process (three step elution) using three elution buffers consecutively 
one after other in a single panning round may have eluted and recovered the phage clones 
that are bound to silica by hydrophobic, hydrogen bonding and electrostatic attractions or 
repulsions; as oppose to one specific buffer being used for all panning rounds including 
elution steps in traditional biopanning experiments. Hence, by using sequential three step 
elution process (optimised biopanning) varying elution buffers in a single panning round, 
the phage clones that resist detection to one elution step may be eluted in the other successive 
elution steps, thereby improving the elution procedure for silica surfaces. 
 
4.4 Conclusion  
To summarise, an optimised biopanning process (sequential three step elution) reported here, 
has eluted and identified most of the silica binders in the early panning rounds, using a 
sequential three step elution process varying elution buffers or pH condition in a single 
panning round. In addition, these three different elution buffers have eluted phage clones 
that may be interaction or charge specific subject to change in the elution buffer pH 
condition. Moreover, complementary experimental and bioinformatics methods have 
demonstrated that the isolated sequences are not target unrelated peptides but rather true 
binders to silica nanoparticles.  
An alternative three step elution method developed have eluted and recovered the phage 
clones that are bound to silica by hydrophobic, hydrogen bonding and electrostatic 
attractions or repulsions; as oppose to one specific buffer being used for all panning rounds 
including elution steps in traditional biopanning experiments. Also, the phage clones that 
resist detection to one elution step have been eluted in the other successive elution steps, 
thereby recovering and improving the elution procedure for silica surfaces. The experimental 
results showed that the high salt magnesium chloride elution buffer have eluted the phage 
clones containing 50% of hydrophobic amino acids, in contrast to 44% and 28% using low 
pH glycine-HCl and high pH triethylamine respectively. Also, with increase in the pH of the 
elution buffers the acidic (-) and polar uncharged amino acid residue composition was 
increased in a step wise manner. However, a reversed trend was observed for the for the 
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groups with basic (+) charged. For example, the phage clones eluted from elution buffer 1 
(low pH) exhibited 6% acidic and 33% polar uncharged amino acid groups. While, the same 
acidic and polar uncharged residue composition gradually increased to 7% and 34% for the 
clones eluted from second elution step (MgCl2, pH-6.1) and 23% and 43% with elution 
buffer 3 (high pH) respectively. Hence, indicating the single elution buffer used for eluting 
the phage clones (Chapter 3) may have resulted in incomplete removal of all strong binders 
and resist detection to substrate silica. Hence, by using sequential three step elution process 
(optimised biopanning) varying elution buffers and pH condition in a single panning round, 
the phage clones that resist detection in single elution step may have eluted in the other 
successive elution steps. Also, an increase in the acidic (-) amino acid composition for the 
phage clones eluted by high pH triethylamine was noticed and might have been be due the 
electrostatic repulsions resulting in the removal of strong silica binders. 
Additionally, the low pH buffer that was used in the first elution step had eluted 63% of 
peptides with net positive charge, while the high salt and high pH buffers have eluted 58% 
and 79% of peptides in the second and third elution steps displaying net neutral and negative 
charged sequences. Also, it was noticed that as the pH condition of the elution buffers 
increase in the elution steps, the net charge of the sequences being eluted from silica surface 
change from positive to negative. For example, the sequences SILPVTR, MPRLPPA, 
ADIRHIK and ADARYKS having high pI (11.1 to 9.7) and net positive charge (+1) were 
eluted mostly in the first elution (high pH) step. While, the peptides HWNTVVS, SPLHSNY 
and ANPTFFS holding near neutral pI (7.8 to 6) and charge (0); as well as sequences 
ANEDTGT and EGWIQTF possessing low pI (3) and net negative charge (-1 to -2) were 
eluted mostly in the second (high salt) and third (high pH) elution steps. However, a few 
sequences that were isolated in the first elution (MPRLPPA, ADIRHIK and ADARYKS) also 
appeared in the second elution step. Similarly, the sequence SPLHSNY that was eluted in the 
second elution step, reappeared in the third elution step, but fewer times. This may suggest 
that the residual sequences remaining from the previous elution steps were carried forward 
sequentially.  
Moreover, the optimised biopanning process has been tested with a panning experiment 
using amplified library mixture obtained from Lot 1 library as a comparator to check the 
three-step elution as well as repanning processes. In this experiment, more or less the same 
silica binders that were identified previously in the Chapter 3 (initial and repanning) 
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experiments reproduced along with few new peptide sequences. A similar trend in terms of 
eluting the sequences in the first two sequential elution steps using low pH, high salt buffers 
that had eluted mostly positively and neutral charged in optimising biopanning process was 
observed in this experiment. However, high pI (9.3) and net positive charge (+1) peptides 
were identified and mostly recovered in the last high pH elution step. Thus, indicating the 
positively charged phage clones might have bound strongly to negatively charged silica 
surface and were not able to elute and recover in the first and second successive elution steps 
resisting detection. Hence, with high pH elution buffer in the third step, these phage clones 
were fully recovered might be due to the electrostatic repulsions. Thus, verifying the 
optimised biopanning process and confirming the reproducibility of the repanning method. 
The results of the relative binding assay showed SILPVTR, ADIRHIK and YSLKQYQ as 
top binders to silica. In addition, the peptides (MPRLPPA and SPLHSNY) displaying the 
motif LP sequences showed better binding. Furthermore, the MimoDB Blast search results 
showed no hits for all the sequences identified from optimised biopanning process (via Lot 
2 library). Similarly, the results obtained from TUPrdecit prediction tool showed (identified 
from separate aliquots of library) very few sequences as target unrelated and most of them 
as target binders theoretically. More importantly, the sequences isolated from phage display 
experiments via two different batches of same library showed no identical sequences. 
However, in the comparative analysis, the two consensus sequences (ADLSVTS and 
VSTPLLA) and the frequency distribution of the amino acids (identified from separate lots) 
showed near similarities towards silica surfaces, thereby indicating the batch to batch library 
diversity. 
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Chapter 5: Interaction studies of silica binding peptides / phages 
with silica nanoparticles 
5.1 Introduction  
This chapter explores an alternate way of selecting material binding peptides and the 
mechanisms by which the phage identified, or synthetically modified peptides bind to the 
surface of silica nanoparticles. Also, this section investigates the effect of C-terminal end 
group modification (acid or amide) and the difference in binding behaviour to silica in 
solution. Moreover, the phage clone displaying the peptide sequences YSLKQYQ, ADIRHIK 
and HYIDFRW have been used for checking phage-silica binding using Transmission 
electron microscopy.  
To date, SiO2-biomolecule interactions have been investigated by a wide range of 
experimental and theoretical techniques. In this section, some of the most recent and 
innovative studies are discussed together with the techniques that have contributed to the 
understanding of molecular interactions. Even though the popularity of using combinatorial 
display techniques for recognising unique peptides having specific affinity for various 
inorganic target materials (discussed in chapter 1, section 1.4) including silica have grown 
rapidly, the precision of molecular recognition for inorganic materials is still challenging 
due to their binding to non-specific targets or limited understanding of the properties and 
changes occurring during silica-peptide interfacial studies. This gap in knowledge has forced 
the scientific community to look for better analytical techniques to understand silica 
interactions with biomolecules in both solution and solid state. As an example of the 
approach, Sarikaya and co-workers reported a peptide-enabled co-assembly strategy for 
developing hierarchical multimaterial nanosurfaces such as quantum dot arrays (QD) and 
further monitored their specific binding affinities using surface plasmon resonance (SPR), 
quartz crystal microbalance (QCM) and atomic force microscopy (AFM)42,43,319,388–390. 
Further, in a simultaneous assembly of material binding peptides to a gold-silica substrate, a 
quartz silica binding QBP1 (PPPWLPYMPPWS) and a gold binding AuBP2 
(WALRRSIRRQSY) peptide showed high affinity to their specific material surfaces as 
measured by SPR (i.e. SBPs-silica and AuBPs-gold)167. Moreover, QCM was used to 
measure the thickness of the very thin silica film coating (~ 5nm) onto the Au substrate, and 
AFM showed specific morphologies of the final material depending on the peptides used. 
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This study further showed that the combination of both materials permitted the design of 
biologically viable probe specific materials167.  
Other groups have reported the ability of SPR technique to detect silica or silver coated 
plasmonic nanostructures tagged with immunoglobulin G (IgG) which further helped in 
recognising early cancer stages and related biomolecules even at low level analyte 
concentrations391. It should be noted that thermodynamic studies of peptide adsorption on 
silica is little explored compared to studies on gold165 or silver surfaces using SPR391. QCM 
is another technique that has been used to investigate binding kinetics, including energy 
dissipation and affinity interactions present between silica (sensor chip) and biomolecules 
passing over the sensor. The biomolecules reported on so far include amino acids392, small 
penta or hexa peptides145,393,394, longer peptides395, human IgG and the hexameric peptide 
ligand (HWRGWV). In this latter study, the short peptide ligand was immobilised on the 
surface of silica coated QCM sensors using polyethylene glycol as a solvent with a surface 
density of ~0.8 chains nm-2 resulting in an increased surface accessibly and allowing a proper 
orientation of the peptide to IgG396.  
Ozaki and co-workers have developed a site-specific process for precipitating silica using 
silica BPs combined with peptide nucleic acids (PNAs) in which the PNA sequence could 
act as a binding module for a complementary DNA sequence309. Here, AFM showed the 
formation of long chains and unique dumbbell shaped silica nanospheres as a result of site-
specific silica biomineralisation on DNA sites. In addition, transmission electron microscope 
(TEM) and dynamic light scattering (DLS) analysis revealed that the control of nanoparticles 
depended on the number of silica binding peptide–PNA conjugates attached to the DNA 
molecule309.  
A study by Bharti and co-workers reported the use of cryo-transmission electron microscopy 
(Cryo-TEM) and small-angle X-ray scattering (SAXS) as tools to study the structural 
properties of bridged silica aggregates directed by the electrostatic adsorption of the globular 
protein lysozyme as a function of pH ranging from 3-11. In this study, a 
theoretical/mathematical model was also used to explain the experimental findings of the 
interacting particles397. In another study, ultraviolet circular dichroism (UV-CD) and 
dynamic light scattering (DLS) has been used as tools to study the effect of surface properties 
of two different types of SiNPs synthesised either by pyrolytic or colloidal processes in water 
and in PBS at 7.4, respectively398. In this study, the surface hydrophobicity/ hydrophilicity 
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was found to affect the amount of BSA adsorbed onto the silica NPs and also gave evidence 
for the formation of protein hard corona (mono-layered or multi-layered) when bovine serum 
albumin was adsorbed398.  
Fluorescence based assays using fluorophores and dyes have been used to quantify peptide 
concentrations in solution. For example, fluorescence is commonly employed to quantify the 
amount of peptide adsorbed on amorphous silica NPs of different size and/or 
functionalities4,10,107. Fluorescamine assays have shown that simply by changing the silica 
surface properties and solution pH, the peptide adsorption mechanism can be modified4,107. 
In this latter study, the adsorption isotherms of peptides KLPGWSG (positively charged), 
AFILPTG (neutral) and LDHSLHS (negatively charged) showed the role of electrostatic/ 
hydrophobic interactions and hydrogen bonding at the aqueous silica interface. Fluorescence 
based assays have also been used to study the biosilicification process using the fluorescent 
dye PDMPO117,399,400. The response of the ‘silicaphilic’ fluorescence to different 
environments such as solvent and pH has been recently probed using fluorescence 
spectroscopy as well as UV-vis, further supported by computational data, dynamic light 
scattering and zeta potential measurements to understand the PDMPO-silica interaction. The 
data show that pH affects charged states of the molecule, particularly in the presence of 
silica, and modified the mode of attachment, with both single point (low anisotropy) or 
multipoint modes (high anisotropy) modes of attachment being possible117.  
Raman based spectroscopic tools have attracted much attention in the last decade for the 
characterisation of biomolecules (i.e. peptides, proteins, DNA) and metal-based compounds 
such as silica and gold358,401,402. Moreover, these techniques have been extended from 
probing inorganic material-peptide/protein interactions358 to study catalytic reactions402 or 
chemical imaging of live cells401. Note that, since surface-enhanced Raman spectroscopy 
(SERS) enhancement is based on the oscillation frequency of the electron plasma, only 
plasmonic nanostructures (i.e. VO, Mo, Au etc.) are suitable. Therefore, Raman based 
spectroscopic techniques have not been yet considered as potential tools to study 
biomolecule interactions on a silica surface itself but for example on a metallic surface such 
as Au with a thin silica coating layer401.  
Although in vitro tools have been employed to study silica-biomolecule interfaces, 
understanding specific molecular recognition and mineral assembly is still challenging using 
current technologies. Therefore, computational studies have been used to generate better 
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engineering of silica-based materials as they are able to provide atomic level information 
including binding free energies, nuclear magnetic resonance (NMR) chemical shifts, 
vibrational frequencies, and electrostatic potentials maps. For example, molecular 
recognition of a solid by a peptide has been studied combining bioinformatics and molecular 
simulations. Oren and co-workers, showed that strong quartz SiO2-BPs always had at least 
one of Pro, Leu, and Trp residues in direct surface contact42,43.  Rimola et al. demonstrated 
by computed adsorption energies that amino acids containing side chains with either polar 
or large aliphatic groups have the most favourable interaction energies towards hydroxylated 
amorphous silica and suggested hydrogen bonds and London dispersive interactions as the 
main driving force403. Recent computational studies using molecular dynamics simulations 
with the CHARMM-INTERFACE force field showed that adsorption of charged peptides 
(i.e. KLPGWSG and LDHSLHS) is highly influenced by the working pH44,124. In contrast, no 
significant difference was observed for neutral peptides (i.e. AFILPTG) which were more 
weakly attached by hydrogen bonds and hydrophobic interactions44,124. Moreover, the 
amount of peptide adsorbed onto the silica surface was shown to be influenced by the particle 
size, being higher for larger particles due to the larger silica surface ionization 10,124. These 
quantitative predictions of peptide-silica binding as a function of pH and particle size were 
comparable and in accordance with experimental measurements (i.e. fluorescamine 
assay)10,124. Although great advances have been made in the mechanisms concerning silica-
biomolecule interactions, the control of selective recognition of biomolecules is still unclear 
and is a challenge for applications including the fabrication of drug delivery systems and 
new catalysts, amongst others. Furthermore, much scientific attention is needed to increase 
our limited fundamental understanding of silica-biomolecule interactions as opposed to 
focussing on an application-oriented approaches.  
In this chapter, three peptide sequences (YSLKQYQ, ADIRHIK and HYIDFRW) identified by 
phage display were chosen to examine the binding of phage and/ or synthetically synthesised 
peptides with silica using the fluorescamine assay and TEM. These sequences were selected 
based on results obtained from experimental phage display, relative binding assay, physico-
chemical properties and bioinformatics analysis (Table 5.1). Further, these peptides have 
been synthesized to primarily test the experimental phage display process, including peptide 
selection process and to understand the peptide binding mechanism on the surface of 
hydrophilic silica nanoparticles at pH-7.5. Moreover, the peptides have been used to 
investigate the effect of functionalising the C-terminal end either with acid (COOH) or amide 
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(CONH2) groups and how that small change can affect the binding process. Additionally, 
TEM has been used to for checking phage-silica binding patterns.  
 
5.2 Materials and Methods 
 Materials  
Chapter 2, section 2.1.1 provides details of materials used for adsorption studies.  
 Methods 
5.2.2.1 Fluorescamine protein quantification assay 
The synthesized and characterized peptides YSLKQYQ, ADIRHIK, HYIDFRW and 
GASESYL isolated by phage display were selected for this protein quantification assay. 
Moreover, the same peptides chemically modified by functionalising the C-terminal end 
group with amide (YSLKQYQ-NH2, ADIRHIK-NH2 and HYIDFRW-NH2) were also used 
for this analysis. The procedures including the protocol and materials used for this assay are 
described in chapter 2, section 2.1.2.7.1. Calibration data for all the peptides were prepared 
and are presented in (Appendix 5.1).    
5.2.2.2 TEM to visualise the binding of phage peptides to silica  
The individual phage clones displaying the peptide sequences YSLKQYQ, ADIRHIK and 
HYIDFRW were selected for probing phage-silica binding studies using TEM. The process 
by which these phage clones were prepared is described in section 2.1.2.5, Chapter 2 under 
the subheading ‘selection of single phage clones for binding studies’. The sampling process 
and protocol including materials used for TEM binding studies is described in Chapter 2, 
section 2.1.2.7.3.   
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5.3 Results and Discussion 
 Selection of SiBPs for experimental binding studies 
It is a critical step to identify which peptides to choose (eg. few peptide sequences out of 
many binders isolated from phage display) for binding studies to verify them experimentally 
in vitro. For peptide-inorganic material binding studies, one can select peptide in different 
ways including the results from the phage display10, affinity binding assays322,323 and based 
on previous knowledge of their binding mechanism to the target material and by rational 
design43,44,129,319. Although, it is common to select inorganic binding peptides merely relying 
on their experimental phage display results (i.e most frequently occurring peptides as the 
main binder)4,10,404; these peptides synthesised were shown to display dissimilar binding 
behaviour with nanoparticles in vitro even after maintaining similar conditions to those 
which  were identified earlier by the phage display process10,13,60,404. This binding variations 
is believed to be due to the complex surface chemistry of the nanoparticles4,10,44,107 and 
dependent on number of binding parameters such as the materials surface chemistry 
including their physico-chemical properties and the binding 
environment4,7,357,9,10,13,44,129,234,355,356. Also, it has been an recognized way to predict the 
likely type of interactions through which the peptides bind to silica nanoparticles by 
analysing the physico-chemical properties such as the charge, pI and functional amino acid 
groups of the isolated peptides from phage display124,328.  
For this study, three peptides were chosen for in vitro silica binding studies. These peptides 
are YSLKQYQ, ADIRHIK and HYIDFRW. Also, the same peptide GASESYL that was 
considered as a control in Chapter 3 is included here for comparison. These peptides were 
selected based on the biopanning method through which they were identified, alongside 
considering relative binding results, pI values, net charge at pH 7 and the functional amino 
acid groups present as shown in Table 5.1. In addition, the bioinformatics analysis 
(possibility of binding to target or unrelated targets) carried out in the Chapter 4 was also 
considered for peptide selection. It is anticipated that these peptides might show better 
binding behaviour with silica nanoparticles under in vitro conditions than those selected only 
based on a single criterion (i.e. relying on experimental phage display data) as in Chapter 3. 
The above parameters considered while selecting the peptides for this adsorption studies 
were grouped as three different criteria; i) Experimental phage display results (Table 5.1, 1-
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4) ii) Physico-chemical properties (Table 5.1, 5-9) and iii) Bioinformatics results (Table 5.1, 
10-11).   
 
Table 5.1. Selection of peptides based on experimental phage display results (1-
4), physico-chemical properties (5-9) and bioinformatics analysis (10-11). 
Experimental phage display results (1-3) taken into consideration include the type of library lot 
used and biopanning approach through which they were identified, alongside their appearance (i.e 
most frequently repeated sequences within the small number of sequences analysed) at different 
phage display experiments and rounds. Physico-chemical properties (5-9) of the peptides taken 
into consideration anticipating their binding behaviour to silica include the pI, hydrophilicity and 
net charge of peptide at pH7; Bioinformatics analysis (10-11) MimoDB analysis results to check the 
authenticity of their binding to target. According to probability prediction analysis, any peptide 
value that is less than 0.5 should be considered a true target binder not a target unrelated peptide 
(described in section 4.3.4). MimoDB search results refers to the sequences that were reported to 
bind to other materials (based on published data) other than to silica (in this study). 
No Criteria for peptide selection HYIDFRW* ADIRHIK* YSLKQYQ* GASESYL 
1 Identified from library lot  Lot 1 
(0211212) 
Lot 2 
(0221501) 
Lot 1 
(0211212) 
Lot 1 
(0211212)  
2 Biopanning method used Repanning 
 
Optimised 
biopanning  
Repanning 
 
Initial 
bioapnning 
3 Frequency repeated  Yes Yes Yes No 
4 Relative binding result High affinity 
binder 
High affinity 
binder 
High affinity 
binder 
Weak binder 
5 pI value 7.76 10.18 9.3 3.3 
6 Net charge @7 0.1 +1.1 +1 -1 
7 C-terminal with amine side chain 
containing group in apeptide 
W K Q - 
8 Ratio of hydrophilic residues / 
total number of residues  
29% 43% 57% 43% 
9 pI value 7.76 10.18 9.3 3.3 
10 MimoDB probability of target 
binder 
Target binder 
(0.23) 
Target binder 
(0.34) 
Target binder 
(0.32) 
Target binder 
(0.41) 
11 MimoDB search results 
(reported to have affinity for) 
Fe
3
O
4
 NPs No hit No hit Sera of peanut 
allergic patient  
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Figure 5.1. Primary structure of silica binding peptides a) YSLKQYQ b) HYIDFRW 
depicting the modified C-terminal group end. Peptide primary structure generated using 
the online tool PepDraw (http://pepdraw.com/). Highlighted in red coloured ring showing the C-
terminal group (Gln, Q) acid (COOH) modified with amide (CONH2).   
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Figure 5.2. Primary structure of silica binding peptide ADIRHIK depicting the 
modified C-terminal group end. Peptide structures generated using the online tool PepDraw 
(http://pepdraw.com/). Highlighted in red coloured ring showing the C-terminal group (Lys, K) 
acid (COOH) modified with amide (CONH2).   
 
Three peptides were synthesized using an automatic microwave assisted peptide synthesizer 
(CEM Liberty1) and prepared as the amide derivative by use of Fmoc-Rink Amide ProTide 
Resins in order to compare the effect of the functional group at the C-terminal on binding to 
silica.  The structure of silica binding peptides portraying the modified C-terminal groups 
can be seen in Figures 5.1 and 5.2. The peptide synthesis procedure used for preparing these 
peptides via Fmoc chemistry is described in section 2.1.2.6.1, Chapter 2. These synthesized 
peptides (YSLKQYQ-OH, YSLKQYQ-NH2, ADIRHIK-OH, ADIRHIK-NH2, HYIDFRW-OH 
and HYIDFRW-NH2) were characterized by HPLC. RP-HPLC (Dionex) equipped with an 
UV detector fixed at 214 nm and a Phenomenex reverse phase porous column (Jupiter® 4 
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µm Proteo 90 Å C12) was used to detect the purity of lyophilized (VirTis® 110 freeze dryer) 
peptides as detailed in section 2.1.2.6.2, Chapter 2. Further, Chromeleon® software was used 
for processing the data peaks thereby analysing the purity of the peptide samples. The purity 
of synthesized peptides YSLKQYQ-OH, YSLKQYQ-NH2, ADIRHIK-OH, ADIRHIK-NH2, 
HYIDFRW-OH and HYIDFRW-NH2 was measured as 93.8%, 92.9%, 94.1%, 97.7%, 77.3% 
and 72.9% respectively (Appendix 2.2).   
 
 Fluorometric quantification of peptide adsorbed to silica by fluorescamine 
A fluorometric method, based on the use of fluorescamine4,10,271,272,354 was performed to test 
the peptide sequences obtained from the experimental phage display processes including the 
peptide selection process and to study the events happening at peptide-silica aqueous 
interface. The fluorescamine assay working principle and procedure including the materials 
used for this assay is described in Chapter 2, section 2.1.2.7.1. These three peptides 
YSLKQYQ, ADIRHIK and HYIDFRW selected based on experimental and bioinformatics 
results besides considering varied physico-chemical properties as shown in Table 5.2. The 
peptide GASESYL was chosen as a control peptide for this binding study, as described earlier 
in Chapter 3.  
Table 5.2. Physico-chemical properties of selected phage displayed silica binding 
peptides. aPhysico-chemical properties of all the sequences were obtained from Innovagen 
(https://pepcalc.com/) and Bachem (http://www.bachem.com/service-support/peptide-
calculator/) peptide property calculator. The side chain amino acid groups (R-CO-N) or (R-OH) that 
are likely responsible for hydrogen bonding are shown separately as hydroxyl (Ser, Thr and Tyr) 
and amine side chain (Asn, Gln) containing groups.  
Peptide 
sequence 
pIa 
Net 
charge 
@pH 7a 
Functional amino acid residues  
Average 
Hydro- 
philicitya 
Acidic 
- 
(D, E) 
Basic 
+ 
(R, K, H) 
Polar 
Unchar
-ged 
Hydrop
-hobic 
Hydroxyl 
side chain 
(S, T, Y) 
Amino side 
chain 
(N,Q,P, W) 
C-
terminal 
group 
YSLKQYQ 9.3 +1 0 1 5 1 3 2 Q -0.4 
ADIRHIK 10.2 +1.1 1 3 0 3 0 0 K 0.6 
HYIDFRW 7.8 0.1 1 2 1 3 1 0 W -0.6 
GASESYL 3.3 -1 1 0 2 3 3 0 L -0.1 
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All three peptides showed nearly similar binding to silica nanoparticles (Figure 5.3), unlike 
peptides selected on the basis of experimental phage display results (Figure 3.4). However, 
the peptide GASESYL with low pI (3.3) and net negative charge (-1), which was selected as 
a control for this adsorption investigation showed least binding to negatively charged silica 
nanoparticles at pH-7.5. Interestingly, the peptide HYIDFRW with pI value 7.8 and net 
neutral or slightly positive charge (0.1) displayed more binding to silica than ADIRHIK and 
YSLKQYQ both having higher pI values (10.2 and 9.3) and net positive charge (+1.1 and +1). 
The binding order observed was HYIDFRW> ADIRHIK> YSLKQYQ> GASESYL. Also, the 
uptake in binding of peptides HYIDFRW, ADIRHIK and YSLKQYQ to silica was high at low 
concentrations until 0.4 mM and eventually becoming steady at higher peptide 
concentrations (0.4 mM to 1.6 mM), probably due to the formation of multi-layers on the 
surface of silica nanoparticles (Figure 5.4)4. However, the control peptide GASESYL showed 
little uptake in binding at low concentrations, while at higher concentrations there was a 
gradual increase in uptake.  
 
 
 
 
Figure 5.3: Adsorption behaviour of selected phage displayed peptides on the 
surface of 82 nm sized silica nanoparticles at pH-7.5 (PBS buffer). The y-axis 
represents the amount of peptide adsorbed to silica in mM, while the x-axis shows the initial 
peptide concentration or peptide added in mM. The theoretical 100% peptide adsorption is shown 
in black dotted line. The error bars represent the standard deviation error calculated as a result of 
the assay being repeated in triplicate. Based on the above data, the binding order of the peptides 
was ranked as HYIDFRW> ADIRHIK> YSLKQYQ> GASESYL. 
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Figure 5.4. Analysis of the above peptides displayed in Figure 5.3. The graph showing 
the peptides and their binding (%) amounts to silica at six different peptide concentrations. The y-
axis represents the percentage of peptide adsorbed to silica, while the x-axis shows the peptide 
added in mM.  
 
The high binding of peptide HYIDFRW to a silica surface is interesting and might be because 
of the involvement of more than one type of interactions including electrostatic, hydrophobic 
and hydrogen bonding4,10,107. The electrostatic interactions between HYIDFRW and silica 
likely arise due to the presence of individual basic amino acids (Histidine at N-terminus and 
Arginine at 6th position) and amine side chain at C-terminal aromatic residue (Tryptophan). 
Thus, increasing the percentage of functional amine groups present at two sites (N-terminal 
and active side chain of amino acids) in the peptide encouraging ionic interactions. The polar 
uncharged amino acid Tyr (Y) present at 2nd position along with other charged polar residues 
including His (H) and Arg (R) are likely responsible for initiating hydrogen bonding 
resulting in multilayers connected by hydrogen bonds4. On the other hand, the possibility of 
hydrophobic interactions cannot be ruled out due to the occurrence of three hydrophobic 
residues (Isoleucine, aromatic Phenylalanine and Tryptophan) at 3rd, 5th and 7th positions of 
the sequence resulting in likely increase in the hydrophobic character, hence dominating the 
overall hydrophobicity in the system leading to hydrophobic interactions at peptide-silica 
surface4. Consequently, this type of binding behaviour of peptide HYIDFRW to negatively 
charged silica at pH-7.5, is likely due to the participation of more than one type of 
interactions. 
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Table 5.3. Likely type of interactions that might be responsible for adsorption of 
peptides and the likely effect of increasing pH and particle size on binding to 
silica particles in PBS solution. The asterisk (*) represents the likely effect of increasing pH 
and particle size on binding to silica was estimated based on the previous studies where peptides 
of similar properties (eg. peptide length, net charge of peptide at pH-7 and same batch of silica 
nanoparticles) were investigated and assessed based on adsorption studies4,44,107. It has to be noted 
that the pH range and nanoparticle sizes considered for these studies include pH-3 to pH-8.5 and 
28 nm, 82 nm and 210 nm. 
Peptides Likely type of interactions 
Likely effect of increasing pH 
and particle size on binding* 
YSLKQYQ Electrostatic/ H-bonding ↑ 
ADIRHIK Electrostatic/ Hydrophobic ↑ 
HYIDFRW Electrostatic/ Hydrophobic/  
H-bonding 
↑ 
 
However, peptides ADIRHIK and YSLKQYQ showed slightly lower binding to silica in        
comparison to HYIDFRW peptide. This can likely be due to the presence of high pI (10.2 and 
9.3), net positive charge (+1.1 and +1) values driving electrostatic interactions first. This 
type of electrostatic binding behaviour to silica is not new and likely arise due to the  
presence of basic positively charged groups (Arg, His and Lys at 4th , 5th and C-terminal 
positions for ADIRHIK; Lysine at 4th position for YSLKQYQ) and side chains containing 
functional amino groups (Gln at 5th and C-terminal position for YSLKQYQ);  thus, giving the 
peptides a constant net positive charge (+1.1 and +1), resulting in the strongest possible ionic 
interactions. Also, it has been reported that biomolecules including peptides or proteins or 
even individual amino acids comprising of positively charged groups have been found to 
display high binding behaviour to negatively charged silica surfaces at neutral or high pH; 
due to the likely involvement of ion pairing mechanism4,44,65,107 as discussed in Chapter 3. 
Nevertheless, ionic interactions are not the only force responsible for the ADIRHIK and 
YSLKQYQ adsorption; it can also be due to the existence of hydrophobic and H-bonding 
respectively. The hydrophobic interactions in the ADIRHIK peptide is highly driven by the 
non-polar groups (Isoleucine at 3rd and 6th position and Alanine at N-terminus of the peptide). 
The hydrogen bonding in YSLKQYQ is largely because of the polar uncharged groups (Tyr 
and Serine) and amino side chain functionalities from Lysine and Glutamine. However, the 
peptide GASESYL with low pI (3.3) and net negative charge (-1), which was selected as a 
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control for this adsorption studies showed least binding to silica nanoparticles. The possible 
reason that prevented binding of peptide GASESYL to silica might be due to the involvement 
of electrostatic repulsions between the negatively charged peptide and silica under these pH 
conditions4. Therefore, based on the available experimental evidence, the peptides would 
perhaps bind to silica surfaces by multiple interactions (ion-pairing and hydrogen bonding 
complemented by hydrophobic and van der Waals forces) as described in Chapter 3, binding 
studies.  
 
5.3.2.1 Effect of C-terminal group on binding to silica   
In order to test the influence of interactions (i.e more than one type) on binding to silica, 
further adsorption studies on the above peptides (YSLKQYQ, ADIRHIK and HYIDFRW) 
were carried out by substituting the C-terminal end carboxylic acid (R-COOH) with an 
amide group (R-CONH2). Encouraged by the above binding results, the same silica binders 
were synthesized by altering the peptide C-terminal end with an amide (NH2) group to 
understand the difference in binding behaviour and the effect of C-terminal group (negative 
charge) upon interaction with a silica surface. Therefore, C-terminal amide group silica 
binders YSLKQYQ-NH2, ADIRHIK-NH2 and HYIDFRW-NH2 have been investigated and 
compared with the corresponding C-terminal acid group peptides including YSLKQYQ-OH, 
ADIRHIK-OH, and HYIDFRW-OH. From the adsorption binding results, it was found that 
the peptides substituted with an amide group at the C-terminus end showed higher binding 
to negatively charged silica nanoparticles than corresponding carboxyl terminal acid group 
peptides (Figure 5.5).  
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Figure 5.5: Adsorption isotherms of peptides synthesized with either acid 
(COOH) or amide (CONH2) at C-terminal group of selected phage displayed 
peptides and their binding behaviour on the surface of hydrophilic silica 
nanoparticles at pH-7.5. The y-axis represents the amount of peptide adsorbed to silica in mM, 
while the x-axis shows the initial peptide concentration or peptide added in mM. The error bars 
represent the standard deviation error calculated as a result of the assay being repeated in 
triplicate. The difference in ratio of peptides (CONH2/COO-) binding to silica at different 
concentrations (mM) are shown in the table on the right-hand side of the graphical plot. 
 
Table 5.4. Effect of C-terminal group on increasing the overall peptide net charge 
and/ or pI at pH-7. aThe change in the net charge or pI values of the peptides (either with acid 
or amide at C-terminal end group) were obtained from Bachem (http://www.bachem.com/service-
support/ peptide-calculator/) peptide property calculator. 
Peptides 
Effect of C-terminal functional group  
Net charge @7
a
 pI
 a 
 
Acid Amide  Difference Acid Amide Difference 
YSLKQYQ 1 2 1 9.6 10.1 0.5 
ADIRHIK 1.1 2.1 1 10.1 11.5 1.4 
HYIDFRW 0.1 1.1 1 7.8 9.9 2.1 
 
This type of increase in binding activity to negatively charged silica (deprotonated silanols) 
by C-terminal amide groups is simply due to the increased activity of electrostatic and 
hydrogen bonding because of NH2 (amide) group in the end. The electrostatic binding 
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behaviour of peptides at pH-7.5 was mainly due to an increase in overall charge by +1 and/ 
or pI by 0.5 to 2.1 respectively (Table 5.4 and Figure 5.6). Thus, probably giving the peptides 
a constant net positive charge, resulting in the strongest possible ionic interactions. However, 
the same amide group attached to the C-terminal end (C=O H-N-H) acts as an hydrogen 
bond acceptor and donor405; hence, increasing the activity of hydrogen bonding either with 
the silica (i.e with silanol Si-OH groups present on the surface of negatively charged silica 
at pH-7.5) or peptide (by polar uncharged groups) forming peptide-peptide bonding resulting 
in multilayer formation or both under these conditions. Recently, it was evidenced that the 
change in surface functionalisation of silica with amino propyl/ amine groups lead to an 
increase in the binding activity at peptide-silica boundary124,406. In another study, where 
selective amino acids (Lys, Arg, His, Ser, Try) were shown to be mainly responsible for an 
increase in peptide binding to silica nanoparticles via electrostatic and H-bonding resulting 
in the precipitation of silica nanoparticles10.   
 
Figure 5.6. Effect of C-terminal group as a function of pH v/s charge (z). The x- axis 
and y-axis signifies the pH (0 to14) and charge (+7 to -7) range considered for plotting this graph.  
The change in the charge of the peptides at varied pH (either with acid or amide at C-terminal end 
group) was calculated from Bachem (http://www.bachem.com/service-support/peptide-
calculator/) peptide property calculator. 
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Thus, providing the support that peptides containing amine functional groups depending on 
the position of amine group (i.e N or C- terminus or side chain) within the peptide backbone 
will likely help in either introducing electrostatic or hydrogen bonding on amorphous silica 
surface at pH-7. Also, depending on the experimental conditions (i.e pH), the silica surface 
would change (no charge at pH-2-3 and increase in negative charge with pH rise) resulting 
in the introduction or removal of an electrostatic binding and/ or repulsive interactions upon 
peptides binding to silica4,107. This study also revealed, the adsorption of peptide to silica 
was found to be sequence dependent and subject to the peptide charge4. Therefore, based on 
the available experimental evidence, the peptides would perhaps bind to silica surfaces by 
more than one type of interaction and could be influenced by experimental conditions.  
Moreover, the above studies might provide a new dimension in the design of phage binding 
peptides to a minor coat protein pIII or major coat protein pVIII in M13 bacteriophage by 
either N-terminal and/ or C-terminal fusion to the target by mimicking the original phage 
constructs alongside using phage fused peptide as a template. From the previous studies, it 
was evident that by changing or modifying the N-terminus insert to coat protein pIII with 
the same peptide sequence screened from phage libraries but by changing the structure (i.e. 
by fusing the similar peptide sequence to coat protein III, one as constrained and another as 
linear fashion) showed different binding behaviour to zinc sulphide (ZnS) and cadmium 
sulphide (CdS) thereby affecting the size and structure of the crystals156.  
In a recent review, site-specific phage functionalisation has been discussed in which a variety 
of synthetic chemical compounds and functional groups were incorporated into selected M13 
phage proteins using chemical modification methods combined with genetic engineering for 
a range of biomedical applications407. To date, a wide variety of materials including RGDS 
peptide, PEG, biotin, fluorophores, fluorescein, enzymes and drugs have been used to target 
coat proteins (pIII and pVIII) by reacting them at specific N-terminal or C-terminal or other 
functional side chain groups including -SH408, -NH2
75,409–413, -COOH410 and -OH414 have 
been reported. 
Another group have mimicked the phage structure by fusing the peptide ligands at C-
terminus and constructed synthetic peptide dendrimers (divalent, tetravalent and 
pentavalent) by engineering the phage displayed peptide that have affinity for collagen, 
showed surface density dependent binding behaviour resulting in the increased efficiency of 
ligand mediated targeting415,416. Similar study has been reported, in which liposomes were 
 Chapter 5 : Interaction studies of silica binding peptides / phages with silica nanoparticles 
 
 
184 
constructed by conjugating the brain binding peptide (isolated via phage display library) and 
a portion of coat protein pIII with GLA sequence, thus delivering the drug to the targeted 
brain tissue by further reducing the toxicity417,418.  Consequently, these mimicked or 
engineered phage peptides had been shown to have potential applications as templates in the 
development of nanocarriers419, drug delivery vehicles417, constructing multi-valent or 
monovalent targeting systems415,416 and in the synthesis of self-assembled hybrid 
nanomaterials88,156. 
Therefore, from the above evidence, the peptides substituted with an amide group at the C-
terminal end showed higher binding to negatively charged silica nanoparticles than 
corresponding carboxyl terminal acid group peptides at pH-7.5. Similarly, confirming the 
likely involvement of multiple interactions (electrostatic and non-electrostatic) upon 
peptides binding to hydrophilic amorphous silica nanoparticles. Moreover, this definite 
binding specificity to silica study by C-terminal amide groups could provide more insights 
possibly in the designing and engineering of silica targeted constructs including nanochips 
or nanomaterials, peptide phage libraries by targeting site specific proteins in M13 
bacteriophage for a range of biomedical and nanotechnological applications. 
 
 TEM to probe silica- phage peptide interactions 
The phage clones displaying the peptide sequences YSLKQYQ, ADIRHIK and HYIDFRW 
were chosen and to observe how the phage binds to silica binding by TEM. The silica 
nanoparticles (82 nm) alone without EM stain 336 are shown in Figure 5.7, a, b. Just to make 
sure whether the EM stain 336 is binding to phage proteins or silica or both; initial 
experiments were performed by adding the EM stain 336 to freshly taken phages from M13 
Ph.D.7 library and silica nanoparticles of size 82 nm. It can be seen from the TEM images 
that the EM stain 336 did not show any binding to silica nanoparticles (Figure 5.7, c, d). 
However, the M13 Ph.D.7 phage library stained with EM stain 336, appeared to be irregular 
thread like structures which are linked to each other (Figure 5.8). Besides, some unfamiliar 
shapes (irregular black agglomerations) are noticed which appear to be clump-like structures 
forming aggregates with the phage. It has been reported that the phage proteins (pIII or 
pVIII) or peptides affixed on the TEM grid and likely bound to the substrate by their tips, 
may then come in contact during the sample drying process forming agglomerations306,420,421.   
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Figure 5.7. TEM images of silica nanoparticles (82 nm) without EM stain 336 (a,b) 
and with EM stain 336 (c,d).   
 
Figure 5.8. TEM images of M13 Ph.D.7 phage library stained with EM stain 336. 
The likely phage structures are indicated by white arrows. Alongside, some unusual shapes 
(irregular black bodies) are noticed which appear to be clump-like structures forming aggregates 
with the phage.  
 
For an ideal TEM phage image, the phage structures should appear filamentous or thread 
like under the TEM. The length and diameter of the filamentous phage have been reported 
as roughly 880 nm and 6.5 nm respectively71,72,422. The other factors that might have affected 
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the proper binding of phage to silica possibly be due to i) improper binding of the EM stain 
336 to phage ii) presence of low amounts of phage clones and PBS forming crystals during 
the sample storage process iii) changes occurring at the phage peptide-silica interface due to 
pH conditions74,281,423–426. Further, it is possible that the differences in structures observed 
arose because of the long storage period (in some cases ca. 2 years) between plaque isolation 
and microscopical investigation. 
Though this experiment failed to identify clear controls (i.e control phage that do not display 
a putative silica binding peptide) and phage structures from the M13 Ph.D.7 library phage 
samples stained with EM stain 336 (Figure 5.8), further binding studies of phage displaying 
YSLKQYQ, ADIRHIK and HYIDFRW peptides on the surface of silica nanoparticles were 
carried out assuming some sort of binding patterns might be observed with these phage 
peptides. The binding of phage displaying YSLKQYQ, ADIRHIK and HYIDFRW peptides on 
the surface of silica nanoparticles can be seen in Figures 5.9, 5.10 and 5.11. In the images 
presented, the phage appears to be binding on the surface of silica by forming a thread like 
structures cross linking with the adjacent silica particles which can be seen indicated in white 
arrows. Further, some phage structures seem to be folded and lying on the surface of the 
silica particles, but this may be artefact of the sample preparation procedure.   
 
Figure 5.9. TEM images of YSLKQYQ phage attached to silica NPs. Phage structures   
thought to bind to silica are shown by white arrows. 
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Figure 5.10. TEM images of ADIRHIK phage attached to silica NPs. Phage structures 
thought to bound to silica are indicated by white arrows. 
 
 
Figure 5.11. TEM images of HYIDFRW phage attached to silica NPs. Phage structures 
thought to bound to silica are pointed by white arrows. 
 
A few relatively recent studies have demonstrated specific binding affinity of M13 phage 
displayed peptides to inorganic or organic surfaces using  microscopy techniques such as 
SEM, TEM, AFM and fluorescence306,322,420,421. For example, the binding of M13 phage 
displaying the ASTLPKA peptide to thiamethoxam (TMX), an organic crystal was confirmed 
by electron microscopy (Figure 5.12, a and b)306. This study also reported high degree of 
specificity (1.47 ± 0.80 nN) between the bacteriophage and organic crystal surface  using 
AFM306.   
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Figure 5.12. Microscopy images showing specific binding affinity between M13 
phage displayed peptides and organic306 or inorganic surfaces322. TEM and Field 
emission-scanning electron microscopy images of phage ASTLPKA bound to organic TMX crystal 
surfaces (a, b). The AFM images of the phage displaying the peptide LGFREKE on pIII showing their 
ends are attached to (c) amorphous and (d) crystalline nickel boride nanoparticles at the tip of pIII, 
which were shown by white arrows.  
 
Another study in 2014 by Ploss et al, used fluorescence microscopy and AFM to measure 
the affinity of bound M13 phage (LGFREKE) to nickel boride (crystalline and amorphous) 
nanoparticles (Figure 5.12, c and d)322. The samples in the study were fluorescently tagged 
(fluorescein isothiocyanate) with anti-M13-monoclonal antibody against phage coat protein 
pVIII. The fluorescent intensity generated as result of phage attachment to nanoparticles 
measured by fluorescence spectroscopy322. In  recent years, several studies have been 
reported using gold labelled anti-phage antibodies for determining and quantifying phage-
substrate binding affinities via microscopy analysis167,323,432–435,340,364,420,427–431.    
Therefore, although, this TEM study suggested some binding between the selected phage 
YSLKQYQ, ADIRHIK and HYIDFRW peptides and silica; more experiments are needed to 
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identify and understand  the unanswered questions i) If only the phage displaying the peptide 
on the tip of the pIII is specifically interacting with silica ii) are there any phage-phage 
interactions (i.e one or the other end of the one phage being attached to other phage) iii) 
other possible non-specific interactions (i.e if any other part of the phage other than the 
peptide displaying end on pIII is bound to silica nanoparticle). The future experiments 
include, the repetition of the above phage-silica TEM binding studies but including more 
specific controls. Then, to visualize morphologically (i.e what are binding to silica, whether 
phage displaying the peptides or the phage itself or both) and measure their binding 
quantitatively using the above discussed microscopy techniques 306,322,420,421.  
 
5.4 Conclusions  
In summary, an alternate way of choosing material binding peptides for verification binding 
studies is introduced that considers a number of parameters including experimental phage 
display results, physico-chemical properties and bioinformatics analysis. All three peptides 
YSLKQYQ, ADIRHIK and HYIDFRW selected by this way exhibited steady and better 
binding (uniformity) to silica after reaching saturation unlike the peptides KIAVIST, 
LPVRLDW, NDLMNRA and GQSEKHL chosen by relying solely on their experimental phage 
display results. Also, the uptake in binding of peptides HYIDFRW, ADIRHIK and YSLKQYQ 
to silica was high at low concentration (0.2 mM) and eventually became steady at higher 
peptide concentrations (0.4 mM to 1.6 mM). Thus, indicating this behaviour could probably 
be due to the formation of multi-layers on the surface of silica nanoparticles. 
The quantitative binding analysis of these peptides suggested that the peptide adsorption to 
silica surfaces would perhaps have more than one type of interaction (i.e. electrostatic, 
hydrophobic and H-bonding) and could be influenced by the experimental conditions; there 
by checking the experimental phage display process including the optimised elution 
approach. The peptide HYIDFRW with pI value 7.8 and net neutral or slightly positive charge 
(0.1) displayed slightly more binding to silica than ADIRHIK and YSLKQYQ both having 
higher pI values (10.2 and 9.3) and net positive charge (+1.1 and +1). This variation in 
binding to negatively charged silica at pH-7.5 in PBS buffer might be due to the participation 
of electrostatic (overall positive charge and individual positive groups His and Arg), 
hydrogen bonding and hydrophobic interactions (Ile, Phe and Trp). However, peptides 
ADIRHIK and YSLKQYQ showed slightly lower binding to silica in contrast to HYIDFRW 
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peptide. This can likely be due to the presence of basic positively charged groups (Arg, His 
and Lys at 4th , 5th and C-terminal positions for ADIRHIK; Lysine at 4th position for 
YSLKQYQ) and side chains containing functional amino groups (Gln at 5th and C-terminal 
position for YSLKQYQ);  thus, giving the peptides a constant net positive charge (+1.1 and 
+1), resulting in the strongest possible ionic interactions. Nevertheless, electrostatic 
interactions might not be the only force responsible for the ADIRHIK and YSLKQYQ 
adsorption; it could also be due to the existence of hydrophobic and H-bonding respectively. 
The hydrophobic interactions in the ADIRHIK peptide is highly driven by the non-polar 
groups (Isoleucine at 3rd and 6th position and Alanine at N-terminus of the peptide). The 
hydrogen bonding in YSLKQYQ is largely because of the polar uncharged groups (Tyr and 
Serine) and amino side chain functionalities from Lysine and Glutamine. However, the 
peptide GASESYL with low pI (3.3) and net negative charge (-1), which was selected as a 
control for this adsorption studies showed least binding to silica nanoparticles. The possible 
reason that prevented binding of peptide GASESYL to silica might be due to the involvement 
of electrostatic repulsions between the negatively charged peptide and silica under these pH 
conditions4.   
Moreover, an increase in binding activity to negatively charged silica nanoparticles was 
noticed for the peptides (YSLKQYQ, ADIRHIK and HYIDFRW) modified with amide (NH2) 
group opposed to carboxyl group at C-terminal end. This change in binding behaviour of 
peptides was possibly driven by an increase in overall charge and/ or pI. Also, with increase 
in the pH, the charge and pI of the peptides will change; resulting in the likely introduction 
or removal of an electrostatic binding and/ or repulsive interactions upon peptides binding 
to silica. Thus, providing the support that peptides containing amine functional groups 
depending on the position of amine group (i.e N or C- terminus or side chain) within the 
peptide backbone will likely help in either introducing electrostatic or hydrogen bonding on 
amorphous silica surface at pH-7.5. Also, depending on the experimental conditions (i.e pH), 
the silica surface would change (no charge at pH-2-3 and increase in negative charge with 
pH rise) resulting in the introduction or removal of an electrostatic binding and/ or repulsive 
interactions upon peptides binding to silica4,107.  
Therefore, from the above evidence, it is clear that the peptides substituted with an amide 
group at the C-terminal end showed higher binding to negatively charged silica nanoparticles 
than corresponding carboxyl terminal acid group peptides at pH-7.5. Similarly, confirming 
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the likely contribution of multiple interactions (electrostatic and non-electrostatic) upon 
peptides binding to hydrophilic amorphous silica nanoparticles. Moreover, this definite 
binding specificity to silica study by C-terminal amide groups could provide more insights 
possibly in the designing and engineering of silica targeted constructs including nanochips 
or nanomaterials, peptide phage libraries by targeting site specific proteins in M13 
bacteriophage for a range of biomedical and nanotechnological applications. 
Furthermore, the TEM exposed some binding patterns between phage and silica surfaces. 
The binding of phage displaying YSLKQYQ, ADIRHIK and HYIDFRW peptides on the 
surface of silica nanoparticles appeared to be thread like structures cross linked with the 
adjacent silica particles. However, some phage structures seem to be broken, folded and 
lying on the surface of the silica particles but this may be an artefact of the sample 
preparation procedure. Although, this experiment failed to identify clear controls (i.e control 
phage that do not display a putative silica binding peptide) and phage structures from the 
M13 Ph.D.7 library phage samples, some exemplar studies were discussed indicating the 
possibility of microscopy techniques including TEM as a tool to be used for probing 
biomolecule-silica interaction studies. The insights gained from this TEM study, combined 
with knowledge obtained from the example studies gives a vision for future experiments. 
These include, the validation binding studies of phage to silica; and how the TEM and other 
microscopy techniques can effectively be used to visualize and measure their specific 
binding quantitatively; what are binding, whether the phage displaying the peptides or the 
phage itself or both and how are they binding to silica surfaces. In the end, by comparing the 
differences in binding to silica by phage displaying peptides verses artificially synthesised 
peptides, could help us in understanding the specific binding patterns. This information 
could perhaps provide more insights to understand the way phage is behaving during the 
biopanning process with substrates.    
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Chapter 6: Overall conclusions and future work 
6.1 Summary of the thesis  
In summary, heptapeptides having affinity for amorphous silica nanoparticles (hydrophilic, 
82 nm) have been isolated and identified by phage display technique using the M13 phage 
display library. To achieve this, three different chemical elution buffers (Gly-HCl, pH-2.2; 
MgCl2, pH-6.1; TEA, pH-11) with specific elution conditions have been used to remove 
unique heptapeptide binding phages from silica nanoparticles via disrupting the electrostatic 
and non-electrostatic interactions. These isolated silica binding peptides were further 
investigated by experimental and bioinformatics studies. 
In this thesis, the silica binding sequences were eluted and identified in two different ways 
by using three different elution buffers mentioned above. The first way is by using traditional 
biopanning process and second one is optimised biopanning process (alternative sequential 
three step elution). The optimised biopanning approach differs from the traditional 
biopanning method as each mentioned buffer (Gly-HCl, pH-2.2; MgCl2, pH-6.1; TEA, pH-
11) were used consecutively one after other in a single screening (biopanning) round, as 
appose to one specific buffer being used for all panning rounds including elution steps in 
traditional biopanning and repanning experiments.  
The optimised biopanning method reported here, have eluted and recovered the phage clones 
that are bound to silica by hydrophobic, hydrogen bonding and electrostatic attractions or 
repulsions; as oppose to one specific buffer being used for all panning rounds including 
elution steps in traditional biopanning experiments. In addition, these three different elution 
buffers have eluted phage clones that may be interaction or charge specific subject to change 
in the elution buffer pH condition. Also, it was noticed that as the pH condition of the elution 
buffers increase in the elution steps, the net charge of the sequences being eluted from silica 
surface change from positive to negative. Hence, indicating the single elution buffer used 
for eluting the phage clones (Chapter 3) may have resulted in incomplete removal of all 
strong binders and resist detection to substrate silica. Hence, by using sequential three step 
elution process (optimised biopanning) varying elution buffers and pH condition in a single 
panning round, the phage clones that resist detection in single elution step may have eluted 
in the other successive elution steps, thereby recovering and improving the elution procedure 
for silica surfaces. Additionally, the low pH buffer that was used in the first elution step had 
eluted 63% of peptides with net positive charge, while the high salt and high pH buffers have 
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eluted 58% and 79% of peptides in the second and third elution steps displaying net neutral 
and negative charged sequences. Hence, suggesting the efficiency of the method to elute and 
isolate most of the silica binders in the early rounds of biopanning, removing the sequences 
that resist detection during traditional bioapnning method; thereby by reducing the number 
of biopanning rounds, saving time, cost and effort. In addition, these three different elution 
buffers could be used to remove interaction or charge specific peptides subject to change in 
elution and pH condition. 
 
Figure 6.1. Schematic representation of proposed adsorption and desorption 
mechanisms of phage clones upon interaction with silica at varied pH and the 
effectiveness of the three-step chemical elution approach (optimised 
biopanning) to that of traditional biopanning process. 
 
Therefore, based on the experimental evidence, we propose this three step chemical elution 
(optimised biopanning) process may be used to isolate interaction  (polar or non-polar) or 
charge specific (positive, neutral or negative) peptide sequences from the silica surface 
subject to elution buffer and pH condition; thus, eluting and recovering the most silica 
binders including the sequences that may resist detection in traditional biopanning using one 
elution buffer (Figure 6.1). 
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Moreover, a repanning method has been reported to recheck the phage display process and 
verify silica binders by checking the reproducibility of the process. The repanning method 
may experimentally verify your own target binding results giving information about any 
possible non-specific binding due to panning limitation (amplification bias), thereby 
checking the direction of the ongoing phage display work. Thus, the repanning method 
reported for silica, appeared to be a straight forward approach to verify phage display 
experimental results by mixing phage clones from different biopanning experiments and 
rounds. Further the complementary bioinformatics suggesting that majority of the peptides 
isolated were target-related sequences and rather true silica binders without any human or 
pathogen or sample contamination, whereas the peptide sequences that were found to have 
exact or part of motif similarity for other targets indicate the possibility of promiscuous 
binding behaviour to multi-materials. Also, the results of sequences isolated from phage 
display experiments via two different batches of same library showed no identical sequences. 
However, in the comparative analysis, the two consensus sequences (ADLSVTS and 
VSTPLLA) and the frequency distribution of the amino acids (identified from separate lots) 
showed near similarities towards silica surfaces, thereby indicating the batch to batch library 
diversity. 
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Figure 6.2. Schematic representation of proposed adsorption and desorption 
mechanisms of phage /peptides upon interaction with silica at varied pH.  
 
To summarize, peptide sequences bound to silica via both electrostatic and non-electrostatic 
interactions have been identified by phage display technique using three different elution 
buffers (0.2 M Glycine-HCl, pH-2.2, 4 M MgCl2, pH-6.1and 100 mM Triethylamine, pH-
11) (Figure 6.2). From the results, it was found that the phage elution (desorption 
mechanism) process to silica was more selective to elution specific buffer and condition (low 
or high pH and salt) and is dependent on silica surface (pH 2-3, charge zero; pH-6, negative 
charge and pH-11, highly negative charge) subject to pH and charge change. The low pH 
elution buffer (0.2 M Glycine-HCl, pH-2.2) mostly eluted phage clones bound by strongest 
possible electrostatic attraction (positively charged peptides) and hydrophobic interactions 
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to silica. While the elution buffers with high salt (4 M MgCl2, pH-6.1) and high pH (100 
mM Triethylamine, pH-11) typically eluted phage clones bound to negatively charged silica 
by hydrophobic or hydrogen bonding and electrostatic repulsion (negatively charged 
peptides) respectively.   
Finally, the quantitative binding analysis of the selected peptides suggested that the peptide 
adsorption to silica surfaces would perhaps have more than one type of interaction (i.e. 
electrostatic, hydrophobic and H-bonding) and could be influenced by the experimental 
conditions. However, an increase in binding activity to negatively charged silica 
nanoparticles was noticed for the peptides modified with amide (NH2) group opposed to 
carboxyl group at C-terminal end. This change in binding behaviour of peptides was possibly 
driven by an increase in overall charge and/ or pI. Also, with increase in the pH, the charge 
and pI of the peptides will change; resulting in the likely introduction or removal of an 
electrostatic binding and/ or repulsive interactions upon peptides binding to silica. Thus, 
providing the support that peptides containing amine functional groups depending on the 
position of amine group (i.e N or C- terminus or side chain) within the peptide backbone 
will likely help in either introducing electrostatic or hydrogen bonding on amorphous silica 
surface at pH-7.5. Therefore, from the above evidence, it is clear that the peptides substituted 
with an amide group at the C-terminal end showed higher binding to negatively charged 
silica nanoparticles than corresponding carboxyl terminal acid group peptides at pH-7.5. 
Similarly, confirming the likely contribution of multiple interactions (electrostatic and non-
electrostatic) upon peptides binding to hydrophilic amorphous silica nanoparticles. 
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6.2 Future directions 
This project was able to investigate and propose the experimental and/ or bioinformatics 
methods for eluting and identifying silica specific peptides and their binding mechanisms 
using phage libraries. However, the assumptions of adsorption or desorption of phage or 
peptide studies was undoubtedly based on the amorphous hydrophilic silica nanosurfaces. 
Therefore, there is a need to investigate the hydrophobic or functionalised silica 
materials181,284 to get a better picture and understanding of the vast and complex silica 
system94; thereby aiding in governing the biomolecule selection using phage display 
technique or in vitro binding studies4,10,24,319. 
Although, the experiment to probe phage-silica binding studies using TEM failed to identify 
clear controls (i.e control phage that do not display a putative silica binding peptide), some 
exemplar studies were discussed indicating the possibility of microscopy techniques 
including TEM as a tool to be used for probing biomolecule-silica interaction studies. The 
insights gained from this TEM study, combined with knowledge obtained from the example 
studies gives a vision for future experiments. These include, the validation binding studies 
of phage to silica; and how the TEM and other microscopy techniques can effectively be 
used to visualize and measure their specific binding quantitatively; what are binding, 
whether the phage displaying the peptides or the phage itself or both and how are they 
binding to silica surfaces. In the end, by comparing the differences in binding to silica by 
phage displaying peptides verses artificially synthesised peptides, could help us in 
understanding the specific binding patterns.  
 
In addition, look at the other reported studies to examine the binding affinity of the phage 
displaying peptide to silica. A few studies have been reported using ELISA and fluorescence 
microscopy. Andrea et al., (2015) used alkaline phosphate linked phage ELISA to assay for 
magnetite nanoparticle binders, after three cycles of panning rounds. With each panning 
round an increase in intensity was detected, which indicated enriching of the phage pool with 
magnetite binding proteins. Results also indicated that a range of binding capabilities were 
present, with two domains groups for lower and higher affinity protein binders364. In another 
study, Serizawa et al., (2005) used phage ELISA to successfully calculate binding affinities 
of selected phage on broad range of synthesis polymers, based on the assumption that 
deposition follows a Langmuir-type adsorption and that each phage concentration present 
identical surface concentration of binding sites. The Langmuir-type adoption model is not 
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suitable for substances with substances with high surface roughness. The binding affinities 
calculated were typically in the range of 1010-1011 436. Studies have also shown that binding 
peptides and phages can also be assessed using fluorescently labelled primary or secondary 
antibodies, and can be analysed using florescence microscopy techniques437,438. As an 
example, Jaworski et al., (2008) used Atto-425-streptavidin to conducted fluorometric 
assays to detect the extent of binding between, biotinylated DNT-binding peptides and its 
alanine-substituted derivatives437.  
 
In this thesis, a few binding studies have been conducted to identify silica-binding peptides. 
However, these studies are not specific as it is unknown which specific residue or amino 
acids in a peptide, are responsible for specific interactions with silica nanoparticle. The 
instruments available currently provide little direct insight into binding mechanisms10. To 
understand adsorption mechanisms, some studies have performed binding assays for mutant 
peptide by making changes in the amino acid sequence. In a study by Patwardhan et al., 
(2012) histidine motifs were replaced with alanine motifs, on a set of two mutants derived 
from pep1 (pep1_6 and pep1_11), to study the interactions and peptide-silica binding. 
Histidine is thought to frequently play a key role in in vitro and in vivo silica binding peptides 
and can form hydrogen bonding with specific functional groups (imidazole, siloxide and 
superficial silanol groups). The adoption of these mutants on the nanoparticle were assessed 
using fluorometric binding assay, changes in zeta potential, and by molecular dynamic 
simulation10. The insights gained from this point mutation study, will be useful in applying 
this knowledge to silica-binding peptide that were identified in this thesis. Few example 
silica binding peptides identified in this study include, LPVRLDW, KIAVIST, YSLKQYQ, 
ADIRHIK and HYIDFRW. 
 
The SiBPs isolated in this study, were eluted using different elution buffers and conditions. 
This knowledge can be used to design and develop material specific elution buffers by 
careful understanding of the material and biomolecule chemistries107,124. Similarly, another 
important factor to consider is the limited fundamental understanding of peptide-material 
interactions which is a major bottle neck for generating peptide based inorganic 
nanomaterials with improved biostability/ compatibility, solubility and functionality and 
increased physico-chemical properties132. In advancing our understanding of peptide mineral 
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interactions a clear understanding of the solution behaviour of both the peptide and the 
material is needed before the interaction of the two can be understood.  
Also, from the adsorption binding results, it was found that the peptides with an amide group 
at the C-terminus showed higher binding specificity to negatively charged silica 
nanoparticles than corresponding carboxyl terminal acid group peptides. This increase in 
amide (NH2) binding activity was mainly due to an increase in overall charge or pI of the 
peptide and is directly proportional to pH change124. Consequently, proving a new dimension 
to design and engineer material specific peptides or phage constructs as a function of charge 
or pI; by targeting the coat proteins pIII and pVIII of M13 bacteriophage either by N-terminal 
and/ or C-terminal fusion. This can help us to mimic the original phage structures for 
developing innovative and advanced biomimetic surfaces for promising applications in 
biomedical and bio-nanotechnology88,416,417,419,441.  
Further, although, online databases are easily available for general organic and inorganic 
materials such as BDB217 or Pep Bank326, no material specific databases have been designed 
for inorganic material binding peptides obtained from distinct classes of combinatorial 
display techniques combined with structural and bioinformatics data. We propose that such 
databases, with all the experimental and computational information relating to the different 
classes of nanomaterials and libraries should be built. These databases will find solutions for 
bias problems and improve our understanding of biomolecule-inorganic material 
interactions which will lead in turn to the development of smart nanomaterials and slowly 
reduce the sole dependence on in vitro display technologies to take this approach forward as 
is presently the case. 
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Appendices 1-8 
Appendix 2.1 
HPLC chromatograms of synthesized silica binding peptides for key binding studies 
 
Figure A1. HPLC chromatograms of synthesized silica binding peptides 
(identified from phage display work) used for binding studies.  The purity of 
LPVRLDW, KIAVIST, GQSEKHL, NDLMNRA and GASESYL peptides was determined as 94.3%, 
93.8%, 95.3%, 80%, and 94.4% respectively.   
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Appendix 2.2 
HPLC chromatograms of synthesized silica binding peptides for key binding studies 
 
Figure A2. HPLC chromatograms of synthesized silica binding peptides 
(identified from phage display work) used for binding studies.  The purity of 
YSLKQYQ-OH, YSLKQYQ-NH2, ADIRHIK-OH, ADIRHIK-NH2, HYIDFRW-OH and HYIDFRW-NH2 
peptides was determined as 93.8%, 92.9%, 94.1%, 97.7%, 77.3% and 72.9% respectively.   
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Appendix 2.3 
Mass spectra (MALDI-TOF/TOF and MS/MS spectrums) of synthesized silica 
binding peptides identified from phage display work and used for key binding studies. 
 
 
Figure A3. Mass spectra of synthesized silica binding peptides (identified from 
phage display work) used for binding studies. The molecular weight of the peptides 
KIAVIST, LPVRLDW and NDLMNRA was measured as 731.41 g/mol, 898.5 g/mol and 833.3 g/mol 
respectively.   
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Figure A3. Mass spectra of synthesized silica binding peptides (identified from 
phage display work) used for binding studies. The molecular weight of the peptides 
GQSEKHL, and GASESYL was measured as 798.41 g/mol and 726.2 g/mol respectively.   
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Appendix 3.1. 
Table A4. Phage titer calculations for relative binding assay (1st time) 
 
Number of 
plaques 
obtaineda 
vol of 
diluted 
phage 
solutionb 
(ml) 
Dilution 
factorc 
bound 
phaged 
(pfu/ml) 
(d=a/b*c)  
Input 
phage 
(pfu/ml) 
Binding ratio 
(bound/input 
*100) 
LPVRLDW 130 0.01 1.0E+04 1.3E+08 2.5E+10 0.52 
GQSEKHL 54 0.01 1.0E+04 5.4E+07 2.5E+10 0.216 
GASESYL 12 0.01 1.0E+04 12000000 2.5E+10 0.048 
NDLMNRA 75 0.01 1.0E+04 7.5E+07 2.5E+10 0.3 
VSRDTPQ  33 0.01 1.0E+04 3.3E+07 2.5E+10 0.132 
KIAVIST 104 0.01 1.0E+04 1.0E+08 2.5E+10 0.416 
HYIDFRW 126 0.01 1.0E+04 1.3E+08 2.5E+10 0.504 
HVPRAMA 37 0.01 1.0E+04 3.7E+07 2.5E+10 0.148 
ELTPLPL 77 0.01 1.0E+04 7.7E+07 2.5E+10 0.308 
QQTNWSL 28 0.01 1.0E+04 2.8E+07 2.5E+10 0.112 
QLAVAPS 19 0.01 1.0E+04 1.9E+07 2.5E+10 0.076 
VGSYLGI 4 0.01 1.0E+04 4.0E+06 2.5E+10 0.016 
GTGSQAS 9 0.01 1.0E+04 9.0E+06 2.5E+10 0.036 
ETALIAA 2 0.01 1.0E+04 2.0E+06 2.5E+10 0.008 
SQTFTSD 13 0.01 1.0E+04 13000000 2.5E+10 0.052 
M13KE 23 0.01 1.0E+03 2300000 2.5E+10 0.0092 
 
Repeat (2
nd
 time) 
 
Number of 
plaques 
obtaineda 
vol of 
diluted 
phageb 
(ml) 
Dilution 
factorc 
bound 
phaged 
(pfu/ml) 
(d=a/b*c)  
Input 
phage 
(pfu/ml) 
Binding 
ratio  
Average 
(1st and 
2nd 
repeats) 
LPVRLDW 123 0.01 1.0E+04 1.2E+08 2.5E+10 0.492 0.506 
GQSEKHL 63 0.01 1.0E+04 6.3E+07 2.5E+10 0.252 0.234 
GASESYL 14 0.01 1.0E+04 14000000 2.5E+10 0.056 0.052 
NDLMNRA 89 0.01 1.0E+04 8.9E+07 2.5E+10 0.356 0.328 
VSRDTPQ  27 0.01 1.0E+04 2.7E+07 2.5E+10 0.108 0.120 
KIAVIST 111 0.01 1.0E+04 1.1E+08 2.5E+10 0.444 0.430 
HYIDFRW 116 0.01 1.0E+04 1.2E+08 2.5E+10 0.464 0.484 
HVPRAMA 46 0.01 1.0E+04 4.6E+07 2.5E+10 0.184 0.166 
ELTPLPL 85 0.01 1.0E+04 8.5E+07 2.5E+10 0.34 0.324 
QQTNWSL 39 0.01 1.0E+04 3.9E+07 2.5E+10 0.156 0.134 
QLAVAPS 26 0.01 1.0E+04 2.6E+07 2.5E+10 0.104 0.090 
VGSYLGI 13 0.01 1.0E+04 1.3E+07 2.5E+10 0.052 0.034 
GTGSQAS 16 0.01 1.0E+04 1.6E+07 2.5E+10 0.064 0.050 
ETALIAA 7 0.01 1.0E+04 7.0E+06 2.5E+10 0.028 0.018 
SQTFTSD 17 0.01 1.0E+04 17000000 2.5E+10 0.068 0.060 
M13KE 13 0.01 1.0E+03 1300000 2.5E+10 0.0052 0.0072 
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Appendix 4.1 
Table A5. Phage titer calculations for relative binding assay  
 
Number 
of plaques 
obtaineda 
vol of 
diluted 
phage 
solutionb 
(ml) 
Dilution 
factorc 
bound 
phaged 
(pfu/ml) 
(d=a/b*c)  
Input 
phage 
(pfu/ml) 
Binding ratio 
(bound/input 
*100) 
SILPVTR 122 0.01 1.0E+04 1.2E+08 2.50E+10 0.492 
ADIRHIK 151 0.01 1.0E+04 1.5E+08 2.50E+10 0.604 
ADARYKS 67 0.01 1.0E+04 67000000 2.50E+10 0.268 
HWNTVVS 55 0.01 1.0E+04 5.5E+07 2.50E+10 0.22 
MPRLPPA 87 0.01 1.0E+04 8.7E+07 2.50E+10 0.348 
YSLKQYQ 148 0.01 1.0E+04 1.5E+08 2.50E+10 0.592 
YNGSANG 29 0.01 1.0E+04 2.9E+07 2.50E+10 0.116 
ANPTFFS 76 0.01 1.0E+04 7.6E+07 2.50E+10 0.304 
SPLHSNY 97 0.01 1.0E+04 9.7E+07 2.50E+10 0.388 
ANEDTGT 79 0.01 1.0E+04 7.9E+07 2.50E+10 0.316 
EGWIQTF 33 0.01 1.0E+04 3.3E+07 2.50E+10 0.132 
LETVVSS 28 0.01 1.0E+04 2.8E+07 2.50E+10 0.112 
ASMNQGG 22 0.01 1.0E+04 2.2E+07 2.50E+10 0.088 
VDTSIFN 18 0.01 1.0E+04 1.8E+07 2.50E+10 0.072 
M13KE 23 0.01 1.0E+03 2300000 2.5E+10 0.0092 
 
Repeat (2
nd
 time)  
 
Number 
of plaques 
obtaineda 
vol of 
diluted 
phageb 
(ml) 
Dilution 
factorc 
bound 
phaged 
(pfu/ml) 
(d=a/b*c)  
Input 
phage 
(pfu/ml) 
Binding 
ratio  
Average 
(1st and 
2nd 
repeats) 
SILPVTR 135 0.01 1.0E+04 1.4E+08 2.50E+10 0.54 0.516 
ADIRHIK 164 0.01 1.0E+04 1.6E+08 2.50E+10 0.656 0.630 
ADARYKS 61 0.01 1.0E+04 61000000 2.50E+10 0.244 0.256 
HWNTVVS 43 0.01 1.0E+04 4.3E+07 2.50E+10 0.172 0.196 
MPRLPPA 92 0.01 1.0E+04 9.2E+07 2.50E+10 0.368 0.358 
YSLKQYQ 136 0.01 1.0E+04 1.4E+08 2.50E+10 0.544 0.568 
YNGSANG 23 0.01 1.0E+04 2.3E+07 2.50E+10 0.092 0.104 
ANPTFFS 66 0.01 1.0E+04 6.6E+07 2.50E+10 0.264 0.284 
SPLHSNY 85 0.01 1.0E+04 8.5E+07 2.50E+10 0.34 0.364 
ANEDTGT 91 0.01 1.0E+04 9.1E+07 2.50E+10 0.364 0.340 
EGWIQTF 26 0.01 1.0E+04 2.6E+07 2.50E+10 0.104 0.118 
LETVVSS 23 0.01 1.0E+04 2.3E+07 2.50E+10 0.092 0.102 
ASMNQGG 28 0.01 1.0E+04 2.8E+07 2.50E+10 0.112 0.100 
VDTSIFN 14 0.01 1.0E+04 1.4E+07 2.50E+10 0.056 0.064 
M13KE 13 0.01 1.0E+03 1300000 2.5E+10 0.0052 0.0072 
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Appendix 4.2 
Table A6: Repanning experimental results to check the optimised biopanning approach and 
reproducibility. Selected silica binders (most frequently observed) were shown in the chapter 
4 and full list of sequences including the additional sequences isolated from Elution strategy 
1 were shwoen here. 
Gly-HCl  
pH-2.2  Freq 
MgCl2 
pH-6.1  Freq 
TEA 
pH-11.1   Freq 
TEA pH-
11.1   
(Repeat) 
Freq 
Most frequently identified silica binders  
TVNFKLY 8/30 VSRDTPQ 12/30 YSLKQYQ 8/30 YSLKQYQ 12/30 
VSRDTPQ 3/30 - - - - - - 
GQSEKHL 2/30 GQSEKHL 6/30 - - - - 
LPVRLDW 1/30 - - - - - - 
GTGSQAS 1/30 - - - - - - 
  TVNFKLY 1/30 - - - - 
  ELTPLPL 1/30 - - - - 
VENVHVR (2/30)  GISDLPS (1/30)  YSFKQYQ (4/30)  YSFKQYQ (5/30)  
YSLKQYQ (2/30)  SPFNRYQ (1/30)  SLSKWSF (2/30)  YNGSANQ  (3/30) 
YNGSANQ (2/30)  ISETRSL (1/30)  GSCSQSQ (1/30)  VENVHVR (1/30)  
FASRSDT (2/30)  YNGSPYQ (1/30)  GLKYTMP (1/30)  SFPLSKY (1/30)  
AIDFARN (1/30)  QSMPQSR (1/30)  TSFEHQP (1/30)  VAPFRLI  
NTADDRK (1/30)  VAPPRFI (1/30)   VHLDSWT  
VPASPWT  (1/30)     TQVLTEA  
IDNSHTH (1/30)     GQGLSLP  
VPNLNMR (1/30)       
 Nil (2/30)   Nil (4/30)   Nil (13/30)  Nil  (4/30)  
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Appendix 4.3 
Table A7: Repanning experimental results to check the optimised biopanning approach and 
reproducibility. Selected silica binders (most frequently observed) were shown in the chapter 
4 and full list of sequences including the additional sequences isolated from Elution strategy 
1 were shwoen here of sequences isolated from Elution strategy 2.  
Gly-HCl  
pH-2.2  
Freq 
Gly-HCl 
pH-7  
Freq 
Gly-HCl 
pH-11    
Freq 
Most frequently identified silica binders 
VSRDTPQ 5/30 VSRDTPQ 6/30 VSRDTPQ 6/30 
TVNFKLY 4/30 TVNFKLY 3/30 TVNFKLY 3/30 
KIAVIST  2/30 - - - - 
HGGVRLY 2/30  - - - - 
GQSEKHL 1/30 GQSEKHL 3/30 GQSEKHL 1/30 
- - YSLKQYQ 3/30 YSLKQYQ 1/30 
- - ELTPLTL 2/30 ELTPLTL 1/30 
LPVRLDW 1/30 LPVRLDW 1/30 - - 
WSLSELH  1/30 - - WSLSELH  1/30 
- - NDLMNRA 1/30 - - 
QQTNWSL 2/30 QQTNWSL 1/30 - - 
FASRSDT 1/30  - - FASRSDT 1/30  
  YNGSANQ 1/30    
  TTQVLEA 1/30  TTQVLEA 1/30  
  VKMESPL 1/30  VKMESPL 1/30  
  SWTALGP 1/30    
  QMHREPA 1/30  QMHREPA 1/30  
QSMPQAR (1/30)  - - ENHVHVR (1/30)  
NQIYSAN (1/30)  - - VENVHVR (1/30)  
STPATLI (1/30)  - - VASHSKP (1/30)  
NAPYRAM (1/30)  - - VAPPRLI (1/30)  
WTTSVGT (1/30)  - - GQGQTIP (1/30)  
TNLSHVP (1/30)  - - DSMSLLQ (1/30)  
VHRDSWT (1/30)  - - AHINVPS (1/30)  
- - VVTPKTA (1/30)  SFNPLAY (1/30)  
Nil (6/30)  Nil (4/30)  Nil (7/30)  
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Appendix 5.1 
 
Figure A8: Peptide calibrations from two different sets of experimental repeats. 
The calibration data plotted for peptides include YSLKQYQ-OH, YSLKQYQ-NH2, ADIRHIK-OH, 
ADIRHIK-NH2, HYIDFRW-OH and HYIDFRW-NH2 at varying known peptide concentrations (0.2-
1.6 mM) in PBS at pH-7.5. The x-axis represents the known amounts of peptide added (mM) and 
the measured absorbance reading was shown in Y-axis. The average R2 (correlation coefficient) 
error (from two different sets of experimental repeats) considered for plotting the peptide 
adsorption isotherms (chapter 5) are shown here. Also, the c and m values used to find the R2 values 
via the equation Y=mx+C are also shown.  
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